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INTRODUCTION
The genus Listeria consists of a group of gram-positive bac-
teria of low G1C content closely related to Bacillus, Clostrid-
ium, Enterococcus, Streptococcus, and Staphylococcus. Listeria
spp. are facultative anaerobic rods of 0.4 by 1 to 1.5 mm that do
not form spores, have no capsule, and are motile at 10 to 25°C
(98, 552, 579). Listeria spp. are isolated from a diversity of
environmental sources, including soil, water, effluents, a large
variety of foods, and the feces of humans and animals. The
natural habitat of these bacteria is thought to be decomposing
plant matter, in which they live as saprophytes. Domesticated
ruminants probably play a key role in the maintenance of
Listeria spp. in the rural environment via a continuous fecal-
oral enrichment cycle (178, 318, 420, 559, 682, 687, 692). The
genus Listeria currently includes six species: L. monocytogenes,
L. ivanovii, L. seeligeri, L. innocua, L. welshimeri, and L. grayi.
Two of these species, L. monocytogenes and L. ivanovii, are
potentially pathogenic. The infectious disease caused by these
bacteria is known as listeriosis. L. monocytogenes causes seri-
ous localized and generalized infections in humans and a va-
riety of other vertebrates, including domesticated and wild
birds and mammals. The official discovery of Listeria microor-
ganisms dates back to 1924, when E. G. D. Murray, R. A.
Webb, and M. B. R. Swann isolated L. monocytogenes as the
etiological agent of a septicemic disease affecting rabbits and
guinea pigs in their laboratory at Cambridge in England (458).
The first cases of human listeriosis were reported in 1929 in
Denmark (481). However, the first recorded culture of L.
monocytogenes dates from 1921, with the bacterium isolated in
France by Dumont and Cotoni from a patient with meningitis
(159, 604). L. ivanovii (formerly known as L. monocytogenes
serotype 5) was first isolated in Bulgaria in 1955 from lambs
with congenital listeriosis (299). Human cases of L. ivanovii
infection are rare (116), the vast majority of reported isolations
of this species being from abortions, stillbirths, and neonatal
septicemias in sheep and cattle (4, 90, 134, 529, 610, 693). A
third species, L. seeligeri, is considered nonpathogenic (555),
although it has been implicated in at least one case of human
listeriosis (556).
For many years, clinical Listeria isolates were a mere labo-
ratory rarity, and the epidemiology of the disease was an un-
resolved mystery (603, 604). However, at the end of the 1970s
and the start of the 1980s, the number of reports on Listeria
isolations begun to increase, and from 1983 onwards, a series
of epidemic outbreaks in humans in North America and Eu-
rope clearly established listeriosis as an important food-borne
infection (46, 180, 386, 421, 572). The foods most frequently
implicated are soft cheeses and dairy products, paˆte´s and sau-
sages, smoked fish, salads, “delicatessen,” and in general in-
dustrially produced, refrigerated ready-to-eat products that are
eaten without cooking or reheating (176, 425–427, 551, 572). In
ruminants, Listeria infection is transmitted by consumption of
spoiled silage, in which these bacteria multiply readily, result-
ing in herd outbreaks (178, 666, 671, 693). Listeria organisms
are widely disseminated in the rural environment and, conse-
quently, contaminate the raw materials used in the preparation
of industrially processed foods and the production plants as
well (237). These bacteria are well equipped to survive food-
processing technologies. For example, they tolerate high con-
centrations of salt and relatively low pHs, and worst of all, they
are able to multiply at refrigeration temperatures (145, 362,
393, 426). This makes Listeria microorganisms a serious threat
to food safety and ranks them among the microorganisms that
most concern the food industry.
Researchers in immunology were interested in L. monocy-
togenes long before its importance as a risk to public health and
food safety was recognized, because an infection highly remi-
niscent of human listeriosis was easily reproducible in labora-
tory rodents and protection could be transferred in syngeneic
mice through spleen cells. Since the pioneering work of Mac-
kaness in the early 1960s, which demonstrated that L. mono-
cytogenes is able to survive and multiply in macrophages, this
bacterium has been used in immunological research as a pro-
totype intracellular parasite (401). For decades, the experi-
mental model of Listeria infection in the mouse has made a
significant contribution to our understanding of the cellular
immune response (615). For example, key concepts such as the
inability of antibodies to protect against infections produced by
intracellular pathogens, the importance of activated macro-
phages in the elimination of intracellular parasites, and that
the T cell is the macrophage-activating element required for
cell-mediated immunity were established based on studies with
the murine model of listeriosis (405, 406, 443, 478, 479).
In addition to the emergence of L. monocytogenes as a major
food-borne pathogen, the 1980s also marked the start of in-
vestigations into the molecular mechanisms underlying Listeria
virulence. The attention of researchers was first drawn to he-
molytic activity, classically considered a virulence marker be-
cause it was present in the pathogenic species but not (with the
exception of L. seeligeri) in the nonpathogenic species. These
studies led between 1986 and 1989 to the discovery of the
hemolysin gene, hly, and to elucidation of the key role that
hemolysin plays in escape from destruction inside phagosomes,
a prerequisite for intracellular bacterial proliferation. So, a
decade ago, hemolysin became not only the first Listeria viru-
lence factor to have its gene characterized, but also the first
bacterial gene product to which a function critical to the sur-
vival of a parasite within the cells of the eukaryote host was
attributed.
L. monocytogenes has since become not only an important
paradigm for immunological investigation but also an impor-
tant model system for analysis of the molecular mechanisms of
intracellular parasitism (107). The identification of the hly gene
was rapidly followed by a succession of discoveries resulting in
complete characterization of the genetic locus to which this
gene maps. This locus is a 9-kb virulence gene cluster that is
involved in functions essential to intracellular survival. The
internalin locus, inlAB, was also identified and characterized at
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this time (193). This locus encodes the first invasin described in
a gram-positive bacterium, implicated in internalization by
cells that are not usually phagocytic, such as epithelial and
endothelial cells and hepatocytes. The progress made in the
molecular characterization of listerial virulence factors during
this period was summarized in a minireview published in 1992
(517). Many advances have since been made that have signif-
icantly increased our understanding of the molecular mecha-
nisms of Listeria intracellular parasitism. The sequencing of the
genomes of L. monocytogenes and L. innocua is currently fin-
ished (European Listeria Genome Consortium, unpublished
data), with the expected outcome that very soon the panorama
of research into the molecular pathogenesis of Listeria spp. will
change dramatically.
The aim of this article is to review the knowledge gathered
during the pregenomic era of Listeria research about the
pathogenesis of listeriosis and the molecular virulence deter-
minants involved. Readers interested more specifically in im-
munopathogenesis and the immune response should consult
reference 497a. Those interested in issues related to taxonomy,
clinical diagnosis and disease management, molecular typing,
epidemiology, ecology, and food safety are also referred to
other publications (145, 176, 289, 395, 550, 551, 573, 594, 605).
For a historical perspective on Listeria spp. and listeriosis, we
recommend the book Listeriosis by the pioneer listeriologist
Heinz P. R. Seeliger (602) and the classical review, “Listeria
monocytogenes and listeric infections,” by Gray and Killinger
(238).
PATHOPHYSIOLOGY OF LISTERIA INFECTION
Clinical Features
The clinical signs of L. monocytogenes infection are very
similar in all susceptible hosts. Two basic forms of presentation
can be distinguished: perinatal listeriosis and listeriosis in the
adult patient. In both instances, the predominant clinical forms
correspond to disseminated infection or to local infection in
the central nervous system (CNS). Listeriosis is usually a very
severe disease—in fact, one of the most deadly bacterial infec-
tions currently known—with a mean mortality rate in humans
of 20 to 30% or higher despite early antibiotic treatment (422,
423, 554, 594).
Fetomaternal and neonatal listeriosis. This form of presen-
tation mainly results from invasion of the fetus via the placenta
and develops as chorioamnionitis. Its consequence is abortion,
usually from 5 months of gestation onwards, or the birth of a
baby or stillborn fetus with generalized infection, a clinical
syndrome known as granulomatosis infantiseptica and charac-
terized by the presence of pyogranulomatous microabscesses
disseminated over the body and a high mortality (336a) (Fig.
1). The infection is usually asymptomatic in the mother or may
present as a mild flu-like syndrome with chills, fatigue, head-
ache, and muscular and joint pain about 2 to 14 days before
miscarriage. Less frequently (10 to 15% of perinatal cases),
late neonatal listeriosis is observed. It generally occurs 1 to 8
weeks postpartum and involves a febrile syndrome accompa-
nied by meningitis and, in some cases, gastroenteritis and
pneumonia. It presumably results from aspiration of contam-
inated maternal exudates during delivery, although hospital-
acquired cases involving horizontal transmission by fomites or
medical personnel in neonatal units have been reported (177,
554, 628). The mortality of late-onset neonatal listeriosis is
lower (10 to 20%), but like early-onset neonatal listeriosis, it
may have sequelae such as hydrocephalus or psychomotor re-
tardation (173). L. monocytogenes is one of the three principal
causes of bacterial meningitis in neonates (391, 554, 594, 645).
Listeriosis in adults. The listerial infection most frequently
reported in nonpregnant adults is that affecting the CNS (55 to
70% of cases). Pure meningeal forms are observed in some
cases, but infection normally develops as a meningoencepha-
litis accompanied by severe changes in consciousness, move-
ment disorders, and, in some cases, paralysis of the cranial
nerves (Fig. 1). The encephalitic form, in which Listeria organ-
isms are isolated with difficulty from the cerebrospinal fluid
(CSF), is common in animals (Fig. 1A to D) but rare in humans
(see below). Its course is usually biphasic, with an initial sub-
febrile phase lasting 3 to 10 days in which there may be head-
ache, vomiting, visual disorders, and general malaise, followed
in a second phase by the onset of severe signs of rhomben-
cephalitis. The mortality rate for CNS infection is around 20%
but may be as high as 40 to 60% if associated with concurrent,
underlying debilitating disease. It has been estimated that L.
monocytogenes accounts for 10% of community-acquired bac-
terial meningitis. Due to effective vaccination against Hae-
mophilus influenzae, L. monocytogenes is now the fourth most
common cause of meningeal infection in adults after Strepto-
coccus pneumoniae, Neisseria meningitidis, and group B strep-
tococci. However, in certain high-risk groups, such as cancer
patients, L. monocytogenes is the most common cause of bac-
terial meningitis (391, 473, 593). Another frequent form of
listeriosis (in some series of patients reported, even more fre-
quent than CNS infection) is bacteremia or septicemia (15 to
50% of cases), with a high mortality rate (up to 70%) if it is
associated with severe underlying debilitating conditions (391)
(see below). There are other atypical clinical forms (5 to 10%
of cases), such as endocarditis (the third most frequent form),
myocarditis, arteritis, pneumonia, pleuritis, hepatitis, colecys-
titis, peritonitis, localized abscesses (e.g., brain abscess, which
accounts for about 10% of CNS infections by Listeria spp.),
arthritis, osteomyelitis, sinusitis, otitis, conjunctivitis, oph-
thalmitis, and, in cows, mastitis (48, 176, 199, 201, 390, 391,
395, 422–424, 550, 628).
An association between clinical episodes of invasive listeri-
osis and a history of gastrointestinal symptoms, including di-
arrhea, vomiting, and fever, was noticed some time ago (286,
542, 599). Investigations of recent food-borne outbreaks have
provided compelling evidence that a febrile gastroenteritis syn-
drome may indeed be the main clinical manifestation of L.
monocytogenes infection (19, 118, 442, 577, 628). The lesson to
be learned from these epidemics is that L. monocytogenes
should be sought as a possible etiologic agent in cases of
diarrheagenic disease in humans. The potential enteropatho-
genicity of L. monocytogenes has also been recognized in ani-
mals, with outbreaks of diarrhea and gastroenteritis having
been reported in sheep (52, 219, 395).
There is also a primary cutaneous form of Listeria infection
characterized by a pyogranulomatous rash. This form occurs
sporadically among farmers and veterinarians and is con-
tracted by direct contact with the genital tract or placenta from
cows having had a miscarriage due to Listeria infection (6, 428).
586 VAZQUEZ-BOLAND ET AL. CLIN. MICROBIOL. REV.
 o
n
 February 18, 2014 by guest
http://cm
r.asm
.org/
D
ow
nloaded from
 
FIG. 1. Clinical and pathological characteristics of Listeria infection in animals and humans. (A to D) Neuromeningeal listeriosis in sheep. (A)
Typical aspect of circling disease, first described by Gill in 1933 in New Zealand (215, 216) and the most characteristic clinical manifestation of
listeriosis in ruminants; the syndrome is characterized by involuntary torticollis and walking aimlessly in circles as a result of brainstem lesions. (B)
In a further step of the infectious process, animals lie on the ground with evident signs of uncoordination (paddling movements) and cranial nerve
paralysis (strabismus, salivation, etc.). (C) Section of the medulla oblongata of a sheep with listerial rhombencephalitis, showing clear inflammatory
lesions in the brain tissue. (D) Microscopic preparation of the brainstem showing extensive parenchymal inflammatory infiltration and typical
perivascular cuffing (one is indicated by an arrowhead) (panels C and D copyright M. Domingo, Barcelona, Spain). (E and F) Stillborn with
generalized L. monocytogenes infection, a clinical condition also known as granulomatosis infantiseptica and characterized by the presence of
military-disseminated pyogranulomatous lesions on the body surface (E) and internal organs (F, liver of the fetus in E) and a high mortality. (G
and H) Extensive pyogranulomatous hepatitis in a lamb experimentally infected with L. ivanovii, with multiple necrotic foci in the liver surface (G)
and the parenchyma (H, hematoxylin/eosin-stained cut from the liver in G, showing two subcapsular pyogranulomes [magnification, 360]).
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Pathogenesis
The pathophysiology of Listeria infection in humans and
animals is still poorly understood. Most of the available infor-
mation is derived from interpretation of epidemiological, clin-
ical, and histopathological findings and observations made in
experimental infections in animals, particularly in the murine
model. As contaminated food is the major source of infection
in both epidemic and sporadic cases (176, 512), the gastroin-
testinal tract is thought to be the primary site of entry of
pathogenic Listeria organisms into the host. The clinical course
of infection usually begins about 20 h after the ingestion of
heavily contaminated food in cases of gastroenteritis (118),
whereas the incubation period for the invasive illness is gen-
erally much longer, around 20 to 30 days (386, 542). Similar
incubation periods have been reported in animals for both
gastroenteric and invasive disease (138, 219, 671).
Ingestion of L. monocytogenes is likely to be a very common
event, given the ubiquitous distribution of these bacteria and
the high frequency of contamination of raw and industrially
processed foods. However, the incidence of human listeriosis is
very low, normally around 2 to 8 sporadic cases annually per
million population in Europe and the United States (176, 301,
554, 649). Higher incidence rates have been reported for spo-
radic listeriosis (for example, 10.9 cases per million population
per year in Barcelona, Spain [476], and 14.7 in France [234]),
but these are exceptional. In epidemic situations, the incidence
in the target population increases by a factor of 3 to 10 (46,
386, 587, 599). Thus, L. monocytogenes seems to have a lower
pathogenic potential than other food-borne pathogens. This is
consistent with the relatively high 50% lethal dose (LD50)
values reported for mice infected experimentally by the oral
(109 [18, 485]) or parenteral (105 to 106 [18, 333, 553]) routes.
The minimum dose required to cause clinical infection in hu-
mans has not been determined, but the large numbers of L.
monocytogenes bacteria detected in foods responsible for epi-
demic and sporadic cases of listeriosis (typically 106) suggest
that it is high. However, these data should be interpreted with
caution, given the long incubation period of invasive listeriosis
and the time normally elapsed between diagnosis and analysis
of the food eaten, during which Listeria organisms can have
multiplied in the patient’s refrigerator. It therefore cannot be
excluded that low doses may be able to cause infection, at least
in immunosuppressed persons, old people, and pregnant
women. Indeed, levels of contamination as low as 102 to 104 L.
monocytogenes cells per g of food have been associated with
listeriosis in humans (176, 425). Obviously, the infectious dose
may vary depending upon the pathogenicity and virulence of
the L. monocytogenes strain involved and the host risk factors.
Pathogenicity of L. monocytogenes. Heterogeneity in the vir-
ulence of L. monocytogenes has been observed in several in
vivo (mice) and in vitro (cell culture) studies (68, 129, 550,
663), but in most cases a clear correlation between the level of
virulence and the origin or type characteristics of the strain
could not be established. However, a recent study has found
statistically significant differences in virulence between strains
of food and clinical origin, the latter having slightly lower lethal
doses (477). On the other hand, there is ample circumstantial
evidence for an association between antigenic composition and
pathogenicity in Listeria spp. The clearest example is provided
by the L. ivanovii-specific serovar 5, which is recovered almost
exclusively from ruminants, especially sheep. In these animals,
serovar 5 strains cause perinatal infections but not encephali-
tis, the most typical clinical manifestations of ovine listeriosis
(134, 397, 606, 610, 693) (Fig. 1A to D). Further evidence
comes from the fact that only 3 of the 12 known serovars of L.
monocytogenes, 1/2a, 1/2b, and 4b, account for more than 90%
of human and animal cases of listeriosis (176, 397, 594), al-
though other serovars, such as 1/2c, are often found as food
contaminants (172, 176). Among the listeriosis-associated se-
rovars, 4b strains cause over 50% of listeriosis cases worldwide,
but strains of antigenic group 1/2 (1/2a, 1/2b, and 1/2c) pre-
dominate in food isolates (52, 172, 550, 557, 591). This suggests
that serovar 4b strains are more adapted to mammalian host
tissues than strains from serogroup 1/2. A phenotypically and
genomically closely related group of serovar 4b isolates was
found to be responsible for major outbreaks of food-borne
human listeriosis in California in 1985 (386), Switzerland from
1983 to 1987 (46), Denmark from 1985 to 1987 (580), and
France in 1992 (233), supporting the notion that some clones
of L. monocytogenes may be particularly pathogenic (302, 510).
A number of observations suggest that there may be differ-
ences in pathogenic tropism between L. monocytogenes’
strains. In humans, for example, serovar 4b strains have been
found to occur more frequently in fetomaternal cases than in
cases not associated with pregnancy (424). In sheep, the two
major clinical forms of L. monocytogenes infection, meningo-
encephalitis and abortion, do not tend to occur simultaneously
in the same flock (13, 397, 671). Molecular epidemiological
evidence for such pathogenic tropism has been presented re-
cently by Wiedman et al. (696). These authors found a corre-
lation between the three serovar-related evolutionary branches
into which L. monocytogenes isolates can be grouped (44, 510,
531, 678) and the pathogenic potential for humans and ani-
mals. Thus, one group of strains (serovars 1/2b and 4b) con-
tained all isolates from human food-borne epidemics and iso-
lates from sporadic cases in humans and animals, another
(serovars 1/2a, 1/2c, and 3a) contained strains from both hu-
man and animal cases but no isolates from human food-borne
epidemics, while a third group (serovar 4a) contained only
animal isolates. A specific ribotype in the first group comprised
all the serovar 4b strains associated with human food-borne
epidemics but less than 10% of the ruminant isolates, suggest-
ing a possible pathogenic tropism for humans (696). This pos-
sible tropism for humans of certain clones of L. monocytogenes
serovar 4b may explain, for example, the observations made in
Scotland, where during the same time period serovar 4b was
most commonly isolated from human cases, whereas most ru-
minant cases were due to serovar 1/2a strains (397). There are
also indications of adaptation to cause a particular clinical
form in L. monocytogenes serovar 4b strains, as deduced from
the analysis of two food-borne outbreaks of human listeriosis
in France in 1992 and 1993, each associated with a different
phage type of this serovar. In these outbreaks, the target pop-
ulation was similar but there was a significant difference in the
percentage of fetomaternal cases (33 versus 80%) (557, 558).
Host risk factors. Host susceptibility plays a major role in
the presentation of clinical disease upon exposure to L. mono-
cytogenes. Thus, most listeriosis patients have a physiological or
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pathological defect that affects T-cell-mediated immunity. This
justifies the classification of L. monocytogenes as an opportu-
nisitic pathogen. The groups at risk for listeriosis are pregnant
women and neonates, the elderly (55 to 60 years and older),
and immunocompromised or debilitated adults with underly-
ing diseases. Listeriosis in nonpregnant adults is associated in
most cases (.75%) with at least one of the following condi-
tions: malignancies (leukemia, lymphoma, or sarcoma) and
antineoplastic chemotherapy, immunosuppresant therapy (or-
gan transplantation or corticosteroid use), chronic liver disease
(cirrhosis or alcoholism), kidney disease, diabetes, and colla-
gen disease (lupus) (176, 423, 551, 554, 594).
Human immunodeficiency virus (HIV) infection is also a
significant risk factor for listeriosis. AIDS is the underlying
predisposing condition in 5 to 20% of listeriosis cases in non-
pregnant adults. It has been estimated that the risk of con-
tracting listeriosis is 300 to 1,000 times higher for AIDS pa-
tients than for the general population. Nevertheless, listeriosis
remains a relatively rare AIDS-associated infection, probably
due to the preventive dietary measures taken by HIV-infected
patients (avoidance of high-risk foods), the antimicrobial treat-
ments that they receive regularly to treat or prevent opportu-
nistic infections, and the fact that HIV infection does not
significantly reduce the activity of the major effectors of im-
munity of Listeria spp. (innate immune mechanisms and the
CD81 T-cell subset [266]) (35, 306, 316, 592).
The health status of the patient greatly influences the out-
come of listeriosis. Immunocompetent patients usually survive
listeriosis, whereas those with underlying debilitating diseases
often succumb to the infection (mean mortality rate for this
group, .30 to 40%) (235, 627). Although most listeriosis cases
are associated with underlying risk factors, there are also a few
adult patients for whom no obvious predisposing condition can
be identified (177, 233, 235). This shows that L. monocytogenes
has the potential to infect immunocompetent individuals. In
some epidemics, all the nonpregnant adult patients had pre-
existing illnesses or immunosuppresive conditions (180, 386),
whereas in others no such predisposing factors were found in
any of the nonperinatal cases (587). This may be due to dif-
ferences in the bacterial load present in the contaminated food
involved or to the degree of virulence of the corresponding
strains of L. monocytogenes.
Entry and colonization of host tissues. (i) Crossing the in-
testinal barrier. Before reaching the intestine, the ingested
Listeria organisms must withstand the adverse environment of
the stomach (Fig. 2). Oral infective doses are lower for cime-
tidine-treated experimental animals than for untreated animals
(586a), and the use of antacids and H2-blocking agents has
been reported to be a risk factor for listeriosis (286, 592). This
indicates that gastric acidity may destroy a significant number
of the Listeria organisms ingested with contaminated food.
There is controversy concerning the point of entry and the
mechanism of intestinal translocation used by L. monocyto-
genes. In an early study by Racz et al. with guinea pigs infected
intragastrically with 1010 L. monocytogenes, detailed histologi-
cal analyses revealed that all the animals developed enteritis
(526). In the initial stages, bacteria were detected mostly in the
absorptive epithelial cells of the apical area of the villi, whereas
in later phases most were inside macrophages of the stroma of
the villi, suggesting that L. monocytogenes penetrates the host
by invading the intestinal epithelium (526). This is consistent
with the observation that L. monocytogenes is able to penetrate
the apical surface of polarized, differentiated human entero-
cyte-like Caco-2 cells with a brush border (322) (see Fig. 3B
and C). In other studies using mice inoculated per os with 108
to 109 bacteria, no invasion of the intestinal villous epithelium
was observed; instead, there was colonization of the Peyer’s
patches (400, 410, 411), suggesting that L. monocytogenes uses
the M-cell epithelium as an entry portal, as reported for other
bacterial pathogens (623). Direct evidence that L. monocyto-
genes may indeed penetrate the host via the M cells overlying
the Peyer’s patches has been provided by a recent study using
a murine ligated-loop model and scanning electron microscopy
(308). However, listerial penetration at this level appears not
FIG. 2. Schematic representation of the pathophysiology of Listeria infection. See text for details.
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to be very efficient, because only small numbers of bacteria are
observed in association with the follicle-associated epithelium
overlying Peyer’s patches (411).
Intestinal translocation of pathogenic listeriae occurs with-
out the formation of gross macroscopic or histological lesions
in the gut of mice (411). This suggests that an epithelial phase
involving bacterial multiplication in the intestinal mucosa is
not required by L. monocytogenes for systemic infection. In-
deed, a recent study using a rat ileal loop model of intestinal
infection (523) has shown that Listeria organisms are translo-
cated to deep organs very rapidly (within a few minutes), dem-
onstrating that crossing of the intestinal barrier occurs in the
absence of prior intraepithelial replication. This study also
showed that defined mutants defective in virulence factors
known to be involved in epithelial cell invasion (InlA and
InlB), intracellular survival (Hly), and cell-to-cell spread
(ActA) (see below), and even the nonpathogenic species L.
innocua, translocated at the same rate as wild-type L. mono-
cytogenes. Translocation was dose dependent, and the presence
of Peyer’s patches in ligated loops did not affect the rate of
translocation, levels of uptake being similarly low for Peyer’s
patches and villous intestine (50 to 250 bacteria per cm2 of
tissue after inoculation of the loop with 109 bacteria) (523).
These findings favor the view that listerial translocation is a
passive, nonspecific process similar to that observed for other
bacteria (36), at least in mice and rats. However, L. monocy-
togenes proliferated in the intestinal wall, whereas L. innocua
did not. The preferential site for bacterial replication was the
Peyer’s patches, and the essential listerial virulence factor Hly
(hemolysin) was indispensable for this process, showing that L.
monocytogenes establishes an active local infection in these
lymphoid structures of the intestine. The foci of infection
consisted of pyogranulomatous reactions in the subepithelial
follicular tissue, with bacteria visible inside permissive mono-
nuclear cells, presumably nonactivated resident macrophages
and dendritic cells (522a, 523). Thus, antigen presentation
events probably already take place in the intestine during the
early phases of host colonization, and this may play an impor-
tant role in the acquired resistance to subsequent reinfection
that develops after primary oral exposure to L. monocytogenes
(394, 400). A recent study has shown that invasion of intestinal
epithelial cells by L. monocytogenes induces the activation of
NF-kB and the subsequent upregulation of interleukin-15 (IL-
15), and that at early stages of an oral infection with L. mono-
cytogenes in mice and rats, intestinal intraepithelial lympho-
cytes become activated and produce Th1-type cytokines. This
suggests that the interaction between intestinal epithelial and
lymphoid cells may be relevant in the local host defence against
listerial infection in the gut (706).
Experimental observations made with the mouse and rat
models of intestinal translocation do not, however, explain how
L. monocytogenes causes enteritis. The association of gastro-
enteric symptoms with fever is consistent with invasive intesti-
nal disease, as observed by Racz in the guinea pig model (526).
Pathogenic Listeria organisms pass directly from cell to cell by
a mechanism involving host cell actin polymerization (see be-
low). Therefore, regardless of the mechanism of entry used,
the bacteria that penetrate the intestinal wall might then in-
vade neighboring enterocytes by basolateral spread, leading to
enteritis. This is consistent with in vitro experimental data
showing that L. monocytogenes enters polarized Caco-2 cells
predominantly via the basolateral surface (196). Gross intesti-
nal lesions develop in experimental animals only if large oral
doses of L. monocytogenes are given (400, 523). Similarly, ep-
isodes of listerial gastroenteritis in humans occur in the form of
outbreaks with very short incubation periods and high attack
rates among immunocompetent adults (118, 577), consistent
with the ingestion of a very high dose of bacteria (as high as
2.9 3 1011, as estimated for one of these oubreaks, caused by
the consumption of heavily contaminated chocolate milk
[118]). Thus, intestinal invasion and the ensuing febrile gastro-
enteritis syndrome probably result from extensive exposure of
the intestine to pathogenic Listeria organisms. However, the
possibility that some L. monocytogenes strains have a greater
enteropathogenic potential and cause intestinal damage at a
lower dose cannot be ruled out.
(ii) Multiplication in the liver. The Listeria organisms that
cross the intestinal barrier are carried by the lymph or blood to
the mesenteric lymph nodes, the spleen, and the liver (411,
523) (Fig. 2). As stated above, this initial step of host tissue
colonization by L. monocytogenes is rapid. The unusually long
incubation period required by L. monocytogenes for the devel-
opment of symptomatic systemic infection after oral exposure
in relation to that for other food-borne pathogens is therefore
puzzling and indicates that listerial colonization of host tissues
involves a silent, subclinical phase, many of the events and
underlying mechanisms of which are unknown.
Experimental infections of mice via the intravenous route
have shown that L. monocytogenes bacteria are rapidly cleared
from the bloodstream by resident macrophages in the spleen
and liver (99, 112a, 405). Most (90%) of the bacterial load
accumulates in the liver, presumably captured by the Kupffer
cells that line the sinusoids. These resident macrophages kill
most of the ingested bacteria, as shown by in vivo depletion
experiments (161), resulting in a decrease in the size of the
viable bacterial population in the liver during the first 6 h after
infection. Kupffer cells are believed to initiate the development
of antilisterial immunity by inducing the antigen-dependent
proliferation of T lymphocytes and the secretion of cytokines
(243). Not all Listeria cells are destroyed by tissue macro-
phages, and the surviving bacteria start to grow, increasing in
numbers for 2 to 5 days in mouse organs (93, 99, 128, 181, 381,
408, 448).
The principal site of bacterial multiplication in the liver is
the hepatocyte (100, 112a, 197, 241, 241a, 563). This finding
has led to the dismissal of the long-held idea that the major
host niche for the parasitic life of L. monocytogenes is the
macrophage population. There are two possible ways for L.
monocytogenes to gain access to the liver parenchyma after its
intestinal translocation and carriage by the portal or arterial
bloodstream: via Kupffer cells, by cell to cell spread, or by the
direct invasion of hepatocytes from the Disse space after cross-
ing the fenestrated endothelial barrier lining the sinusoids. L.
monocytogenes has been shown to efficiently invade hepato-
cytes in vitro (149, 701).
Electron microscopy of hepatic tissue from infected mice
suggests that L. monocytogenes goes through the complete
intracellular infectious cycle in hepatocytes (197, 621), includ-
ing actin-based intercellular spread (see below). Direct passage
from hepatocyte to hepatocyte would lead to the formation of
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infectious foci in which L. monocytogenes disseminates through
the liver parenchyma without coming into contact with the
humoral effectors of the immune system. This may explain why
antibodies play no major role in anti-Listeria immunity (516).
During the early steps of liver colonization, polymorphonu-
clear neutrophils are recruited at the sites of infection, forming
discrete microabscesses. Neutrophils have been shown to play
an important role in controlling the acute phase of Listeria
infection (561) and in mediating the destruction of Listeria-
infected hepatocytes in vivo (99). Hepatocytes respond to Lis-
teria infection by releasing neutrophil chemoattractants and
exhibiting an increase in adhesion to neutrophils, resulting in
microabscess formation (560). They also respond by initiating
an apoptosis program that may be critical for removing Liste-
ria-infected cells from the liver tissue at early stages of infec-
tion (448a, 560). Using transgenic mice expressing a degrada-
tion-resistant IkB transgene, it has been shown recently that
NF-kB activation in mouse hepatocytes is essential to clear L.
monocytogenes from the liver, possibly by coordinating local
innate immune response (368). Two to four days after infec-
tion, neutrophils are gradually replaced by blood-derived
mononuclear cells together with lymphocytes to form the char-
acteristic granulomas (283, 408) (Fig. 1G and H). These gran-
ulomas are the histomorphological correlate of cell-mediated
immunity and presumably act as true physical barriers that
confine the infectious foci, impeding further bacterial dissem-
ination by direct cell-to-cell passage (516).
Between days 5 and 7 postinfection, L. monocytogenes bac-
teria start to disappear from mouse organs until their complete
clearance as a result of gamma interferon (IFN-g)-mediated
macrophage activation and the induction of an acquired im-
mune response primarily mediated by CD81 lymphocytes,
which together destroy Listeria-infected cells (241a, 268, 328,
441). These cytotoxic T lymphocytes (CTL) are directed
against listerial epitopes present in secreted virulence-associ-
ated proteins, such as Hly (59, 71, 266, 281, 625, 677), the
metalloprotease Mpl (79), and the surface protein p60 (203,
204, 267, 624), and possibly also in somatic housekeeping pro-
teins such as superoxide dismutase (280). Protection against L.
monocytogenes also involves a vigorous Th1-biased CD41 T-
cell response (125, 203) and innate mechanisms such as the
activation of IFN-g-producing natural killer (NK) cells in re-
sponse to IL-12 and tumor necrosis factor alpha (TNF-a) se-
cretion by infected macrophages (125, 166, 268, 290). Hepato-
cytes may contribute to protection by becoming less permissive
to intracellular proliferation of Listeria organisms upon expo-
sure to IFN-g (244), especially if costimulated with other cy-
tokines (646).
The above course of events is accelerated in immune ani-
mals, resulting in rapid elimination of L. monocytogenes from
the liver (Fig. 2). This is probably the most common outcome
of L. monocytogenes infection in humans and animals in nor-
mal conditions, given the potentially high frequency of expo-
sure to the pathogen via contaminated food and the relatively
rare occurrence of clinical disease. Indeed, T lymphocytes di-
rected against Listeria antigens are commonly found in healthy
individuals (457), probably due to chronic stimulation of the
immune system by L. monocytogenes antigens that are presum-
ably continuously delivered to the immune system via food. A
recent study has shown that the nonpathogenic species L. in-
nocua can enhance a previously established L. monocytogenes-
specific T-cell memory via recognition of cross-reactive p60
epitopes shared by the two species (204). L. innocua is com-
monly found in food (573), and as stated above, it is translo-
cated to the deep organs of mice as efficiently as L. monocy-
togenes. Therefore, repeated contact with L. innocua may boost
protective immunity against pathogenic Listeria spp., possibly
explaining in part the rare occurrence of listeriosis in the gen-
eral population.
If the infection is not controlled by an adequate immune
response in the liver, as may occur in immunocompromised
individuals, unlimited proliferation of L. monocytogenes in the
liver parenchyma may result in the release of bacteria into the
circulation (Fig. 2). L. monocytogenes is a multisystemic patho-
gen that can infect a wide range of host tissues, as indicated by
its capacity to cause septicemia involving multiple organs and
by the variety of potential sites of localized Listeria infection
(see above). However, the principal clinical forms of listeriosis
clearly show that L. monocytogenes has a pathogenic tropism
towards the gravid uterus and the CNS (Fig. 2).
(iii) Colonization of gravid uterus and fetus. Abortion and
stillbirth due to Listeria spp. have been reproduced experimen-
tally by intravenous, oral, and respiratory inoculation in natu-
rally susceptible gestating animal hosts, such as sheep, cattle,
rabbits, and guinea pigs, as well in pregnant mice and rats (1,
238, 239, 329, 450, 487, 488, 586). This shows that L. monocy-
togenes gains access to the fetus by hematogenous penetration
of the placental barrier (Fig. 2). In pregnant mice, the blood-
borne bacteria first invade the decidua basalis and then
progress to the placental villi, where they cause diffuse inflam-
matory infiltration and necrosis (1, 535, 536). Macrophages
appear to be excluded from the murine placenta, neutrophils
acting as the main antilisterial effector cell population (251a).
Using homozygous mutant mice, it has been shown recently
that colony-stimulating factor-1 is required for the recruitment
of neutrophils to the infectious foci in the decidua basalis. This
occurs via induction of neutrophil chemoattractant synthesis by
the trophoblast (251a). In humans, placental infection is char-
acterized by numerous microabscesses and focal necrotizing
villitis (502, 582). Colonization of the trophoblast layer fol-
lowed by translocation across the endothelial barrier would
enable the bacteria to reach the fetal bloodstream, leading to
generalized infection and subsequent death of the fetus in
utero or to premature birth of a severely infected neonate with
miliary pyogranulomatous lesions (the above-mentioned gran-
ulomatosis infantiseptica) (Fig. 1E and F).
The depression of cell-mediated immunity during pregnancy
(686) presumably plays an important role in the development
of listeriosis. In laboratory rodents, pregnancy reduces resis-
tance to L. monocytogenes (58, 399) and significantly prolongs
the course of primary infection in the liver (1). The T-cell-
dependent elimination of L. monocytogenes from the organs of
pregnant mice is delayed in late pregnancy. This correlates
with a failure in the production of IFN-g and results in listerial
invasion of placental and fetal tissues (463). Abnormally high
physiological levels of estrogenic hormones, such as those that
occur during late pregnancy, may account for the disruption of
T-cell-mediated resistance to infection, as treatment of mice
with steroids inhibits the proliferative response to L. monocy-
togenes of splenic T cells and increases susceptibility to Listeria
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infection (524). This correlates with a decrease in the produc-
tion of IL-2 (524), a cytokine that stimulates resistance to
Listeria spp. in mice (255). The intracellular killing function of
macrophages has also been shown to be decreased by b-estra-
diol, which is associated with inhibition of both IL-12 and
TNF-a secretion in vivo (578). Local depression in the cellular
immune response in the placenta, which physiologically is im-
portant for preventing rejection of the fetus, may also contrib-
ute to the higher susceptibility to uterine infection by L. mono-
cytogenes (398, 535, 536). It is not known why mothers suffering
Listeria-induced miscarriage never develop CNS infection or
overt septicemic disease.
(iv) Invasion of the brain. In humans, CNS infection by
Listeria spp. presents primarily in the form of meningitis. This
meningitis, however, is often associated with the presence of
infectious foci in the brain parenchyma, especially in the brain
stem (391, 473), suggesting L. monocytogenes has a tropism for
nerve tissue. The neurotropism and special predilection of L.
monocytogenes for the rhombencephalon are shown most
clearly in ruminants, in which listerial CNS infection, in con-
trast to the situation in humans, develops mainly as primary
encephalitis. In these animals, infectious foci are restricted to
the pons, medulla oblongata, and spinal cord (Fig. 1C). Al-
though there is inflammatory lymphocyte or mononuclear cell
infiltration of the meninges, this condition occurs as an exten-
sion of the brain process, and macroscopic lesions may not
even be evident or may be restricted to basal areas, midbrain,
and cerebellum. Unilateral cranial nerve paralysis is a charac-
teristic of listerial rhombencephalitis in ruminants, leading to
the well-known circling disease syndrome (92, 103, 215, 216,
312, 534, 666, 693) (Fig. 1A and B). In humans, primary non-
meningeal brain infection is seldom observed. However, as in
ruminants, it develops as cerebritis involving the rhomben-
cephalon (15, 20, 69, 390, 391, 473).
Brain lesions in listerial meningoencephalitis are typical and
very similar in humans and animals. They consist of perivas-
cular cuffs of inflammatory infiltrates composed of mononu-
clear cells and scattered neutrophils and lymphocytes (Fig.
1D). Bacteria are generally absent from these perivascular
areas of inflammation. Parenchymal microabscesses and foci of
necrosis and malacia are also typically present (Fig. 1D). Bac-
teria are relatively abundant in these lesions, within phagocytes
or free in the brain parenchyma around the necrotic areas (92,
103, 312, 315, 412, 489). Depletion experiments in mice using
a neutrophil-specific monoclonal antibody have shown that
neutrophils play a critical role in eliminating L. monocytogenes
from infectious foci in the brain (389a). Less commonly, bac-
teria are observed within neurons in both natural (412, 489)
and experimentally induced (588) infections. This is consistent
with in vitro data showing that the invasion of cultured neurons
is a relatively rare event (151, 505). However, neurons are
efficiently invaded in vitro by direct cell-to-cell spread from
infected macrophages or microgial cells (151). A recent study
(146) has shown that L. monocytogenes can efficiently invade
sensory neurons of rat dorsal root ganglia but not hippocampal
neurons, suggesting that there may be differences in the sus-
ceptibility to infection among different types of neurons. The
relevance of neuronal invasion to the pathogenesis of Listeria
encephalitis is subject to speculation, as discussed below.
The mechanisms by which L. monocytogenes infects the CNS
are still largely unknown. Numerous attempts have been made
to reproduce listerial meningoencephalitis in susceptible ani-
mal hosts and laboratory rodents using various routes of inoc-
ulation, with variable success. Intravenous delivery of the in-
oculum does not usually result in CNS infection in sheep (103).
This, and the usual absence of visceral involvement in natural
cases of ovine listerial encephalitis, seems to argue against a
hematogenous route of infection. The topographic distribution
of the lesions in sheep, strictly confined to the brainstem, and
the frequent unilateral involvement of the trigeminal nerve,
with neuritis affecting distal portions of a single or a few fas-
ciculi in only one of the nerve branches, led to the hypothesis
that L. monocytogenes invades the brain by centripetal migra-
tion along cranial nerves (17, 92, 661). To test this hypothesis,
Asahi and coworkers (17) scarified oral, nasal, and labial mu-
cosae of mice with L. monocytogenes. Most mice developed
neurological signs, such as torticollis, rolling movements, and
paralysis of the hindlegs, 5 days after infection. These signs
correlated with the presence of mononuclear and round cell
infiltrations along the trigeminal nerve, in the corresponding
nerve ganglion, and in the medulla oblongata, suggesting ret-
rograde bacterial ascension along the cranial nerve to the
brainstem. In another experiment, 4 of 11 goats inoculated in
the lip developed listerial encephalitis 17 to 28 days after in-
oculation, with microscopic lesions identical to those found in
natural cases of listeriosis, with ganglioneuritis of the trigem-
inal nerve (17). In spontaneous cases of ovine listerial en-
cephalits, bacteria have been observed in linear arrays in indi-
vidual nerve fibers, inside axons, and with actin tails (91, 92,
489), suggesting active intra-axonal movement. Experiments
using a double-chamber cell culture system and dorsal root
ganglia neurons provided evidence that L. monocytogenes can
infect axons and spread along them towards the nerve cell body
(146).
Experimental evidence has been obtained that intra-axonal
bacterial transport may indeed occur in vivo. Otter and Blake-
more (489) developed a mouse model in which L. monocyto-
genes was injected distally into the sciatic nerve. Paralysis of the
leg into which the bacteria were injected occurred 7 to 12 days
later, and examination of the spinal cord revealed lesions very
similar to those found in the brains of naturally affected sheep.
Bacteria were seen in these lesions in neutrophils and, in some
cases, in axons (489). The feasibility of ascending intra-axonal
transport via the termini of the trigeminal nerve was tested by
experimentally injecting L. monocytogenes directly into the
dental pulp of sheep through a hole drilled in the tooth crown
(22). Six of 21 sheep developed neurological signs 20 to 40 days
after challenge, and most animals showed histological enceph-
alitis and trigeminal ganglioneuritis on the side of inoculation.
These observations favor the view that L. monocytogenes may
directly invade exposed sensory terminal ramifications of the
cranial nerve in the mouth and reach the brain by centripetal
spread. They also demonstrate that cases of mild CNS invasion
by Listeria organisms may occur without overt clinical signs.
This is important because it provides one possible explanation
for the relatively small number of cases with neurological man-
ifestations that are observed among animals exposed to con-
taminated silage in a herd affected by listerial encephalitis
(and, by extension, to humans exposed to Listeria-contami-
nated food). However, in another study in which brains from
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natural cases of sheep with meningoencephalitis were ana-
lyzed, inflammatory infiltration was observed only in the intra-
cranial portion of the trigeminal tract, always associated with
meningitis adjacent to proximal parts of cranial nerves. The
authors were of the opinion that cranial nerve invasion was
only secondary to a hematogenous brain infection and oc-
curred by centrifugal spread from the brainstem (103). The
above-mentioned experiments with the two-chamber model
(146) suggested that both retrograde and anterograde trans-
port of L. monocytogenes may occur inside infected neurons.
Although intravenous inoculation only occasionally gives
positive results, intracarotid inoculation consistently results in
encephalitis in sheep (103, 314, 486). This supports the notion
that L. monocytogtenes may indeed reach the brain via the
blood. Strong evidence that meningoencephalitis in ruminants
has a vascular basis is provided by the nature of the brain
lesions themselves, with extensive perivascular infiltrates and
mononuclear microabscesses and necrotic foci developing in
close proximity to brain capillaries (103) (Fig. 1D). In contrast
to intravenous inoculation, intracarotid delivery provides the
inoculum direct access to the vascular system of the brain,
enabling bacteria to bypass the clearance mechanisms of or-
gans such as the spleen and liver. In an immunocompetent
host, these clearance mechanisms should be sufficient to elim-
inate rapidly a single-dose intravenous inoculum, preventing
the bacteria from invading the brain. Intracarotid inoculation
in sheep causes CNS lesions involving the choroid plexus and
the ependyma of the cerebral ventricles and aqueduct, result-
ing in primary meningitis and secondary lesions in the adjoin-
ing cerebral tissues (17). These brain structures are only rarely
affected in natural cases of listerial meningoencephalitis in
ruminants (103). The reason for these differences between
natural and experimental lesion patterns probably resides in
the concentration of bacteria in the blood, as this is an impor-
tant factor affecting the mode by which bacterial pathogens
gain access to the CNS (659, 660). This concentration would
reach an extraordinarily high peak in the brain after intraca-
rotid delivery, and high-grade bacteremia is more likely to
cause meningitis due to massive bacterial penetration across
the epithelium lining the choroid plexus, which has an excep-
tionally high rate of blood flow. In contrast, low-grade bacte-
remia, such as that resulting from the release of bacteria into
the blood from infectious foci located in distant organs (e.g.,
the liver), tends to be associated with multiple foci in the brain
parenchyma due to individual penetrations along the extensive
microvascular endothelial bed (660).
Experimental infections in small laboratory animals also
provide evidence for a hematogenous route of CNS invasion
for L. monocytogenes. Intravenous inoculation in mice results
in meningoencephalitis in a significant proportion of animals
that survive the initial systemic phase of infection. Lesions
include choroiditis, meningitis, and the characteristic perivas-
cular cuffing and parenchymal pyogranulomatous foci in the
brainstem (31, 103). No brain invasion is detected in mice
challenged with low infective doses that induce only transient
bacteremia, even if there is significant bacterial multiplication
in the spleen and liver. However, brain invasion is achieved
with high infective doses causing severe systemic disease and
prolonged bacteremia (31). This suggests that the persistence
of large numbers of bacteria in the blood is essential for the
induction of meningoencephalitis by L. monocytogenes. This
conclusion is consistent with a recent study by Blanot and
coworkers (47), who adapted a model of otitis media in gerbils
to study listerial CNS invasion. With a low infective dose of L.
monocytogenes (103/ear), these authors induced persistent low-
level bacteremia (102 bacteria/ml) which was associated with
the development of rhombencephalitis in gerbils mimicking
that observed during human listerial meningoencephalitis, with
leptomeningitis, parenchymal foci, and perivascular sheaths.
The number of bacteria in the liver and spleen of gerbils
decreased by day 5 postinoculation, but growth in brain tissue
was unrestricted (47), suggesting that nerve tissue is a privi-
leged niche for the multiplication of L. monocytogenes. CNS
invasion was also regularly observed in mice after oral or sub-
cutaneous inoculation (9, 17, 522). These infection routes im-
ply systemic involvement and, clearly, also lymphohematog-
enous dissemination of bacteria to the brain.
In experiments with orally or subcutaneously infected mice,
parenchymal brain lesions are irregularly observed, but
marked inflammatory lesions in the meninges and ventricular
system (choroid plexus, lateral, third and fourth ventricles, and
aqueduct) are consistently recorded (9, 522). This striking af-
finity of L. monocytogenes for mouse ventricular structures was
also noted after direct intracerebral inoculation (588), which
prevents primary blood-borne exposure of the ependyma via
the choroid plexus. In contrast, no involvement of the ventric-
ular system was noticed in the gerbil model (47). These obser-
vations suggest that there may be anatomical and physiological
differences in the brains of the various animal species that
affect L. monocytogenes neuropathogenesis. Indeed, this may
account for the differential characteristics of listerial CNS in-
fection in humans and ruminants. However, it cannot be ex-
cluded that the peculiar characteristics of listerial meningoen-
cephalitis in ruminants result from the fact that an alternative
primary nonvascular mechanism of CNS invasion, which may
perfectly coexist with hematogenous dissemination, has specif-
ically evolved in these animals. Ruminants eat plant material,
the physical characteristics of which may lead to small breaches
of the oral mucosa. If animals are fed contaminated silage,
these small wounds are repeatedly exposed to L. monocyto-
genes during rumination, favoring invasion of the trigeminal
nerve terminals and subsequent intraneural, direct spread to
the brain stem.
Bacterial pathogens such as H. influenzae, N. meningitidis, S.
pneumoniae, and Streptococcus suis cross the blood-brain bar-
rier (BBB) primarily via the choroid plexus. This enables them
to reach the CSF and create purulent meningitis by spreading
through the subarachnoid space (525, 659, 660, 697). Although
in human listerial infections of the CNS, purulent meningitis
also occurs and bacteria may also be detected in the CSF, it is
clear that L. monocytogenes, unlike other meningitis-causing
bacterial pathogens, tends to affect brain parenchymal tissue.
This may reflect a tropism for the microvascular endothelium,
in particular that lining the capillary bed of the rhombenceph-
alon, resulting in significant or preferential (in ruminants)
crossing of the BBB at this point. Direct uptake by endothelial
cells of bacteria circulating free in the blood is one possible
mechanism by which L. monocytogenes may cross the micro-
vascular BBB. Evidence for this mechanism is provided by an
electron microscopic study of human brainstem tissue, in which
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bacteria have been observed within endothelial cells or adher-
ing to the luminal face of the microvascular endothelium (335).
This mechanism is also consistent with in vitro data showing
that L. monocytogenes is able to invade cultured human brain
microvascular endothelial cells (BMEC) (245, 246). The liste-
rial surface protein InlB, of the internalin family (see below),
has been shown to be required for invasion of endothelial cells
in vitro (246, 498), indicating that specific bacterial molecules
are actively involved in the interaction with the BBB. L. mono-
cytogenes efficiently replicates for long periods of time within
brain microvascular cells without causing any evident damage,
creating heavily infected foci from which bacteria spread to
neighboring cells by actin-based motility (246). In this way, L.
monocytogenes may reach and disseminate easily into the pro-
tected spaces of the CNS.
L. monocytogenes infection induces a potent response in
cultured endothelial cells which is accompanied by the upregu-
lation of endothelial adhesion molecules (P- and E-selectin,
ICAM-1, and VCAM-1) (see below), leading to an increase in
the binding of polymorphonuclear leukocytes to infected en-
dothelial cells (152, 247, 330, 600, 618). Heterologous plaque
assays using infected macrophages as vectors have demon-
strated that L. monocytogenes can spread efficiently from mac-
rophages into endothelial cells (157, 246). Therefore, the re-
cruitment of phagocytes to the infected endothelium, primarily
a host defense response, may also be used by L. monocytogenes,
in addition to direct invasion, to cross the BBB. Evidence for
a significant role in vivo for such a Trojan horse mechanism of
CNS invasion, presumably involving direct bacterial cell-to-cell
spread from infected phagocytes carried by the blood after
adhesion to endothelial cells, has been provided recently by
Drevets (154). This author showed that phagocyte-associated
L. monocytogenes accounted for 30% of the total bacterial
population circulating in the bloodstream after intravenous
inoculation. These entrapped bacteria spread to endothelial
cells in vitro, and Listeria-infected peripheral blood leukocytes
successfully established brain colonization in vivo (154). It is
unknown whether trafficking of infected phagocytes across the
BBB, as part of the inflammatory influx induced by endothelial
and underlying brain tissue infection, occurs in vivo during
CNS invasion by L. monocytogenes.
Hypothetical scenario. From the information presented
above, the following hypothetical scenario for the pathogenesis
of listeriosis can be proposed. Clinical outcome of Listeria
infection depends on three major variables: (i) the number of
bacteria ingested with food, (ii) the pathogenic properties of
the strain, and (iii) the immunological status of the host. In
immunocompetent individuals with no predisposing condi-
tions, ingestion of low doses of L. monocytogenes will probably
have no effect other than the development or boosting of
antilisterial protective immunity. In contrast, oral exposure to
large doses is likely to result in an episode of gastroenteritis
and fever and, depending on the virulence of the strain, pos-
sible invasive disease. Immunocompromised and debilitated
individuals, however, cannot mount an immune response
strong enough to control bacterial proliferation in the liver, the
primary target organ of L. monocytogenes, and are therefore
susceptible to invasive disease following the ingestion of a
lower inoculum. Inefficiently restricted growth of L. monocy-
togenes in the hepatocytes in these individuals is likely to result
in an increase in the critical mass of bacteria and their release
into the bloodstream. The ensuing prolonged bacteremia will
result in local infections in secondary target organs (particu-
larly the brain and placenta) or in septicemic disease in se-
verely immunocompromised hosts. Figure 2 summarizes the
key steps of the pathophysiology of Listeria infection.
INTRACELLULAR INFECTIOUS CYCLE
In addition to multiplying within macrophages, Listeria or-
ganisms are invasive pathogens that can induce their own in-
ternalization in various types of cell that are not normally
phagocytic. These include epithelial cells (194, 435, 518), fi-
broblasts (359, 641), hepatocytes (149, 242, 701), endothelial
cells (157, 245, 498), and various types of nerve cell, including
neurons (151). Listeria organisms have been also shown to be
taken up by and survive within dentritic cells (253, 345). In the
interior of all cells that L. monocytogenes is able to penetrate,
whether macrophages or nonprofessional phagocytes, it devel-
ops an intracellular life cycle with common characteristics (Fig. 3).
Internalization
The cycle begins with adhesion to the surface of the eu-
karyote cell and subsequent penetration of the bacterium into
the host cell. The invasion of nonphagocytic cells involves a
zipper-type mechanism, in that the bacterium gradually sinks
into diplike structures of the host cell surface until it is finally
engulfed. During this process, the target cell membrane closely
surrounds the bacterial cell and does not form the spectacular
local processes or membrane ruffles characteristic of invasion
by Salmonella and Shigella spp. (147, 322, 358, 435, 642) (Fig.
3B and C). The structures, mechanisms, and signal transduc-
tion cascades involved in the interaction between the bacte-
rium and the cell during phagocytosis are only beginning to be
elucidated.
The multisystemic nature of listerial infection indicates that
L. monocytogenes probably recognizes a number of different
eukaryotic receptors. The C3bi and C1q complement receptors
have been reported to be involved in L. monocytogenes uptake
by phagocytic cells (10, 115, 155, 156). L. monocytogenes is also
efficiently internalized in the absence of serum, indicating that
nonopsonic receptor-ligand interactions are also involved in
host cell recognition by Listeria spp. (509). The eukaryote cell
receptors used by Listeria spp. include the transmembrane
glycoprotein E-cadherin (435), the C1q complement fraction
receptor (61), the Met receptor for hepatocyte growth factor
(HGF) (615a), and components of the extracellular matrix
(ECM) such as heparan sulfate proteoglycans (HSPG) (12)
and fibronectin (217). The macrophage scavenger receptor was
shown to bind L. monocytogenes lipoteichoic acids and hence
may also be involved in Listeria-macrophage interactions (160,
240). The bacterial ligands identified to date are all surface
proteins, such as the internalins InlA and InlB, the actin-
polymerizing protein ActA, and p60 (see below). Recently,
several putative adhesion factors of L. monocytogenes have
been identified by screening transposon mutants for defective
attachment to eukaryotic cells. Among these putative adhesins
are the surface protein Ami, an autolysin with a C-terminal
cell wall-anchoring domain similar to InlB (60, 429, 445) (see
below), and Lap, a 104-kDa surface protein involved in attach-
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ment to Caco-2 cells (581a). Also recently, a 24.6-kDa fi-
bronectin-binding protein has been identified in L. monocyto-
genes by screening a genomic library in Escherichia coli for
fibronectin binding (215). Bacterium-host cell interactions in-
volving lectins (482) may also be involved in L. monocytogenes
adhesion to eukaryotic cells (174). Indirect evidence has been
obtained for an L. monocytogenes adhesin containing a-D-ga-
lactose, involved in uptake by mouse CB1 dendritic cells (253)
and human HepG22 hepatocarcinoma cells (114) upon recog-
nition of a carbohydrate receptor at the eukaryotic cell surface.
The presence in L. monocytogenes of lectin-like ligands medi-
ating binding to D-glucosamine, L-fucosylamine, and p-amino-
phenyl-a-D-mannopyranoside moieties has also been indirectly
demonstrated (110).
Intracellular Proliferation and Intercellular Spread
During invasion, Listeria bacteria become engulfed within a
phagocytic vacuole (194) (Fig. 3D). Little is known about the
characteristics of the Listeria-containing vacuolar compart-
ment, but the vacuoles become acidified soon after uptake
(25). There is evidence that L. monocytogenes ensures its in-
travacuolar viability by preventing phagosome maturation to
the phagolysosomal stage (11). Thirty minutes after entry, the
bacteria begin to disrupt the phagosome membrane (194), and
within 2 h, about 50% of the intracellular bacterial population
is free in the cytoplasm (655) (Fig. 3E). This membrane dis-
ruption step is essential for listerial intracellular survival and
proliferation (220) and is mediated by the hemolysin in com-
bination with phospholipases (see below).
Once in the cytosol, bacteria multiply (Fig. 3E), with a dou-
bling time of approximately 1 h (194, 518), i.e., approximately
three times slower than in rich medium. In L. monocytogenes,
intracellular growth does not involve the upregulation of
known stress proteins (261) (see below), and auxotrophic mu-
tants requiring aromatic amino acids or purines for growth in
minimal medium grow inside cells at rates similar to those of
the wild-type parent strain (413). This indicates that the cyto-
plasmic compartment is permissive for Listeria proliferation.
However, three metabolic genes (purH, purD, and pyrE, in-
volved in purine and pyrimidine biosynthesis) and an arginine
ABC transporter (arpJ) have been shown to be induced within
cells (336). Mutation of these genes had no major effect on
intracellular proliferation and virulence (336), which can mean
that certain nutrients are present in the host cell cytoplasm at
concentrations that, although not limiting, are sufficiently low
that L. monocytogenes has to upregulate certain metabolic
genes to grow efficiently within cells. Recent experimental ev-
idence indicates that pathogenic Listeria spp. may exploit hex-
ose phosphates from the host cell cytoplasm for efficient intra-
cellular growth (543) (see below). Evidence has also been
recently presented that antimicrobial peptides from the host
cell cytosol, such as ubiquicidin found in macrophages (283a),
may play a role in restraining intracellular proliferation of L.
monocytogenes. Nothing is known about the listerial mecha-
nisms counteracting these inhibitory peptides.
Intracytoplasmic bacteria are immediately surrounded by a
cloud of a fine, fuzzy, fibrillar material composed of actin
filaments, which later (around 2 h postinfection) rearranges to
form an actin tail of up to 40 mm at one of the poles of the
bacterium (see Fig. 6B). This actin tail consists of two popu-
lations of cross-linked actin filaments, one formed by relatively
long, axially arranged actin bundles and the other by shorter,
randomly arranged filaments. The polar assembly of actin fil-
aments propels the bacterial cell in the cytoplasm with a mean
speed of 0.3 mm/s, in a fashion reminiscent of the “action-
reaction” principle that governs rocket movement. Moving Lis-
teria cells leave an evanescent trail of F-actin undergoing de-
polymerization at the distal end, the steady-state length of
which is proportional to the speed of bacterial movement. This
movement is random, so some bacteria eventually reach the
cell periphery, come into contact with the membrane, and push
it, leading to the formation of finger-like protrusions with a
bacterium at the tip (Fig. 3F and G). These pseudopods pen-
etrate uninfected neighboring cells and are in turn engulfed by
phagocytosis, resulting in the formation of a secondary phago-
some delimited by a double membrane (Fig. 3H), with the
inner membrane originating from the donor cell (Fig. 3G).
Bacteria escape rapidly (within 5 min) from the newly formed
vacuole by dissolving its double membrane, reach the cyto-
plasm, and initiate a new round of intracellular proliferation
and direct intercellular spread (117, 453, 549, 601, 652, 654–
656) (Fig. 3A). In tissue culture, this infectious cycle is re-
flected in the formation of plaques in the cell monolayer (641,
672). Actin-based intracytoplasmic movement and cell-to-cell
spread are mediated by the listerial surface protein ActA (see
below).
VIRULENCE FACTORS
Hemolysin
The hemolysin gene, hly, was the first virulence determinant
to be identified and sequenced in Listeria spp. Subsequent
FIG. 3. Stages of listerial intracellular parasitism. (A) Scheme of the intracellular life cycle of pathogenic Listeria spp. (reproduced from
reference 655 with permission of the Rockefeller University Press). In anticlockwise order: entry into the host cell by induced phagocytosis,
transient residence within a phagocytic vacuole, escape from the phagosome into the cytoplasm, cytosolic replication and recruitment of host cell
actin onto the bacterial surface, actin-based motility, formation of pseudopods, phagocytosis of the pseudopods by neighboring cells, formation of
a double-membrane phagosome, escape from this secondary phagosome, and reinitiation of the cycle. (B to H) Scanning and transmission electron
micrographs of cell monolayers infected with L. monocytogenes (B) Numerous bacteria adhering to the microvilli of a Caco-2 cell (30 min after
infection). (C) Two bacteria in the process of invasion (Caco-2 cell, 30 min postinfection). (D) Two intracellular bacteria soon after phagocytosis,
still surrounded by the membranes of the phagocytic vacuole (Caco-2 cell, 1 h postinfection). (E) Intracellular Listeria cells free in the host cell
cytoplasm after escape from the phagosome (Caco-2 cell, 2 h postinfection). (F) Pseudopod-like membrane protrusion induced by moving Listeria
cells, with the bacterium being evident at the tip (brain microvascular endothelial cell, 4 h postinfection; taken from reference 245 with permission).
(G) Section of a pseudopod-like structure in which a thin cytoplasmic extension of an infected cell is protruding into a neighboring noninfected
cell (notice that the protrusion is covered by two membranes) (Caco-2 cell, 4 h postinfection). (H) Bacteria in a double-membrane vacuole formed
during cell-to-cell spread (Caco-2 cell, 4 h postinfection).
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characterization of the hly locus led to discovery of the chro-
mosomal virulence gene cluster in which most of the genetic
determinants required for the intracellular life cycle of patho-
genic Listeria spp. reside (see below). The hly product, Hly, was
also the first virulence factor for which a precise role in the
pathogenesis of Listeria infection was demonstrated. Hly is a
key virulence factor essential for pathogenicity, having a vital
role not only in intracellular parasitism but also in several
other functions in the interaction of listeriae with their verte-
brate host.
Characterization and role in escape from phagosome. In
1941, Harvey and Faber (269) demonstrated for the first time
the production of a soluble hemolysin by L. monocytogenes.
During the 1960s and 1970s, various researchers tried to purify
this hemolysin and characterize its biochemical and toxic prop-
erties (218, 303, 305, 475, 620, 683). Jenkins et al. (303) were
the first to provide evidence that the Listeria hemolysin is
similar in function and antigenicity to streptolysin O (SLO)
from Streptococcus pyogenes. Kingdon and Sword (334) showed
that the hemolysin was inhibited by cholesterol, that its opti-
mum pH was below 7, and that it had cytotoxic properties in
phagocytic cells. They were also the first to suggest that the
hemolysin might be involved in the disruption of phagosomal
membranes (15, 334). In 1985, Vicente et al. (676) reported the
molecular cloning of a chromosomal fragment from L. mono-
cytogenes that conferred hemolytic activity on E. coli. These
authors were the first to use molecular genetics in the study of
listerial virulence factors. Finally, in 1987, Geoffroy et al. (207)
provided the first unambiguous evidence that the hemolysin of
L. monocytogenes is an SLO-related cytolysin belonging to the
family of cholesterol-dependent, pore-forming toxins (CDTX).
This toxin was given the name listeriolysin O (LLO), and one
of its key characteristics was determined, its low optimum pH
(5.5) and the narrow pH range at which it is active (4.5 to 6.5)
(207). Later, the 58-kDa CDTX hemolysin of L. ivanovii,
ivanolysin O (ILO), was purified and characterized (669), and
it was also shown that the weakly hemolytic but nonpathogenic
species L. seeligeri produces, albeit in small amounts, an LLO-
related CDTX (208, 376).
The strong correlation between hemolytic activity and
pathogenicity in the genus Listeria (the pathogenic species L.
monocytogenes and L. ivanovii are hemolytic [see Fig. 5],
whereas the nonpathogenic species are not; the exceptional
case of L. seeligeri will be discussed below) (250, 605, 626) and
the observation that the spontaneous loss of hemolysin pro-
duction results in avirulence (288) led Gaillard et al. (195) and
various other groups to generate isogenic hemolysin mutants
of L. monocytogenes by transposon mutagenesis (108, 323,
518). These mutants were much less virulent in mice (increase
of .4 log units in the LD50). Spontaneous revertants from
which the transposon was lost recovered both hemolytic activ-
ity and pathogenicity, and reintroduction of the hly gene in
trans into the nonhemolytic mutants restored virulence to wild-
type levels (108, 195, 323, 518). Genetic analysis of the point of
insertion for one of these mutants led, in 1987, to the identi-
fication and characterization of the hemolysin gene (432, 436).
Cell culture studies of the effects of hly inactivation showed
that hemolysin is required for the survival and proliferation of
L. monocytogenes within macrophages and nonprofessional
phagocytes (194, 359, 518). Electron microscopy of L. mono-
cytogenes-infected cultured epithelial cells revealed that hly
mutants remained within the vacuolar compartment, whereas
hemolytic bacteria were free in the cytoplasm (194). The het-
erologous expression of hly in Bacillus subtilis conferred on this
nonpathogenic bacterium the ability to escape from the phago-
cytic vacuole and to proliferate within cells (although it did not
become pathogenic, indicating that virulence factors other
than LLO were required for infection) (45). These studies
demonstrated the key role played by LLO in the intracellular
infectious cycle of pathogenic Listeria spp., as a mediator of
phagosome membrane disruption. LLO not only mediates lysis
of the primary phagosomes formed after the uptake of extra-
cellular bacteria but is also required for the efficient escape of
L. monocytogenes from the double-membrane vacuole that
forms upon cell-to-cell spread (202) (Fig. 3D and H). The
pores or membrane lesions caused by LLO (Fig. 4) probably
facilitate the access of Listeria phospholipases to their sub-
strates (see following section), leading to total dissolution of
the physical barrier that delimits the phagosomal compart-
ment.
Sequencing of the genes for LLO (436), ILO, and the L.
seeligeri hemolysin (seeligerilysin [LSO]) (257) revealed a high
degree of similarity at both the protein (86 to 91%) and nu-
cleotide (76 to 78%) levels and confirmed that the deduced
proteins are members of the CDTX family of cytolysins. This
family of toxins has 23 recognized members from different
gram-positive genera, all of which are very similar in structure
(40 to 70% amino acid sequence similarity) and show antigenic
cross-reactivity (7, 8, 633). Portnoy et al. (519) demonstrated
that, despite their structural and functional similarity, not all
LLO-related toxins can mediate escape from phagosomes.
These authors expressed the genes encoding SLO and perfrin-
golysin O (PFO, the CDTX from Clostridium perfringens) in B.
subtilis and observed that only PFO facilitated intracellular
growth. However, unlike LLO, PFO damaged host cells (519).
The pfo gene was also unable to complement an hly mutation
in L. monocytogenes for virulence in mice. The resulting strain
was hemolytic and able to escape from phagosomes, but PFO
again damaged the host cell, preventing the intracellular pro-
liferation of the bacteria (310). This indicates that LLO has
FIG. 4. Pore-forming activity of LLO. Sheep erythrocyte ghost af-
ter treatment with purified LLO, showing the ring-shaped oligomeric
structures of the toxin attached to the membrane. (Bar, 100 nm.)
(Reproduced from reference 300 with permission of the publisher).
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evolved structural features to prevent cytoxicity which are not
present in PFO from an extracellular pathogen. By selecting
for pfo-expressing L. monocytogenes mutants capable of nor-
mal intracellular growth, the same research group identified
PFO mutations capable of mediating lysis of the vacuole but
devoid of toxic effects on the infected host cell (311). One type
of mutation decreased the cytosolic half-life of PFO (see be-
low). Another type of mutation, very interestingly, modified
the pH optimum of PFO, making it similar to that of LLO, with
low levels of activity at pH 7.4 (a pH similar to that of the
eukaryotic cell cytoplasm). This low optimal pH, similar to that
within phagosomes, is thought to provide the basis for com-
partmentalized activity of LLO in an acidified vacuole and for
protection against the potential deleterious effect on cell mem-
branes of leakage of the toxin into the cytoplasm. This is
probably a key element in the adaptation of L. monocytogenes
to intracellular parasitism. Direct evidence for a link between
the low optimum pH and compartment-specific pore-forming
activity of LLO in macrophage phagosomes has been provided
by a recent study using the membrane-nonpermeating fluoro-
phore 8-hydroxypyrene-1,3,6-trisulfonic acid (25). It was shown
that L. monocytogenes-containing phagosomes acidify rapidly
after bacterial uptake. This was followed by an increase in pH
and dye release from the vacuole. Loss of the fluorophore was
prevented by lysosomotropic agents, such as ammonium chlo-
ride and bafilomycin A1 (25). Bafilomycin A1 was also shown
to block L. monocytogenes escape from the primary vacuole in
epithelial cells (102). These experiments indicate that a lower-
ing in pH results in activation of LLO present in the phago-
some lumen, leading to membrane destabilization, pH equili-
bration, and consequent deactivation of LLO.
Recent experimental evidence has shown that a PEST-like
sequence present at the N terminus of LLO and absent in PFO
is responsible for the rapid degradation of the listerial toxin in
the host cell cytosol (127a). PEST-like sequences are thought
to target eukaryotic proteins for phosphorylation and degra-
dation, and deletion of this sequence in L. monocytogenes LLO
led to increased cytotoxicity and lower virulence. When the
sequence was introduced in PFO and the chimeric toxin was
expressed in L. monocytogenes, bacteria were less cytotoxic
than those expressing wild-type PFO and were able to replicate
intracellularly. These data suggest that adoption of a PEST
motif in LLO is another strategy used by L. monocytogenes,
together with the low pH optimum, to restrict the activity of
the toxin to the host cell vacuole, thereby preserving the intra-
cellular niche for bacterial proliferation (127a). A recent re-
port has also shown that L. monocytogenes mutants expressing
a PEST-deleted hly allele, although fully hemolytic, are
strongly impaired in the ability to escape from the phagocytic
vacuole. This suggests that the PEST motif in LLO may also
play a specific role in the disruption of the phagosomal mem-
brane, e.g., by serving as a ligand for targeting to that mem-
brane other factors required for its efficient disruption (381a).
Structure-function. CDTXs typically have a conserved un-
decapeptide, ECTGLAWEWWR, in the C-terminal region (7,
8). Single-amino-acid substitutions in this undecapeptide in
LLO produce L. monocytogenes strains with various degrees of
attenuation, proportional to the loss of cytolytic activity of the
respective hemolysin variants (440). Mutational analyses of the
undecapeptide in several other CDTXs have also demon-
strated the importance of this motif for activity (511, 583, 608).
LSO, the L. seeligeri hemolysin, has an Ala-to-Phe substitution
in this conserved motif (257), and this may be one of the
reasons for the lower hemolytic activity of this species. The
undecapeptide contains the Cys residue that confers on
CDTXs the characteristic after which this group of toxins was
formerly designated (i.e., “thiol activated or oxygen labile”),
that is, inhibition by oxidation or thiol-reacting compounds and
reactivation by thiol-reducing agents (8, 633). It was formerly
assumed that activation by thiol-reducing agents was due to the
breakage of an intramolecular bond. However, once the se-
quences of many of these toxins became available, it was clear
that only one Cys residue was present in most of the toxins of
the family. It was also thought that this residue was essential
for activity, presumably serving as the ligand in the interaction
with membrane cholesterol (see below) (8, 633). However,
replacement of this residue with Ala in LLO (440) and in other
toxins of the family (511, 583) did not significantly affect ac-
tivity, although it did render the molecule insensitive to inac-
tivation by oxidation or thiol-alkylating agents. Replacement
with Gly or bulkier amino acids, however, abolished most of
the activity, indicating that the mechanism underlying Cys-
mediated reversible inhibition of cytolytic function probably
involves steric hindrance due to formation of toxin dimers or
heterodimers with other proteins via disulfide bridges. Indeed,
ILO copurifies with a major 27-kDa protein from the culture
supernatant of L. ivanovii (349, 669) (the small, secreted in-
ternalin i-InlE [169]), and this heterodimer is resolved by treat-
ment with thiol-reducing agents (669). Its nonessential role for
cytolytic activity in vitro raises the question of why there is such
strong selection pressure for conservation of the Cys residue
among CDTXs. This residue may have a major role in vivo, for
example, as a modulator of toxin activity (activation in low pH,
reducing environments) or as a facilitator of host membrane
targeting for other virulence-associated proteins (for example,
i-InlE) that may associate with the CDTX in a heterodimer.
Cholesterol irreversibly inhibits the cytolytic activity of
CDTXs, and these toxins are active only against cholesterol-
containing membranes, reflecting that this membrane com-
pound is a key toxin target (8, 633). The observation that
soluble CDTXs form highly stable amphiphilic complexes with
cholesterol led to the development of a simple one-step
method to purify these toxins from the culture supernatant by
selective precipitation with cholesterol (669, 670). With this
technique, it was shown that a cytolytically inactive, truncated
form of LLO lacking the C-terminal region including the un-
decapeptide was nonetheless able to form cholesterol-toxin
complexes. The conclusion was that LLO possesses functional
domains for cholesterol binding located outside the C-terminal
region and independent from those involved in cytolysis. It also
appeared clear that the undecapeptide containing the Cys res-
idue was not essential for interaction of the toxin with choles-
terol (670). Unfortunately, the ability of these truncated LLO
molecules to bind to membranes was not tested. Such an ex-
periment would have indicated whether cholesterol acts as the
primary binding receptor for LLO. If this were so, then prior
treatment of the toxin with cholesterol should block the cho-
lesterol-binding sites on the molecule and prevent the interac-
tion of the toxin with the target membrane. However, recent
experiments have demonstrated that preincubation with cho-
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lesterol does not impede the binding of LLO-cholesterol com-
plexes to target membranes (300). This is consistent with ex-
perimental data showing that PFO mutations in critical
residues of the undecapeptide resulting in impaired binding to
membranes (see below) did not affect binding specificity for
cholesterol (608). The mechanism by which CDTXs disrupt
membranes involves the transition from monomeric, water-
soluble toxin to noncovalently bound oligomeric, insoluble arc-
and ring-shaped toxin structures that insert into the mem-
brane, forming large pores about 20 to 30 nm in diameter (8,
41, 42, 452, 609, 633) (Fig. 4). An interesting observation was
that although cholesterol-complexed LLO binds to target
membranes, the toxin does not oligomerize to form pores
(300). All these findings suggest that cholesterol is involved not
in the initial binding of soluble toxin monomers to the mem-
brane but at a subsequent stage of membrane-toxin interaction
that leads to polymerization and membrane intercalation. In-
deed, early observations of CDTX activity, showing that at 4°C
cytolysis does not occur although binding is unaffected (8, 633),
did already indicate that membrane binding and disruption are
independent events in CDTX function. This is consistent with
experimental data showing that most of the anti-LLO mono-
clonal antibodies that neutralize cytolytic activity do not affect
binding to target membranes (123, 464). The ability of noncy-
tolytic LLO-cholesterol complexes to bind cell membranes is
also consistent with such complexes being able to induce cyto-
kine expression (474), IL-1 release (707), and the induction of
lipid second messengers (618), host cell responses that require
prior interaction of the toxin with membrane receptors. This
observation raises the interesting possibility that LLO released
extracellularly and rendered noncytolytic by the formation of
complexes with free cholesterol present in body fluids may be
targeted to the cell membranes and mediate signaling events
upon binding.
Membrane binding was not affected in LLO mutants with
impaired cytolytic activity due to amino acid substitutions in
the ECTGLAWEWWR undecapeptide, including Trp-to-Ala
substitutions, which almost totally abolish toxin function (440).
These data suggested that the motif itself is not primarily
involved in the initial interaction of the toxin monomer with
the target membrane. This contrasts with other experimental
data showing that weakly hemolytic PFO mutants with Phe
replacements in the three Trp residues of the Cys-containing
region (Trp436, Trp438, or Trp439) had significantly lower
erythrocyte membrane-binding activities (608). Circular di-
chroism spectral analyses of the membrane-associated form of
these PFO mutant toxins suggested that both Trp438 and
Trp439 are involved in a conformational change that occurs
during oligomerization and pore formation (462). Thus, the
impaired interaction of PFO mutant toxins with the membrane
may reflect either that the motif is directly involved in the
interaction with the membrane or that it is required for correct
toxin folding during oligomerization and membrane insertion
during pore formation. The latter interpretation is consistent
with the observed inhibition of pneumolysin (PLY; the CDTX
from Streptococcus pneumoniae) self-interaction by derivatiza-
tion of the single Cys residue with the thiol-active agent di-
thio(bis)nitrobenzoic acid (213), suggesting that the domain
carrying the undecapeptide is involved in toxin autoaggrega-
tion. The precise role of the conserved undecapeptide in
CDTX function is still not understood and further research on
this aspect is clearly needed.
A picture of the possible mechanism underlying membrane
disruption and cytolysis by CDTXs has begun to emerge in the
last few years from crystallographic studies, functional model-
ing, and detailed structural analyses performed with SLO,
PLY, and, in particular, PFO (214, 461, 493, 494, 566, 611).
Given the high degree of sequence similarity between mem-
bers of this toxin family it can be assumed with a reasonable
degree of certainty that most of the predicted functional fea-
tures are extrapolable to LLO. CDTXs are composed of four
domains of which the first three would be involved in toxin
oligomerization and membrane disruption and the fourth pri-
marily in binding to the membrane. This is consistent with
experimental data showing that the membrane-binding activity
is associated with the C-terminal half of the toxin molecule
(491) and that neutralizing antibodies that map to domain 4
inhibit binding to cellular membranes (130), whereas neutral-
izing epitopes that do not inhibit binding to membranes map to
domain 1 (123). Membrane contact would facilitate the inter-
action of toxin molecules with cholesterol, which is buried in
the membrane. Binding to cholesterol would then trigger a
conformational change in the protein, increasing its hydro-
phobicity and membrane affinity, favoring a more intimate
interaction between toxin monomers and the lipid layer. The
resulting hydrophobic monomers would become partially em-
bedded in the membrane, diffuse laterally, and collide with
other monomers to form polymeric aggregates. This would
explain why initial binding of CDTXs to the membrane is
reversible and temperature independent whereas the subse-
quent steps are irreversible and are blocked at 4°C. At this low
temperature, membrane dynamics are presumably restricted,
resulting in kinetic energy requirements incompatible with
membrane penetration, lateral diffusion, and oligomerization.
A region that interacts with the membrane has recently been
identified in domain 3. This region contains two transmem-
brane domains that undergo an a-helix to b-strand transition,
creating a pair of hairpin structures that penetrate the mem-
brane. There is some debate over the extent of membrane
penetration; some studies claim that the pore is not a hole in
the bilayer but instead an unusual phospholipid phase struc-
ture (214), whereas others favor the view that the the two
amphipathic b-hairpins completely span the bilayer, creating a
true pore (611).
Other roles in infection. Evidence is accumulating that LLO
is a multifunctional virulence factor with many important roles
in the host-parasite interaction other than phagosomal mem-
brane disruption. Exogenous and endogenous exposure to
LLO may induce a number of host cell responses, such as cell
proliferation and focus formation in transfected fibroblasts
(131), activation of the Raf–Mek–mitogen-activated protein
(MAP) kinase pathway in epithelial cells (647, 647a, 685),
mucus exocytosis induction in intestinal cells (97), modulation
of internalization via calcium signaling (680) and cytokine ex-
pression in macrophages (355, 474), degranulation and leuko-
triene formation in neutrophils (619), apotosis in dendritic
cells (252), phosphoinositide metabolism (618), lipid mediator
generation (618), NF-kB activation (330), and expression of
cell adhesion molecules in infected endothelial cells (153, 330,
351). More details of these aspects of LLO can be found below.
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LLO also plays a critical role in the protective immune
response to L. monocytogenes infection in two ways. First, the
LLO-mediated release of bacteria into the cytosol and subse-
quent intracellular growth are essential for major histocompat-
ibility complex (MHC) class I-restricted listerial antigen pre-
sentation and the induction of specific protective cytotoxic
CD81 T cells (23, 33, 71, 284, 285). Second, LLO is itself a
major protective antigen recognized by Listeria-specific CD81
CTLs during listerial infection (32, 59, 281, 574, 625). LLO has
been shown to be processed very efficiently into peptides that
are presented by MHC class I molecules (677). One LLO
peptide, nonamer LLO 91–99, is an immunodominant epitope
that induces CD81 CTLs, which protect in vivo against L.
monocytogenes infection and confer significant anti-Listeria im-
munity on naive mice upon passive transfer (265, 495). Pore
formation by exogenous LLO has also been shown to mediate
the delivery of soluble antigens to the TAP-dependent cytoso-
lic MHC class I antigen presentation pathway (121, 122). This
may be an additional mechanism involved in the generation of
CD81 CTLs against antigens secreted by extracellular L.
monocytogenes bacteria. LLO also elicits a potent humoral
response, and several studies have shown that the detection of
LLO-specific antibodies can be used in the serodiagnosis of L.
monocytogenes infection in humans and animals (34, 211, 212,
248, 382, 394, 396). An old paradigm of cell-mediated immu-
nity, that antibodies are not involved in protection against
intracellular parasites (328), has recently been challenged by
Edelson et al. (163), who showed that a murine anti-LLO
neutralizing monoclonal antibody increases resistance to Lis-
teria infection in mice. It is therefore possible that the humoral
arm of the immune system is also involved in protection
against L. monocytogenes infection and that LLO plays a key
role here also.
Phospholipases
Pathogenic Listeria spp. produce three different enzymes
with phospholipase C (PLC) activity that are involved in viru-
lence. Two, PlcA and PlcB, are present in L. monocytogenes
and L. ivanovii; the third, SmcL, is specific to L. ivanovii.
Characterization. Production of phospholipase activity by L.
monocytogenes was first described in 1962 by Fuzi and Pillis
(191), who reported opacity reactions in egg yolk agar that
correlated in intensity with the hemolytic activity of the strains
tested (see Fig. 12). This activity was detected in hemolytic
fractions of L. monocytogenes culture supernatants and was at
first wrongly identified as being due to the hemolysin itself
(303, 304, 332). However, the application of careful fraction-
ation procedures led to separation of the hemolytic and phos-
pholipase activities (305, 620). The L. monocytogenes phospho-
lipase was characterized as a secreted phosphatidylcholine
(PC) cholinephosphohydrolase (PC-PLC;EC 3.1.4.3) similar to
that responsible for the lecithinase activities of Bacillus cereus
and C. perfringens (375). The purified PC-PLC/lecithinase is a
zinc-dependent enzyme with an apparent molecular mass of 29
kDa, active over a wide pH range (5.5 to 8.0), and with a broad
substrate spectrum (206, 223). On lipid micellar dispersions,
this PLC rapidly hydrolyzes PC, phosphatidylethanolamine
(PE), and phosphatidylserine (PS). It also, to a lesser extent,
hydrolyzes sphingomyelin (SM) but does not or only very
weakly hydrolyzes phosphatidylinositol (PI) (206, 223). How-
ever, PI is rapidly hydrolyzed in erythrocyte ghosts and in
PI-PC-cholesterol liposomes, leading to the formation of ino-
sitol-l-phosphate (223). The purified enzyme is atoxic for mice;
it is weakly hemolytic in guinea pig, horse, and human eryth-
rocytes but not in sheep erythrocytes (206).
Lecithinase activity, like hemolytic activity, is an easily rec-
ognizable phenotypic marker closely associated with pathoge-
nicity in the genus Listeria (528) (see Fig. 12). As for hly,
transposon mutagenesis was used to identify the lecithinase
gene. Two types of lecithinase-deficient, attenuated-virulence
mutants were isolated. In the first type, the transposon was
inserted into mpl (532), which encodes a zinc-metalloprotease
(140), and the first gene of a 5.7-kb operon located immedi-
ately downstream from hly (434) (see Fig. 8). The second type
of lecithinase-deficient mutant resulted from transposon inser-
tion into the actA gene, located downstream from mpl in the
operon and encoding the actin nucleator ActA (672) (see fol-
lowing section). Cloning of the DNA region targeted by the
transposons in this mutant led to identification of the structural
gene encoding the nonspecific listerial PLC, plcB. This gene
occupies the third position in the 5.7-kb operon, called the
lecithinase operon (see Fig. 8). The sequence of the plcB prod-
uct, PlcB, is very similar to those of the PC-PLC precursor of
B. cereus (38.7% identity over 253 amino acids) and the a-toxin
precursor from C. perfringens (22.4% identity over 223 amino
acids) (672). Western immunoblotting of PlcB in the L. mono-
cytogenes culture supernatant detects two antigenically related
bands of 33 and 29 to 30 kDa (206, 470, 532). This indicates
that PlcB, like the B. cereus and C. perfringens PC-PLCs (309,
657), is secreted as an inactive proenzyme that is processed in
the extracellular medium by proteolytic cleavage. The secreted
PlcB proenzyme contains 264 amino acids, including a 26-
residue N-terminal propeptide of 2.9 kDa, which is cleaved to
give the faster-migrating mature, active enzyme. PlcB must be
secreted in an inactive form to prevent bacterial membrane
damage due to degradation of its phospholipids. The lecithi-
nase-deficient mpl insertion mutant described above produced
only the larger PlcB band corresponding to the inactive proen-
zyme (532), and complementation of this mutant with mpl
restored the lecithinase phenotype and production of the ac-
tive 29- to 30-kDa PlcB form (520). Thus, Mpl, which is en-
coded by the first gene of the lecithinase operon and, like PlcB,
is also a zinc-dependent metalloenzyme, is involved in process-
ing of the PC-PLC/lecithinase into its mature and active form
in the L. monocytogenes culture supernatant.
The plcA gene, which encodes a PI-specific PLC, was iden-
tified in L. monocytogenes earlier than plcB by chromosome
walking in the region upstream from hly (82, 377, 431) (see Fig.
8). Its secreted product, PlcA, is a 33-kDa polypeptide similar
to the PI-PLCs from Bacillus thuringiensis, B. cereus, and Staph-
ylococcus aureus (around 30% primary sequence identity) and
eukaryotic PI-PLCs, such as that produced by Trypanosoma
brucei (431). The purified PlcA enzyme is highly specific for PI,
with a pH optimum between 5.5 and 6.5 in Triton X-100-mixed
micelles, suggesting that, like LLO, it would be active in acid-
ified phagocytic vesicles. No hydrolyzing activity was observed
with PC, PS, PE, PI 4-phosphate, or PI 4,5-bisphosphate (222).
The enzyme is able to hydrolyze glycosyl PI (GPI)-anchored
eukaryotic membrane proteins (222, 431), although much less
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efficiently than the orthologous enzyme from B. thuringiensis
(200).
The animal pathogen L. ivanovii produces an additional
PLC that is specific for SM. This SMase was purified from L.
ivanovii culture supernatant after selective removal of ILO by
sequestration with cholesterol and shown to contribute to the
hemolytic activity of this species (669). In contrast to L. mono-
cytogenes, which is weakly hemolytic, L. ivanovii produces a
strong bizonal lytic effect on sheep blood agar, with an inner
halo of complete hemolysis surrounded by a ring of incomplete
hemolysis similar to that for b-toxin-producing S. aureus and B.
cereus (546, 607, 669) (Fig. 5). The outer ring of incomplete
hemolysis is completely lysed if erythrocytes are exposed to a
soluble product released by the actinomycete Rhodococcus
equi (546, 626, 667, 668) (a cholesterol oxidase [467]), giving
rise to a characteristic shovel-shaped patch of synergistic he-
molysis (Fig. 5). This CAMP-like hemolytic reaction is rou-
tinely used for the identification of L. ivanovii (605, 606, 668).
The gene encoding the L. ivanovii SMase, smcL, has recently
been identified and sequenced. Its predicted protein product,
SmcL, is highly similar (around 50% identity) to the known
bacterial SMases from S. aureus (b-toxin), B. cereus, and Lep-
tospira interrogans (226). Gene disruption and complementa-
tion studies have demonstrated that smcL is the determinant
responsible for the differential hemolytic properties of L.
ivanovii (225, 226). SmcL is functionally very similar to the S.
aureus b-toxin in terms of membrane-damaging activity, as
revealed by the similar ability of the two molecules to elicit
shovel-shaped CAMP-like reactions with R. equi and the lytic
selectivity for SM-rich membranes (both enzymes lyse sheep
erythrocytes, in which SM accounts for 51% of total membrane
phospholipids, but not horse erythrocytes, in which the SM
content is only 13.5%) (Fig. 5). However, SmcL does not cause
the hot-cold lysis typical of b-toxin (unpublished data), indi-
cating that, despite their structural and functional similarities,
there are differences in the mechanisms underlying membrane
damage between these two homologous bacterial SMases.
Role in virulence. The observation that Hly2 mutants of L.
monocytogenes are able to escape to the cytosol and grow
within certain human epithelial cells (Henle 407 and HeLa
cells) suggested that listerial membrane-active products other
than Hly may be involved in phagosome disruption (518). Such
a role for a listerial phospholipase was first shown for PlcB.
Sequential insertional mutagenesis of the lecithinase operon of
L. monocytogenes revealed that a plcB mutant formed smaller
plaques in infected J774 macrophage monolayers and accumu-
FIG. 5. Hemolytic activities of pathogenic Listeria spp. Left panels, spontaneous hemolysis of L. monocytogenes (L. mo.) and L. ivanovii (L. iv.)
on sheep blood agar; compare the narrow ring of b-hemolysis produced by L. monocytogenes (here exceptionally evident) with the striking
multizonal lytic activity of L. ivanovii, which is due to the production of an additional cytolytic factor (the sphingomyelinase SmcL). Bacteria were
cultured at 37°C for 36 h and then left at 4°C for 48 h. Right panels, synergistic (CAMP-like) hemolysis of L. ivanovii and b-toxin (sphingomy-
elinase)-producing S. aureus (S. au.) with R. equi (vertical streak); L. ivanovii and S. aureus elicit identical shovel-shaped patches of synergistic
hemolysis, reflecting functional relatedness of the sphingomyelinases C produced by these two bacteria (see text and reference 226 for details). The
CAMP-like effect results from the total lysis of the halo of sphingomyelinase-damaged erythrocytes exposed to a cholesterol oxidase from R. equi
(467). As shown in the two upper right panels, the L. ivanovii sphingomyelinase is active towards sheep erythrocytes (which contain 51%
sphingomyelin in the membrane) but not towards horse erythrocytes (13.5% sphingomyelin only). Note that the inner zone of spontaneous
hemolysis that surrounds L. ivanovii colonies, due to the activity of the hemolysin (ivanolysin O), is not influenced by the source of erythrocytes.
Bacteria were cultured at 37°C for 24 h.
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lated within double-membrane vacuoles (672). This indicated
that the PlcB phospholipase is required for efficient lysis of the
secondary phagosomes formed after listerial cell-to-cell spread
(Fig. 3H). Using in-frame deletion mutants, Hly was shown to
be dispensable for efficient lysis of the primary vacuole of
Henle 407 cells as long as PlcB was produced, suggesting that
PlcB also mediates escape from primary phagosomes in these
cells (414). Immunofluorescence studies with infected cells
showed that PlcB accumulates in L. monocytogenes-containing
vacuoles, colocalizing with the endosomal-lysosomal marker
Lamp1 (415). In the absence of Hly, a Dmpl mutation caused
defects in escape from primary phagosomes and cell-to-cell
spread similar to those in a DplcB mutant or a double Dmpl
DplcB mutant, consistent with Mpl’s being involved in the
activation of pro-PlcB (414, 415). Using the Dmpl mutant, it
was shown that intracellular activation of proPlcB is mediated
not only by Mpl, but also via an Mpl-independent pathway
presumably mediated by a lysosomal cysteine protease. PlcB
activation by both pathways is sensitive to bafilomycin A1, an
inhibitor of the vacuolar proton pump ATPase, indicating that
this activation is, as for LLO, low-pH dependent and hence
vacuolar compartment specific (415). A recent study has shown
that intracellularly multiplying bacteria contain pools of pre-
formed pro-PlcB. These pools are suddenly secreted when pH
decreases below 7.0 by an unknown mechanism involving the
Mpl-mediated release of active enzyme (416). The amount of
the processed form of PlcB, but not that of proPlcB, is signif-
icantly lower in cells infected with an ActA2 mutant, indicating
that proPlcB proteolytic activation occurs predominantly in
secondary vacuoles (415). This is consistent with PlcB’s playing
a key role in cell-to-cell spread. PlcB has recently been shown
to be required for intercellular spread from macrophages to
different types of mammalian cells, including brain microvas-
cular endothelial cells in vitro (246), and for spread in murine
brain tissue in vivo (589). This provides experimental evidence
for a major role of PlcB-facilitated cell-to-cell spread in the in
vivo physiopathogenesis of Listeria infection.
plcA-deficient strains were initially isolated during a search
for molecular determinants involved in cell-to-cell spread
based on the screening of a library of transposon-induced mu-
tants for small-plaque formation (82, 641). These plcA inser-
tion mutants were 1,000-fold less virulent in mice, failed to
grow in mouse organs, and were defective in intracellular pro-
liferation in macrophages (82). However, this severe virulence
deficiency was due to a polar effect on the downstream gene
prfA, which encodes the transcriptional activator of Listeria
virulence genes with which plcA is cotranscribed (see below).
Subsequent studies with an in-frame plcA deletion mutant re-
vealed only a slight reduction in virulence and in the ability to
escape from the primary phagosomes of murine bone marrow
macrophages (83) (see below). Another study showed that the
expression of plcA in the nonpathogenic species L. innocua
promotes transient intraphagolysosomal multiplication of this
otherwise nonintracellularly replicating bacterium (597). The
relevance of this observation to the role of plcA in pathogen-
esis is, however, unknown. Insight into the contribution of
PlcA to virulence could only be obtained by systematic com-
parison of the behavior of single and double plcA and plcB
deletion mutants in mice and cell culture infection assays
(629). As expected, the absence of PlcA led only to a minor
defect in in vivo virulence (threefold increase in mouse LD50)
and in escape from primary vacuoles. Cell-to-cell spread was
unaffected. The lack of PlcB, on the other hand, resulted in
more significant attenuation (20-fold increase in LD50) and, as
noted earlier, defective cell-to-cell spread, but escape from
primary phagosomes of bone marrow macrophages was not
impaired. However, a double DplcA DplcB mutant was found
to be severely impaired in virulence (500-fold increase in
LD50) and in its ability to escape from the primary phagosome
and to spread from cell to cell (414). In a Dhly background,
PlcB was found to be essential, but PlcA made only a minor
contribution to escape from primary vacuoles (414). Overall,
these data indicated that PlcA has only a minor individual role
in virulence but acts synergistically with PlcB and Mpl (which
themselves also have an accessory role in virulence) to achieve,
in conjunction with LLO, optimal levels of escape from pri-
mary and secondary phagosomes.
Recent experimental evidence has indicated that the L.
ivanovii SMase also plays an accessory role in pathogenesis
similar to that of PlcA and PlcB. A lack of SMase production
in L. ivanovii results in a moderate decrease in virulence (four-
fold increase in mouse LD50) and in intracellular growth rate
in bovine epithelial cells. Complementation with the smcL
gene facilitated intracellular survival of the nonpathogenic spe-
cies L. innocua in macrophages and conferred on an L. mono-
cytogenes mutant devoid of any known membrane-damaging
virulence determinant (hly, plcA, and mpl/plcB) as well as of
the actA gene the ability to proliferate within epithelial cells.
Electron microscopy of these cells showed that SmcL mediates
the disruption of primary vacuoles and the release of bacteria
into the cytosol (225, 226).
There are several possible reasons to explain the presence in
pathogenic Listeria spp. of such a panoply of phospholipases
with redundant functions in phagocytic vacuole destabilization.
First, the relative amounts of membrane phospholipids differ
between cells (5). Second, in a given cell type, membrane
phospholipids are asymmetrically distributed in the lipid bi-
layer, with some mostly present in the outer (SM) or inner (PE,
PS, and PI) lipid leaflets and others equally represented in the
two lipid layers (PC) (5). Third, membrane asymmetry is in-
verted during phagocytosis, and in double-membrane phago-
somes, there is presumably a mixed situation, with bacteria
bound by membranes with normal and inverted lipid asymme-
tries. Last, transmembrane asymmetry is also modified in a
number of physiological and pathological conditions, such as
during apoptosis or during cellular activation associated with
increased levels of intracellular Ca21 (39, 360), so it is likely
that variations in phagosome membrane lipid composition oc-
cur during the host cell adaptive response to infection. Conse-
quently, (i) the contribution of each phospholipase to phago-
some disruption may differ according to cell type and (ii), in
the same cell type, the sequential or combined action of several
phospholipases with different substrate specificities and mech-
anisms of action may be important for optimal bacterial escape
from phagosomes with variable membrane lipid bilayer topol-
ogy and composition. In this scenario, the PlcB phospholipase,
which is able to degrade most membrane phospholipids, is
likely to be a key player in phagosome disruption whatever the
composition and distribution of lipids in the membrane, lead-
ing to complete dissolution of the physical barrier that sepa-
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rates bacteria from their cytoplasmic niche. The role of PlcA,
in contrast, is more difficult to understand if we consider that
PlcB has been reported to efficiently hydrolyze PI in biological
membranes and liposomes in vitro (see above). PI is moreover
a minor lipid in eukaryotic membranes. However, it is clear
that PlcA potentiates the membrane-damaging activity of PlcB,
which may not depend exclusively on enzymatic activity itself
but on particular structural features of the enzyme molecule
affecting its membrane insertion and the accessibility to its
specific substrate in natural conditions. The role in pathogen-
esis played by the cleavage of GPI-anchored surface proteins
by PlcA is unknown. The production by L. ivanovii of an
additional phospholipase specific for SM is particularly intrigu-
ing if we take into account that plcA and plcB are sufficient for
pathogenesis in L. monocytogenes. It is possible that the hemo-
lysin and the PlcA/PlcB phospholipase tandem of L. ivanovii
are less efficient in disrupting the phagocytic vacuole and that
SmcL is required to facilitate disruption of the SM-rich luminal
leaflet of phagosomes. Another possibility, suggested by the
selective membrane-damaging activity of the enzyme for sheep
erythrocytes, is that SmcL is involved in the pathogenic tropism
of L. ivanovii for ruminants (226). An attractive hypothesis is
that SmcL has specifically evolved in L. ivanovii because some
of the ruminant cell types or vacuolar compartments important
in pathogenesis have, like ruminant erythrocytes, membranes
containing large amounts of SM. Consistent with a role for
SmcL in host adaptation, expression of smcL was shown to
promote intracellular growth of the L. monocytogenes mutant
devoid of any membrane-damaging factor in bovine MDBK
cells but not in canine MDCK cells, a similar kidney-derived
epithelial cell line from a mammalian species that is not nat-
urally susceptible to L. ivanovii (225).
Besides their mechanical function in escape from the phago-
some, listerial PLCs may also play an important role in patho-
genesis by subverting the host signaling pathways mediated
by phospholipid hydrolysis products such as diacylglycerol
(DAG), ceramide (CER), and inositol phosphates. These lipid
metabolites regulate key cell processes, including cell growth
and differentiation, apoptosis, and the synthesis of cytokines
and chemokines (346, 596), and hence their generation during
Listeria infection may play an important role in adapting host
cell and tissue inflammatory responses to the needs for intra-
cellular life and host tissue colonization. Higher levels of lipid
turnover with accumulation of DAG and CER have been
shown to occur 3 to 4 h after infection of murine J774 macro-
phages by L. monocytogenes. An involvement of bacterial PLCs
in this DAG and CER generation activity was suggested by the
fact that cells infected with a DplcA DplcB mutant showed a
smaller increase in the levels of these mediators (629). How-
ever, this double mutant still induced the generation of DAG
and CER (629), suggesting the involvement of endogenous
phospholipases in this host cell response. Pathogenic Listeria
spp. also induce phosphoinositide metabolism and DAG accu-
mulation in infected human umbilical vein endothelial cells
(HUVECs), and this response was shown, using mutant bac-
teria and exogenously added purified proteins, to be depen-
dent on the synergistic interaction between LLO and PlcA
(617). Since prior treatment with LLO was a prerequisite for
the observation of such a response upon external stimulation
of the cells, it was suggested that LLO-induced pores provide
PlcA with access to PI in the inner membrane leaflet (617).
Similar LLO-PlcA cooperation-dependent induction of phos-
phoinositide hydrolysis and concomitant cell activation has
been observed in neutrophils (619). The listerial phospho-
lipases PlcA and PlcB have also been shown to be required for
persistent NF-kB activation in P388D1 macrophages (272) and
for full induction of CER generation associated with NF-kB
activation and enhanced E-selectin expression and neutrophil
rolling and adhesion in HUVECs (600). An association be-
tween PlcA and PlcB expression, intracellular Ca21 signaling,
and listerial internalization has been reported in J774 macro-
phages during early time points of infection (680), but the
underlying mechanism and true relevance of these observa-
tions are unknown. Recently, using L. ivanovii isogenic mu-
tants and heterologous expression in an L. monocytogenes dou-
ble plcA plcB mutant, it has been shown that the SmcL SMase
mediates CER generation in infected host cells. This required
the previous release of bacteria into cytosol and was associated
with increased apoptosis of infected MDBK cells (Gonza´lez-
Zorn et al., unpublished data).
ActA
A great deal of attention has been paid in recent years to the
study of the actin-based intracellular motility of pathogenic
Listeria spp. (27, 87, 105, 105a, 147, 366a, 401, 402, 515, 581,
630, 636). No classical motor proteins such as myosin have
been found to be involved in bacterial intracellular motility,
and the actin tail of moving Listeria organisms is functionally
similar to the poorly understood actin polymerization process
observed in lamellipodia, responsible for the locomotion of
eukaryotic cells. Therefore, interest in listerial actin-based mo-
tility has transcended microbial pathogenicity, as it provides
cell biologists with a relatively simple model for dissecting the
molecular mechanisms underlying actin cytoskeleton assembly
and function. This model has the enormous advantage that a
single bacterial protein is sufficient to promote the actin re-
cruitment and polymerization events responsible for intracel-
lular movement. This protein is ActA (142, 339), the product
of the actA gene (672).
The central role of ActA in listerial intracellular motility and
virulence was initially revealed by the unusual phenotype of an
isogenic actA mutant of L. monocytogenes in infected tissue
culture cells (339). After entry, these bacteria were capable of
escaping into the host cytoplasm, but could not move intracel-
lularly and accumulated as microcolonies in the perinuclear
area of the cell (Fig. 6). The mutant was unable to recruit actin,
as shown by staining with fluorescein isothiocyanate-labeled
phalloidin, a fungal toxin that binds to F-actin and paralyzes
the actin cytoskeleton. In addition, the actA mutant was highly
attenuated in the mouse infection model (142, 339).
The actA gene encodes a secreted 639-amino-acid protein
with a 610-residue mature form that is attached to the bacterial
cell wall via its C-terminal region (Fig. 6). Several lines of
experimental evidence have demonstrated the essential role of
ActA in actin-based bacterial motility. Transfection experi-
ments in epithelial cells showed that ActA is targeted to the
mitochondrial surface and that these organelles recruit actin
filaments in a way similar to actA-expressing bacteria (513).
Microfilament-associated proteins such as a-actinin and fim-
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brin were also recruited to the ActA-decorated mitochondria
in transfected cells. Thus, ActA, whether anchored to the bac-
terial or mitochondrial membrane, can induce the formation of
an actin cytoskeleton. Although transfection experiments con-
clusively demonstrated that ActA alone was essential for actin
filament recruitment, they did not show how this protein gen-
erates intracellular bacterial motility. This was achieved by
heterologous expression of the actA gene in L. innocua and S.
pneumoniae, bacteria that are otherwise incapable of actin-
based motility. This demonstrated that ActA itself mediates
actin polymerization-driven bacterial movement (340, 631).
Mature ActA from L. monocytogenes can be arbitrarily di-
vided into three distinct domains: (i) N-terminal domain (ami-
no acids 1 to 234), which is rich in cationic residues; (ii) central
region of proline-rich repeats (amino acids 235 to 394); and
(iii) C-terminal domain (amino acids 395 to 610), with a highly
hydrophobic stretch spanning residues 585 to 606 that anchors
the protein to the bacterial surface (Fig. 6). Early structure-
function studies with actA deletion constructs expressed in
transfected cells (189, 513) or in a Listeria background and
tested in Xenopus egg extracts (365, 409) permitted an initial
attribution of specific functions to these domains of the ActA
protein. The N-terminal region plays an essential role, as it
contains all the information necessary to initiate F-actin as-
sembly and bacterial movement (Fig. 6). A domain rich in
positively charged residues (amino acids 129 to 153) in this
region was identified as being strictly required for actin assem-
bly. Amino acids 117 to 121 were shown to be critical for
filament elongation, and deletion of amino acids 21 to 97 led to
discontinuous actin tail formation, suggesting a role in main-
tenance of the dynamics of actin-based motility for this do-
main. Interestingly, a synthetic peptide corresponding to part
of this domain (residues 33 to 74) was shown to interact with
F-actin in vitro (365). In the central region, a domain of pro-
line-rich repeats (amino acids 265 to 396) is required for bind-
ing of the focal contact proteins vasodilator-stimulated phos-
phoprotein (VASP) and Mena (see below). Listeria mutants
lacking this region of ActA are still able to recruit actin to the
bacterial surface and to move intracellularly, albeit at signifi-
cantly lower speeds. This indicates that while the VASP and
Mena proteins are not essential for the initiation of actin
assembly on the bacterial surface, they are important for the
efficiency of the process (366, 472, 632). There is significant
structural and functional similarity between the C-terminal
half of ActA (including the proline-rich repeat region) and
zyxin (224), a eukaryotic protein associated with focal adhe-
sions and actin stress fibers that may be considered a eukary-
otic homolog of the listerial surface protein.
The mechanism by which ActA induces actin polymerization
and bacterial motility is now beginning to be understood. ActA
FIG. 6. Actin-based intracellular motility. (A) Schematic structure and functional motifs of ActA (see text for details; amino acids numbered
according to references 339 and 672). (B) Cos-1 cells infected with L. monocytogenes and labeled with FITC-phalloidin (actin stain, green) and
rhodamine-conjugated anti-Listeria antibody (red) at 4 h postinfection; moving bacteria with actin tails are visible. (C and D) Giemsa stain of
Caco-2 cells infected with L. monocytogenes wild-type (C) and DactA mutant (D) at 4 h postinfection; DactA mutant bacteria do not move
intracellularly and do not spread to neighboring cells, growing in the cytoplasm as a microcolony close to the nucleus.
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is not detected in the actin tail (341, 471), so clearly the listerial
surface protein is not necessary for stabilization of the actin
meshwork left behind by moving Listeria cells. In the proximal
region of this tail, F-actin filaments tend to be unidirectionally
polarized, with barbed ends oriented towards the bacterial cell
surface, indicating that actin nucleation is occurring at this
point (655, 656). This suggested that ActA could act as an actin
nucleator. However, globular (G)-actin monomer-binding ac-
tivity could not be unequivocally demonstrated in ActA until
very recently (96, 708), so the question arose whether ActA
must be modified in vivo in the mammalian cell to have ade-
quate actin-binding function (e.g., by phosphorylation [70]), or
whether another host molecule interacts with ActA and coop-
erates with it to trigger actin nucleation. Systematic searches
for such a host factor among known actin cytoskeleton-bind-
ing, cross-linking, and regulatory proteins revealed that many,
including a-actinin, tropomyosin, talin, vinculin, fimbrin (plas-
tin), filamin, villin, gelsolin, ezrin/radixin, cofilin, profilin, co-
ronin, Rac, CapZ, Arp3, and VASP, colocalize with Listeria-
associated actin filaments (86, 105, 117, 126, 139, 338, 361, 409,
514, 564, 650, 653).
Profilin and VASP were found exclusively at the point of
actin assembly, in close association with the bacterial cell (88,
653), suggesting that they are actively involved in initiation of
the Listeria-induced actin polymerization process. Profilin is a
G-actin-binding protein, and its function in actin assembly is to
bring ATP-actin to the barbed end of the filament in a complex
that lowers the critical concentration for polymerization. Pro-
filin interacts with polyproline (503), and poly-L-proline beads
have been used to deplete profilin from cell extracts, resulting
in the abolition of actin tail formation and bacterial motility
(653). As profilin colocalizes with ActA at the site of actin
polymerization and ActA has four polyproline motifs, it was
thought that profilin was involved in actin nucleation by re-
cruiting G-actin to the site of ActA expression on the bacterial
surface. However, profilin was shown to associate only with
bacteria in cell extracts or within infected cells, and not with
ActA-expressing bacteria grown in culture medium, indicating
that it requires an additional host factor to interact with ActA
(653). VASP, in contrast, was shown to interact directly with
ActA in vitro (88). VASP and its homolog Mena, which is also
present between the bacterial surface and the growing actin tail
(210), normally colocalize with actin filaments in focal contacts
and in dynamic membrane processes (515, 538). VASP and
Mena belong to the Drosophila Enabled (Ena)/VASP family of
proteins, known to be involved in neural development. They
are organized into three domains, an EVH1 (Ena-VASP ho-
mology 1) domain, a proline-rich central domain, and an
EVH2 C-terminal domain. VASP has been shown to act as a
ligand for profilin, vinculin, and zyxin (88, 210, 319, 537). Thus,
by binding to ActA and profilin, VASP and Mena may estab-
lish a direct connection between intracellular Listeria cells and
the cytoskeletal components of the host cell (210, 367). The
EVH1 domain of the Ena/VASP-like proteins has been shown
to bind directly to the proline-rich motif FPPPP, repeated
three to four times in ActA, depending on the L. monocyto-
genes strain. This proline-rich ActA sequence is a novel
polyproline motif that mimics the natural interaction between
Ena/VASP proteins with their endogenous ligands in the focal
adhesion proteins zyxin and vinculin. VASP has also been
shown to interact with filamentous (F)-actin via its C-terminal
EVH2 domain (85, 367, 472). These data strongly suggest that
VASP may act as a bridge between polymerization-competent
profilin/actin complexes and ActA and between ActA and the
actin tail itself, thereby favoring assembly of the actin network
that is used for bacterial propulsion across the cytosol. How-
ever, profilin is not essential for listerial actin-based motility
(409), and the same is true for Ena/VASP-like proteins be-
cause, as indicated above, deletion of their ligand motif on
ActA does not prevent (although it does impair) listerial actin-
based motility.
A major clue to the mechanism by which ActA induces actin
polymerization came from recent experiments showing that the
N-terminal 264 amino acids of the protein interact with the
Arp2/3 complex, resulting in a dramatic increase in actin nu-
celation activity (690, 691). First identified in Acanthamoeba,
the Arp2/3 complex, which includes two actin-related proteins,
Arp2 and Arp3, caps pointed ends, cross-links actin filaments,
and has weak actin nucleation activity (403, 456). This complex
was shown to initiate actin assembly on the surface of Listeria
cells in a reconstituted cell-free system (689). The Arp2/3 com-
plex is activated by proteins of the Wiskott-Aldrich syndrome
protein (WASP)/Scar family, which connect the cytoskeleton
with the signaling pathways involved in the dynamic remodel-
ing of the actin framework (404, 562, 700, 704). It has been
demonstrated that the p21-Arc subunit of the Arp2/3 complex
binds to the C-terminal domain of Scar1 and the related
WASP. Strikingly, the N-terminal 264 amino acids of ActA, the
C-terminal p21-Arc-binding fragment of Scar1, and the C-
terminal fragment of WASP are similar in sequence, and all
increase the nucleation activity of the purified Arp2/3 complex
(404). Indeed, C-terminal fragments of Scar1 that bind Arp2/3
completely block actin tail formation and Listeria motility in
cell extracts and in cells overexpressing the corresponding
Scar1 constructs, although Listeria organisms are able to initi-
ate actin cloud formation. Motility is restored by adding puri-
fied Arp2/3 complex (419). Thus, Arp2/3 is clearly an essential
host cell factor for actin-based motility, and the major role of
ActA is probably to regulate the activity of this multiprotein
complex. Recent studies have demonstrated that the N-termi-
nal region of ActA plays a critical role in binding and stimu-
lating the nucleation activity of the Arp2/3 complex (514a,
626a, 708). Two domains in this ActA region (residues 56 to 76
and 92 to 109), with sequence similarity to WASP homology 2
domains, bind to actin monomers (708) (Fig. 6). A third N-
terminal domain (residues 115 to 150, in particular the posi-
tively charged motif 117-KKRRK-121), with sequence similar-
ity to the Arp2/3 homology region of WASP family proteins,
binds Arp2/3 and competes for this binding with the the WASP
family proteins N-WASP and Scar1 (514a, 708) (Fig. 6). It thus
appears that ActA uses a mechanism similar to that of the
endogenous WASP family proteins to promote Arp2/3-depen-
dent actin nucleation.
However, using pure proteins in solution with assembled
F-actin in the presence of ATP (the hydrolysis of which re-
leases free energy for actin assembly), Loisel et al. (389) dem-
onstrated recently that Arp2/3 in combination with VASP or
WASP is not sufficient for actin-based motility. Wild-type
movement was only reconstituted upon addition of capping
protein and actin depolymerizing factor (ADF or cofilin), pre-
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viously shown to be required for the depolymerization of actin
tails (564) and to increase the rate of propulsion of L. mono-
cytogenes in highly diluted, ADF-limited cell extract (86). In
accordance with these observations, a cofilin homology se-
quence similar to that in WASP family proteins has been iden-
tified in the N-terminal fragment of ActA and shown to be
critical for stimulating actin nucleation with the Arp2/3 com-
plex in vitro and for actin-based motility in cells (626a). These
data indicate that adequate turnover and the maintenance of
high levels of ATP-G-actin and profilin-actin are essential for
elongation of the actin tail and motility (389).
Gelsolin, a protein that caps barbed ends and severs actin
filaments and which concentrates behind motile bacteria, was
also shown to increase the length of actin tails and to support
higher intracellular velocities. However, unlike ADF, gelsolin
is not essential for Listeria motility (361). Loisel et al. (389)
also confirmed that neither profilin nor VASP is essential for
actin-based motility, although their absence causes the rate of
bacterial movement to decrease 3- to 10-fold. Similarly, the
actin filament cross-linking protein a-actinin, which is uni-
formly distributed over the actin tail (117), is not required for
movement, but in its absence there is an apparent lack of
rigidity in the actin tail and a greater tendency for bacteria to
drift in solution (389). These findings emphasize that while
relatively few proteins are sufficient to build the core of the
actin motor of L. monocytogenes, many other host cell proteins,
some with as-yet-unknown functions, may be involved in the
actin cytoskeletal processes that lead to ActA-mediated liste-
rial intracellular motility. Among these proteins is LaXp180
(506), recently identified using the yeast two-hybrid system
aproach and shown to colocalize with intracellular Listeria
cells. LaXp180 is a putative binding partner of the phospho-
protein stathmin, involved in the regulation of microtubule
dynamics. By immunofluorescence it was demonstrated that
stathmin also colocalizes with intracellular ActA-expressing L.
monocytogenes (506). The role in infection of these newly iden-
tified proteins that are recruited to the listerial cell surface
remains to be elucidated.
The motile force for intracellular bacterial movement is
thought to be provided by the continuous deposition of actin
monomers at the interface between the bacterial cell surface and
the growing tail of tangled actin filaments immobilized in the
cytosol that serves as a support structure for propulsion. To be
effective, this motion system requires that actin deposition occur
at only one pole of the bacterial cell, pushing it forward. This is
indeed the case, as shown by the fact that the actin tail extends
only from one end of the bacterium. This unidirectional actin
polymerization appears to be related to the asymmetrical distri-
bution of ActA on the bacterial cell. ActA accumulates at one of
the bacterial poles and is totally absent from the other (the newly
formed pole after bacterial division), which corresponds to the
leading edge of movement opposite the place where actin tail
formation occurs (341, 656). The basis of this polar ActA expres-
sion is not fully understood, but it clearly depends on the bacterial
cell cycle and septum formation. Recent experiments with S.
pneumoniae cells and polystyrene beads hemispherically deco-
rated with purified ActA have provided convincing evidence that
asymmetric distribution of ActA is indeed sufficient for direc-
tional actin assembly and movement (81, 631).
Because actin-based intracellular motility and intercellular
spread are crucial for Listeria virulence, it is not surprising that
the second pathogenic species of the genus, L. ivanovii, also
possesses these features (320). The actA gene from L. ivanovii,
i-actA, encodes a protein larger than ActA from L. monocyto-
genes. The similarity between the two proteins is also limited
(34% identity) (230, 348). However, ActA and i-ActA have a
similar overall structure (charged N-terminal region, central
region of polyproline motifs, and C-terminal membrane an-
chor region), and the functional domains required for actin
recruitment and VASP binding are also conserved (209). The
two proteins do indeed have the same function, and i-actA
restores actin tail formation in an actA mutant of L. monocy-
togenes (230). Remarkably, the ActA proteins are the only
polypeptides encoded by the central virulence gene cluster that
have the same function but a high degree of sequence diver-
gence between L. monocytogenes and L. ivanovii (see below).
Differences in the interactions of the two species with the
eukaryote host may have resulted in different selection pres-
sures for conservation of actA genes in L. monocytogenes and
L. ivanovii. Alternatively, actin-based motility may only require
a set of conserved functional modules correctly exposed in
space, the core protein carrying these modules tolerating sig-
nificant deviations and even the insertion of other species-
specific functional motifs. L. seeligeri has also been shown to
contain actA-homologous sequences (232). However, this spe-
cies cannot induce actin polymerization in mammalian cells
even if it is manipulated so that it can escape from the phago-
somes of infected cells (321). The avirulence of this strain may
have led to the mutational corruption of a protein with a
function that is no longer required.
Two other intracellular bacteria, Shigella flexneri and Rick-
ettsia spp., and vaccinia virus have similar mechanisms of in-
tracellular movement and cell-to-cell spread by continuous po-
lar actin assembly (38, 190, 231, 278, 389). Bacterially induced
actin polymerization has also been studied in great detail in S.
flexneri, and interestingly, the bacterial protein involved in this
process, IcsA, has no sequence similarity to ActA. IcsA also
has a polar distribution on the bacterial surface and induces
polar actin deposition but uses a different mechanism of actin
nucleation, involving activation of the Cdc42 effector WASP to
form a ternary IcsA-WASP-Arp2/3 complex (105a, 164). Thus,
it appears that ActA and IcsA have evolved convergently, with
both subverting the signaling pathway that controls actin cy-
toskeletal dynamics but by different strategies, accounting for
their structural differences.
Recently, evidence has been presented that ActA may also
be involved in the entry of L. monocytogenes into eukaryotic
cells, probably by recognition of an HSPG receptor (12). In-
deed, putative heparan sulfate (HS)-binding motifs, typically
consisting of clusters of positively charged amino acids with
interdispersed hydrophobic residues, have been identified in
the N-terminal region of ActA. One such motif is very similar
to the HS ligand of the Plasmodium circumsporozoite protein,
and treatment of target cells with a synthetic peptide contain-
ing this malarial HS-binding motif significantly inhibited liste-
rial attachment. In addition, by using CHO cells deficient in
HS synthesis, it was shown that the absence of ActA reduced
the binding and uptake of L. monocytogenes only in cells con-
taining this glycosaminoglycan. A family of HSPGs, the synde-
cans, are bound to cell membranes via a membrane-spanning
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core protein, colocalize with actin bundles at the eukaryotic
cell surface, and are thought to act as bridges between the
ECM and the cortical cytoskeleton (530, 710). It therefore
seems plausible that the interaction of ActA with an HSPG
receptor induces transmembrane signaling events leading to
cytoskeletal rearrangements and phagocytosis. Definitive con-
firmation that ActA plays a major role in L. monocytogenes
internalization by host cells has recently been obtained by
using an in-frame DactA mutant. Loss of ActA production in
this mutant resulted in a decrease in invasiveness of up to a
factor of 60 to 70 in epithelial cells, which was fully recovered
upon complementation with the actA gene (Sua´rez et al., sub-
mitted for publication).
Although it is a major surface-exposed virulence factor, ActA is
not presented by either MHC class I or class II molecules. This is
only achieved if ActA is manipulated so that it is delivered in
soluble form to the cytosolic MHC class I-processing compart-
ment. However, the CD81 CTLs so elicited against the listerial
surface protein are not protective in vivo (120).
Internalins
Internalins are the protein products of a family of virulence-
associated genes found in pathogenic Listeria spp. The first
members of this family to be characterized, InlA and InlB,
encoded by the inlAB operon, were identified in L. monocyto-
genes by screening a bank of transposon-induced mutants for
impaired invasiveness in Caco-2 cell monolayers. InlA was
shown to function as an invasin, mediating bacterial internal-
ization by these normally nonphagocytic epithelial cells, and
was therefore named internalin (193). A large number of in-
ternalin homologs have since been identified in both L. mono-
cytogenes and L. ivanovii (150, 168, 169, 527) (Fig. 7). An
element common to all internalins is a leucine-rich repeat
(LRR) domain consisting of a tandem repeat arrangement of
an amino acid sequence with leucine residues in fixed positions
(317). The typical LRR unit of internalins consists of 22 amino
acids, with leucine or isoleucine residues at positions 3, 6, 9, 11,
16, 19, and 22 (— —L— —L— —L—L— —N—I— —I/L—
—L). This sequence forms a novel, right-handed helix desig-
nated parallel b-helix, with a turn after every LRR unit, first
identified in the pectate lyase of Erwinia chrysanthemi (277,
705). The LRR domain is thought to be involved in specific
protein-protein interactions. LRR domain proteins are numer-
ous among eukaryotes, in which they are involved in a variety
of functions, such as cell adhesion, as is the case for decorin,
fibromodulin, and the glycoprotein Ibg, or receptor-ligand in-
teractions and signal transduction pathways, as is the case for
Trk, CD14, and the adenylate cyclase of Saccharomyces cerevi-
siae (337). LRR proteins are less frequent among prokaryotes
and most are virulence factors, like YopM of Yersinia pestis and
Yersinia pseudotuberculosis, IpaH of Shigella flexneri, and the
filamentous hemagglutinin of Bordetella pertussis (55, 264,
407). The occurrence in pathogenic Listeria spp. of a multigene
family of LRR-containing proteins is unusual among pro-
karyotes.
The internalins best characterized in terms of structure and
function are InlA and InlB. InlA comprises 800 amino acids,
which can be subdivided into two functional regions. The N-
terminal half of InlA contains, in addition to a signal peptide (a
feature common to all internalins), 15 LRR units (A repeats),
whereas the C-terminal half contains three longer repeat se-
quences (B repeats) and a cell wall anchor comprising the
sorting motif LPXTG followed by a hydrophobic membrane-
spanning region of approximately 20 amino acids and a few
positively charged amino acids (Fig. 7). This distal LPTXG
motif, like similar motifs in other surface proteins covalently
linked to the peptidoglycan in gram-positive bacteria, has been
shown to be responsible for the attachment of InlA to the
bacterial cell envelope in a process mediated by the enzyme
sortase (105b, 135, 179, 371, 465, 466, 590). InlB comprises 630
amino acids with seven LRR units in the N-terminal part (149).
The LPXTG motif and the hydrophobic tail are absent from
the C-terminal part of InlB. Instead, InlB has a 232-amino-acid
region consisting of tandemly arranged repeats about 80 amino
acids long, each starting with the sequence GW. This domain,
FIG. 7. Structure of the members of the internalin multigene fam-
ily from L. monocytogenes and L. ivanovii (reproduced with modifica-
tions from reference 358 with permission of the publisher with data
from Dominguez-Bernal et al. [unpublished data]). S, signal peptide;
B, B-repeats; C, Csa domain repeats C-repeat; D, D-repeats. See text
for details.
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known as the cell surface anchor (Csa) domain, is responsible
for the attachment of InlB to the bacterial surface (60). The
Csa domain mediates a novel mechanism of protein-bacterial
surface association in which InlB is partially buried in the cell
wall, interacts with the cytoplasmic membrane, and uses lipo-
teichoic acid as a ligand (313). This type of association appears
to be relatively weak, as significant amounts of InlB are found
in the supernatant of L. monocytogenes cultures and InlB is
released from the bacterial surface upon incubation in buffers
with high Tris-HCl concentrations (60, 455). Another surface
protein of L. monocytogenes, the putative autolysin/adhesin
Ami, also associates with the bacterial cell wall via a Csa
domain (313).
inlAB mutants are severely impaired in host cell invasion,
and both InlA and InlB have been shown to be required for
entry of L. monocytogenes into normally susceptible nonphago-
cytic cells in vitro (143, 149, 193, 196, 197, 242, 246, 385). The
invasion processes mediated by InlA and InlB are apparently
similar from a mechanistic point of view (of the zipper type
[417, 642]), but the two proteins follow different signaling path-
ways to achieve entry (see below). InlA and InlB are sufficient
to trigger internalization by appropriate host cells, as shown by
their ability to confer invasiveness on normally noninvasive
bacteria, such as L. innocua and Streptococcus faecalis, and to
induce the internalization of latex beads coated with the puri-
fied proteins (62, 63, 373, 455).
Functional analysis of InlA has shown that the N-terminal
region encompassing the LRR domain and the interrepeat
region is necessary and sufficient for bacterial entry into per-
missive cells (373). Monoclonal antibodies directed against the
LRR domain block InlA-mediated entry, indicating that this
structure is essential in the entry process (435). The host cell
receptor for InlA is E-cadherin, a calcium-dependent intercel-
lular adhesion glycoprotein composed of five extracellular do-
mains and a cytoplasmic tail (205, 703). This receptor was
identified by affinity chromatography on a column with co-
valently coupled InlA onto which a Caco-2 cell extract was
loaded. Definitive evidence that E-cadherin is a principal re-
ceptor for InlA was obtained by transfection experiments using
fibroblasts nonpermissive for invasion by L. monocytogenes;
expression of the gene of the chicken homolog of E-cadherin,
L-CAM, made these fibroblasts fully susceptible to invasion by
recombinant L. innocua expressing the inlA gene but not to
invasion by wild-type L. innocua or by a DinlA mutant of L.
monocytogenes (435). E-cadherin accumulates at the gap junc-
tions between intestinal epithelial cells but is also present over
the entire basolateral face of these cells, consistent with exper-
imental data showing that L. monocytogenes preferentially pen-
etrates polarized intestinal Caco-2 cells via their basolateral
surface (196, 650). E-cadherin is also present on the surface of
hepatocytes, dendritic cells, brain microvascular endothelial
cells, and the epithelial cells lining the choroid plexus and
placental chorionic villi, all of which are potential targets dur-
ing Listeria infection. The cadherin specific to the nervous
system, N-cadherin, does not promote InlA-mediated entry
(435), which correlates with the observation that direct inva-
sion of neurons by L. monocytogenes is not efficient (151).
However, certain sensory neurons seem to be permissive for
InlA-mediated internalization of L. monocytogenes because
they may express E-cadherin (146). InlA presumably interacts,
via its LRR region, with the first extracellular domain of E-
cadherin (372). This interaction leads to bacterial adherence,
but entry is mediated by the intracytoplasmic domain of E-
cadherin, which presumably leads to actin cytoskeleton rear-
rangement via a- and b-catenins (372a).
Upon contact with susceptible eukaryotic cells, InlB induces
membrane ruffling and tyrosine phosphorylation of several
proteins, including Gabl. Cbl, and Shc, implicated in mem-
brane localization and activation of the phosphatidylinositol
3-kinase (PI3K) p85/p110. This PI3K, known to be involved in
the control of the actin cytoskeleton, is stimulated by InlB,
resulting in activation of PLC-g1 and in increased levels of
phosphoinositide second messengers. Inhibition studies have
shown that p85/p110 PI3K does not participate in InlA-medi-
ated uptake but is indispensable for InlB-mediated phagocy-
tosis (45a, 296, 297). Met, a receptor tyrosine kinase which
physiologically serves as ligand for hepatocyte growth factor
(HGF), has been recently identified as a signaling receptor for
InlB. Interaction with InlB tyrosine phosphorylates the 145-
kDa subunit of Met, a binding partner of PI3K. Met-deficient
cell lines are unable to mediate InlB-dependent entry, suggest-
ing a major role for this receptor in L. monocytogenes invasion
(615a). Using affinity chromatography, a second receptor for
InlB has been identified in gC1q-R, the cellular ligand of the
globular part of the C1q complement fraction. Pretreatment of
target cells with soluble C1q or anti-gC1q-R antibodies im-
paired InlB-mediated entry, and transfection of the gC1q-R
gene in nonpermissive cells promoted internalization of InlB-
coated beads (61). However, gC1q-R lacks a transmembrane
domain, suggesting that it may function as a coreceptor rather
than a signaling receptor. As for InlA, the LRR region of InlB
is sufficient for entry into mammalian cells (62, 297). The X-ray
crystal structure of the InlB LRR domain has been recently
determined: it consists of an elongated structure resembling a
bowed tube with an extensive solvent-exposed surface area.
Three regions were identified as potential candidates for me-
diating protein-protein interaction: two were in the concave
face of the tube, consisting, respectively, of clusters of hydro-
phobic and negatively charged amino acids; the other was at
the tip and contained two calcium ions, which may serve as
bridging molecules in the interaction with host cell receptors
(412a).
Evidence indicates that InlA and InlB have different cell
specificities and may therefore play an important role in cell
and host tropism. Dramsi et al. (149) analyzed in detail the
effect of in-frame inlA and inlB deletions and corresponding
gene complementations in an internalin double mutant on L.
monocytogenes entry into various cell types. They showed that
InlA but not InlB mediates entry into human Caco-2 intestinal
cells and that InlB is necessary for invasion of murine TIB73
hepatocytes, whereas InlA is not. However, in the human he-
patocyte cell line HepG-2, both InlA and InlB were required
for internalization. More recently, the entry of L. monocyto-
genes into HUVECs and brain microvascular endothelial cells
has been shown to be dependent on InlB but not on InlA (157,
246, 247, 498). The available data indicate that the role of InlA
in invasion is restricted to E-cadherin-expressing cells, whereas
InlB mediates entry into a wider range of cell types from
various animal species, including certain epithelial and fibro-
blast cell lines, such as Vero, HEp-2, HeLa, CHO, L2, and
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S180 cells, as well as hepatocytes and endothelial cells (150,
246, 435, 455, 498). InlA has also been shown to contribute to
at least 50% of serum-independent phagocytosis by macro-
phages (584), indicating that at least one macrophage receptor
recognizes this listerial surface protein.
A major breakthrough in our understanding of InlA function
has been the recent discovery by Lecuit et al. (372) that a Pro
residue at position 16 in the first extracellular domain of E-
cadherin is critical for this interaction with InlA. The presence
of a Pro residue at position 16 of E-cadherin correlated with
permissivity to invasion of the host cell. Thus, cells expressing
mouse and rat E-cadherin, both of which have a Glu residue at
this position, do not allow InlA-dependent entry, whereas cells
expressing human E-cadherin, L-CAM, and guinea pig E-cad-
herin, with Pro16, are totally permissive to invasion by InlA-
expressing bacteria. A Pro163Glu substitution in human E-
cadherin abolished interaction with InlA, whereas replacement
of the Glu16 residue with a Pro in mouse E-cadherin resulted
in a gain of function (372). These findings are important in that
they are the first to identify a possible molecular basis for host
specificity in a bacterial pathogen. They also make necessary
reevaluation of the available experimental information on the
role of InlA and InlB in virulence, in particular, data obtained
from in vivo studies in mice and rats, in which no clear patho-
physiological role of the inlAB determinant could be identified
despite its proven involvement in cell invasion in vitro. In such
in vivo studies, for example, the inlAB locus has been shown to
affect only very slightly the persistence of L. monocytogenes in
mouse liver and not to be essential for the invasion of hepa-
tocytes in vivo (14, 149, 150, 197, 242, 385). Similarly, no role
for the inlAB-encoded internalins was detected in intestinal
invasion and translocation in mouse and rat ligated ileal loop
models (119, 523) or in the development of murine cerebral
listeriosis (589). Despite the different cell specificities of InlA
and InlB, a double DinlAB mutant was 10 times less invasive
than a single inlA mutant in Caco-2 cells, indicating that the
two internalins synergize to optimize invasiveness. Such syner-
gistic activity of InlA and InlB is also evident in human hepa-
tocytes, with DinlA, DinlB, and DinlAB mutations reducing the
rate of entry by factors of 2 to 5, 10, and 100, respectively (149).
However, the heterologous expression of inlB did not confer
on L. innocua the ability to invade murine hepatocytes (149). It
is therefore possible that the absence of InlA recognition by
E-cadherin in mouse tissues impairs the targetting of L. mono-
cytogenes to certain critical cell types in vivo, thereby prevent-
ing the appropriate interaction of InlB with host cell surface
receptors.
The study of Lecuit et al. (372) raises important questions
about the usefulness of the widely used mouse model, at least
for those aspects in which InlA and InlB are potentially in-
volved. Indeed, as described above, oral infection with L.
monocytogenes leads to invasion of the intestinal epithelium in
guinea pigs, which have the permissive type of E-cadherin, but
not in mice and rats, which express a Listeria-nonpermissive
isoform of the intercellular adhesion molecule.
The observation that InlB alone is not sufficient to mediate
entry of L. innocua into murine hepatocytes whereas comple-
mentation with the inlB gene restores full invasiveness to a
DinlAB mutant (149) clearly shows that other L. monocyto-
genes-specific products are involved in the interaction with host
cells. This is also indicated by the significant level of residual
invasiveness of inlAB mutants both in vitro (143, 150, 157, 196,
197, 247, 253, 385, 435) and, especially, in vivo (14, 149, 196,
242, 385, 589). It seems very likely that other members of the
Inl repertoire play a role similar to that of InlA and InlB in the
interaction with the eukaryotic cell surface. In addition to the
inlAB operon, six other genes encoding putative surface-asso-
ciated internalins (inlC2, inlD, inlE, inlF, inlG, and inlH) have
been identified in L. monocytogenes. These internalin genes are
distributed in three loci, two of which contain three internalin
genes each and correspond to a single internalin islet that has
presumably evolved differently in two isolates of L. monocyto-
genes serovar 1/2a (150, 527) (see Fig. 7 and below). All these
newly identified internalins have signal peptides and LRR do-
mains with various numbers of repeat units in their N-terminal
halves and, like InlA, an LPXTG motif at their C-terminal
ends, suggesting that they are covalently bound to the bacterial
cell wall. Deletion of the inlGHE gene cluster did not affect
entry into a number of mammalian cell lines, suggesting that
these internalins, unlike InlA and InlB, are not involved in
invasion. However, counts of the DinlGHE mutant in the liver
and spleen were 3 and 2.5 log10 units below those of the
wild-type parental strain, indicating that the missing internalins
are somehow important for host tissue colonization in vivo
(527). Deletion of the inlGHE-homologous inlC2DE gene clus-
ter and of the additional inlF gene identified in the other strain
also had no effect on entry into various cell types; however,
here the absence of these internalin loci did not affect the
bacterial counts in mouse organs (150). This, together with
evidence indicating that internalin gene homologs are also
present in the nonpathogenic species L. innocua (193), sug-
gests that members of this multigene family may have biolog-
ical functions not exclusively related to virulence.
All the above-mentioned internalins are large, cell wall-as-
sociated proteins which, until very recently (see below), had
been found exclusively in L. monocytogenes. Their genes are
preferentially expressed extracellularly and, with the exception
of the inlAB operon, are independent of the listerial virulence
regulator PrfA (75, 527). A new group of LRR proteins has
recently been identified in both L. monocytogenes and L. ivano-
vii. Structurally, they are very similar to the large internalins
but lack the C-terminal (B) repeat region, the LPXTG motif,
and the membrane anchor (Fig. 7). The internalin proteins of
this class are therefore generally smaller (around 30 kDa ver-
sus the 80 and 71 kDa of InlA and InlB, respectively) and are
released in soluble form into the culture supernatant. InlC
(167), also called IrpA (143), is the prototype of this group of
small, secreted internalins (167) and is the only secreted in-
ternalin detected to date in L. monocytogenes. Unlike the genes
encoding the large, cell wall-associated internalins, all the
genes encoding these secreted internalins are PrfA dependent.
Indeed, this property was fundamental to the discovery of this
subfamily of internalins: InlC was identified in the culture
supernatant as a major 30-kDa protein that was overproduced
in L. monocytogenes after complementation with the prfA gene
in multicopy, which results in the artificial upregulation of
PrfA-dependent proteins (143, 167, 384). In L. ivanovii, five
PrfA-dependent secreted internalins (i-InlC, i-InlD, i-InlE, i-
InlF, and i-InlG) have been reported (168, 169, 350), three of
which (i-InlE, i-InlF, and i-InlG) are encoded in a large viru-
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lence gene cluster containing additional genes encoding se-
creted internalins (225; Dominguez-Bernal et al., unpublished;
see also below). Internalization and intracellular growth were
found to be similar for an L. monocytogenes inlC deletion
mutant and the parental wild-type strain when tested in several
cell types in vitro. The inlC mutation, however, resulted in
significantly lower virulence in mice (decrease in 1 log10 in the
bacterial load in organs) after infection by the intravenous or
oral route (143, 167). A significant loss of virulence in mice has
also been observed for the Di-inlE and Di-inlF mutants of L.
ivanovii (169). Like most PrfA-dependent genes (see below),
inlC is preferentially expressed in the cytoplasm, especially at
late stages of infection, when bacteria are in the process of
active intercellular spread (75, 167). This suggests that InlC
may be involved in the dissemination of infection. However,
cell-to-cell spread was found not to be affected in an inlC
mutant (143, 167, 246). No intracellular target has yet been
identified for InlC, and the role in virulence of the small,
secreted internalins remains unknown.
Other Virulence Factors
The listerial proteins reviewed so far are true virulence fac-
tors because they primarily accomplish tasks specifically re-
quired for parasitization of the vertebrate host and have
evolved exclusively in pathogenic Listeria species. In addition
to these virulence factors, other listerial products have been
identified that also contribute to survival within the host. Al-
though some of them have a major influence on the outcome
of the host-parasite interaction, their participation in patho-
genesis is more indirect, as they are probably involved in gen-
eral houskeeping functions also necessary for saprophytic life.
This does not exclude the possibility that some of these bac-
terial products may have evolved specific characteristics and
differ in certain aspects from their counterparts in nonpatho-
genic Listeria spp. as a result of adaption to the lifestyle of a
facultative intracellular pathogen.
p60 (iap). On agar plates, L. monocytogenes gives rise spon-
taneously to colonies with an altered, stable, rough phenotype.
These bacteria form long filamentous structures composed of
chains of individual cells (354). Although these rough mutants
produce wild-type levels of Hly, their virulence is attenuated
(288). This lack of virulence correlates with impaired invasive-
ness, particularly in fibroblasts (354). This invasion deficit re-
sults from a defect in the production of a major 60-kDa extra-
cellular protein, p60, that is found both in the culture
supernatant (354) and associated with the cell wall (570) and
which, when added exogenously, disaggregates the bacterial
chains and restores invasiveness (354). The p60 protein is en-
coded by the iap (for invasion-associated protein) gene, which
in L. monocytogenes encodes a 484-residue polypeptide con-
taining a central repeat region of Thr-Asn units (343). The
expression of iap is independent of PrfA (72, 75) and is con-
trolled at the posttranscriptional level (342). p60-homologous
proteins are synthesized by all Listeria spp., but in each species
there are specific differences in amino acid sequence that can
be used for identification purposes in PCR-based and immu-
nological assays (74, 77). Only the L. monocytogenes protein is
able to restore invasiveness to p60-defective rough mutants
(73). There is some experimental evidence supporting a role of
p60 in intestinal invasion and in vivo survival (279, 282). A
recent study using recombinant p60 from L. monocytogenes has
shown that the protein binds specifically to Caco-2 intestinal
cells (499). The p60 protein has a murein hydrolase activity
required for normal septum formation and essential for cell
viability (702), which makes it difficult to determine the precise
role of p60 in virulence because iap mutations are lethal. It has
recently been shown that p60 is a major antigen in the protec-
tive response against L. monocytogenes (203, 204, 267).
Antioxidant factors. Macrophages become listericidal after
their immunological activation by cytokines such as IFN-g or
by engagement of complement receptor 3 during C3b-facili-
tated opsonic phagocytosis of L. monocytogenes (84, 115, 146,
181). Although it is unclear how macrophages kill intracellular
parasites such as L. monocytogenes, it is thought that the gen-
eration during the oxidative burst of reactive oxygen interme-
diates (ROI) and, via interaction of the superoxide anion with
nitric oxide (NO), reactive nitrogen intermediates (RNI) plays
a key role. In vitro experimental data indeed suggest that ROI
and RNI contribute significantly to the macrophage-mediated
killing of L. monocytogenes (28, 37, 57, 294, 483, 484). Some
studies suggest a major involvement of ROI (294, 454, 484),
whereas others indicate that both ROI and RNI are required
and may even act in synergy (3, 490). Iron is required for the
catalytic reactions leading to the generation of ROI and RNI,
and the correct intracellular homeostasis of this element has
been reported to be essential for adequate macrophage listeri-
cidal activity (181). In vivo, inducible NO synthase (NOS) has
been shown to be expressed during listerial encephalitis by
macrophages in microabscesses at the sites of active bacterial
multiplication (315). Inhibition of NO synthesis by a specific
NOS inhibitor was also found to exacerbate listerial infection
in mice (28, 56).
In spite of this evidence, catalase and superoxide dismutase
(SOD), enzymes that are produced by bacteria primarily to
detoxify the endogenous free oxygen radicals generated during
prokaryotic oxidative metabolism but which also play a key role
in counteracting the oxygen-dependent microbicidal mecha-
nism of the host during infection (175, 185, 256, 258, 445, 658),
appear to have only a minor involvement, if any, in Listeria
virulence. Thus, loss of catalase activity in an L. monocytogenes
transposon-induced mutant had no measurable effect on pro-
liferation in mouse organs (369). Studies of a cat deletion
mutant confirmed that catalase is not involved in L. monocy-
togenes virulence in the mouse model. This lack of a significant
role for catalase in pathogenesis is consistent with the reported
isolation of spontaneous catalase-negative L. monocytogenes
mutants from listeriosis patients (76, 165, 643). Similarly, loss
of SOD activity by deletion of the sod gene (65) led to at most
a slight decrease in the proliferation capacity of L. monocyto-
genes in vitro in mouse bone marrow-derived macrophages
(which exhibit a clearly detectable oxidative burst in response
to this pathogen) and in the organs of experimentally infected
mice. These effects were slightly more pronounced with a cat
sod double mutant (Brehm et al., unpublished data), indicating
that catalase and SOD may together provide some levels of
resistance to bacterial killing.
The insignificant protective role of catalase and SOD in
virulence is consistent with the kinetics of L. monocytogenes
populations within macrophages, with most bacteria being
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killed very rapidly (within 3 min) in the vacuolar compartment
after uptake (127, 533). It is also consistent with the particular
characteristics of L. monocytogenes intracellular parasitism, in
which bacteria multiply in the cytoplasm, a comparment where
toxic concentrations of ROI and RNI are unlikely to be
present, thereby rendering catalase and SOD activities unnec-
essary for bacterial survival. Indeed, in listerial intracellular
parasitism, only a small percentage of bacteria need to survive
destruction in the phagosome and reach the cytoplasm to ini-
tiate a productive infection (128). For this “minimal” survival,
Listeria cells may exploit other more specialized resources to
cope with oxidative stress, such as stress response mechanisms
(see below). Microbicidal mechanisms other than the produc-
tion of ROI or RNI, such as lysosomal enzymes (270), de-
fensins (374, 469), and cytosolic antimicrobial peptides (283a),
may play a critical role in the host defense against Listeria
infection (262, 616), but nothing is known about the relevance
to pathogenesis of such oxygen-independent killing mecha-
nisms and the putative listerial factors that may counteract
them.
Metal ion uptake. Iron is a key element for all living cells,
including prokaryotic cells, serving as cofactor for a large num-
ber of enzymes and essential proteins involved in electron
transport processes. In animal host tissues, iron is not freely
available because it is sequestered by ferric transferrin in se-
rum and by ferritin and heme compounds within cells. Thus,
bacterial pathogens have evolved specialized mechanisms to
capture iron for growth in host tissues, and these mechanisms
play an important role in virulence (502a). In L. monocyto-
genes, iron not only stimulates growth in synthetic medium but,
if administered to infected mice in salt form, also increases
bacterial proliferation rates in the liver and spleen and de-
creases the LD50 (639, 644). In humans, hypersideremia after
massive blood transfusions has been identified as an important
risk factor for listeriosis (594). Unlike many other bacteria,
Listeria does not seem to secrete extracellular iron scavengers
(siderophores).
Three different iron uptake systems have been described in
L. monocytogenes. One involves the direct transport of ferric
citrate to the bacterial cell by a citrate-inducible system (2).
Another system involves an extracellular ferric iron reductase,
which uses as a substrate naturally occurring iron-loaded cat-
echolamines and siderophores (2, 21, 111, 112, 133). The third
system may involve a bacterial cell surface-located transferrin-
binding protein (263), although the existence of such a mech-
anism has been questioned (43). No experimental evidence is
currently available on the contribution of these iron uptake
systems to the pathogenesis of L. monocytogenes infection.
In addition to its role as an essential nutrient, iron is also
used by pathogenic bacteria as a signal molecule for the reg-
ulation of virulence gene expression. This sensory system is
based on the marked differences in free iron concentrations
between the environment and intestinal lumen (high) and host
tissues (low) (387). Expression of hly has been shown to be
induced in conditions of iron limitation, indicating that this
metal ion plays a role in the regulation of virulence gene
expression in L. monocytogenes (see below).
Recently, a P-type ATPase involved in copper transport,
CtpA, has been identified in L. monocytogenes. A ctpA knock-
out mutant was impaired in in vivo survival in tissues of in-
fected mice but had normal intracellular growth in HeLa and
J774 cell monolayers (182). Copper is a cofactor in a variety of
redox enzymes, such as SOD, that are involved in the disposal
by bacteria of toxic ROI generated during the oxidative burst
of macrophages (2a). However, the marginal implication of
SOD in L. monocytogenes virulence (see above) indicates that
the involvement of CtpA in pathogenesis may be more indirect
and related to the regulation of metal ion homeostasis.
Stress response mediators. As indicated above, a small pro-
portion of L. monocytogenes cells survive the stressful, hostile
conditions of the phagocytic vacuole and reach the cytoplasm,
where they proliferate, leading to the spread of the infection
(128). Survival under stress involves an adaptive response me-
diated by a set of conserved proteins that are upregulated in
vitro upon exposure to heat shock, low pH, oxidative agents,
toxic chemical compounds, starvation, and, in general, any
situation in which bacterial growth is arrested. These proteins
may be chaperones that assist in the proper refolding or as-
sembly of stress-damaged proteins or proteases that degrade
damaged proteins, ensuring that essential physiological path-
ways function correctly in stressed cells (229).
Analysis of the stress response of L. monocytogenes, includ-
ing that to heat and cold shock conditions, has revealed simi-
larities to that of other prokaryotes (24, 261, 507, 508). In
facultative intracellular pathogenic bacteria, for example, Sal-
monella, general stress proteins have been shown to be induced
upon infection of macrophages (78, 95). In L. monocytogenes,
in contrast, stress proteins appear not to be required for intra-
cellular proliferation. This has been shown by Hanawa et al.
(261), who found that none of the 32 listerial proteins selec-
tively induced in J774 macrophages infected for 5 h were the
same as any of the stress proteins produced when bacteria were
subjected to various environemental stresses. It has also been
shown that the alternative sigma factor sB is not involved in L.
monocytogenes virulence, although its expression is activated in
stress conditions and is required for osmotolerance (26, 695).
This may be explained by the particular characteristics of L.
monocytogenes intracellular parasitism, which develops mainly
in a nonaggressive environment, the host cell cytoplasm, much
less hostile than that of the phagolysosome in which Salmonella
bacteria proliferate. However, adaptation to sublethal environ-
mental stresses has been shown to protect L. monocytogenes
against the lethal action of toxic compounds (392), indicating
that in this bacterium there is a “stress-hardening” adaptive
response that may be important for survival in hostile condi-
tions. There is evidence that the adaptive response of L. mono-
cytogenes to acidic conditions, such as those encountered in the
stomach and in certain foods, may be relevant to pathogenesis.
Thus, development of acid tolerance results in increased inter-
nalization by Caco-2 cells and higher survival rates in lipo-
polysaccharide-activated macrophages (101a). Acid adaptation
also results in higher loads of L. monocytogenes bacteria in the
intestine and the mesenteric lymph nodes after oral infection
in mice (576a). Stressful conditions are also likely to be en-
countered during the transient residence in the phagolyso-
some. Consistent with this, the stress response of L. monocy-
togenes involves the induction of hly, which encodes the
principal factor involved in escape from the phagocytic vacuole
(634, 635) (see below).
Recently, a group of virulence-associated stress mediators
VOL. 14, 2001 LISTERIAL PATHOGENESIS AND VIRULENCE DETERMINANTS 611
 o
n
 February 18, 2014 by guest
http://cm
r.asm
.org/
D
ow
nloaded from
 
involved in intravacuolar survival and subsequent escape to the
cytoplasm have been identified in L. monocytogenes. All these
stress proteins have highly conserved counterparts in B. subti-
lis, in which they have stress tolerance-related functions and
are involved in the signaling cascade of sporulation. One of
these stress proteins is ClpC, an ATPase belonging to the heat
shock protein-100 (HSP-100)/Clp family, a class of highly con-
served proteins involved in stress tolerance in many prokary-
otic and eukaryotic organisms (585, 638, 684). The locus en-
coding this protein, clpC, was identified by Rouquette et al.
(569) by transposon mutagenesis and selection for iron-depen-
dent growth in synthetic medium. The original intention was to
identify genes involved in iron uptake (567). However, the
phenotype of the mutants isolated, the mutations of which all
mapped to the clpC locus, had nothing to do with iron metab-
olism but was instead related to a defect in resistance to the
nutritional stress caused by iron deprivation (569). clpC is
upregulated in heat shock conditions (42°C) and preferentially
expressed during stationary phase, a pattern consistent with
this gene’s being induced by general stress conditions. The
clpC mutants were found to be highly susceptible to several
stresses, including high temperature and high osmolarity in
addition to iron limitation. Their growth in bone marrow mac-
rophages and in vivo survival in the organs of infected mice
were also severely impaired, resulting in a substantial loss of
virulence (decrease of 3 log10 units in bacterial counts) (568,
569). Electron microscopy showed that clpC mutants remained
confined to the phagocytic vacuole, indicating either that ClpC
is involved in lysis of the phagosomal membrane (568) or, more
probably, that the loss of ClpC reduces bacterial fitness to the
extent that L. monocytogenes is no longer capable of surviving
within the phagosome or producing sufficient quantities of
active membrane-damaging virulence factors.
Expression of clpC was found to be almost abolished in an
L. monocytogenes prfA* mutant, in which the PrfA regulon is
constitutively overexpressed (see below), and in culture condi-
tions that trigger the activation of PrfA. This suggests that the
listerial virulence gene transcriptional activator protein nega-
tively controls ClpC. This repressor effect is apparently re-
leased as L. monocytogenes enters the stationary phase, indi-
cating that the stress-induced clpC-activating regulatory
pathways prevail over PrfA (548). No canonical PrfA boxes
(the binding site for PrfA in PrfA-regulated promoters) were
identified in the promoter region controlling the expression of
clpC, suggesting that expressional crosstalk between PrfA and
ClpC is mediated by an intermediary negative regulator acti-
vated by PrfA. Expressional interplay between a true virulence
determinant and a stress mediator has been described in other
facultative intracellular pathogens, such as Salmonella spp. In
these bacteria, the stress response mediator RpoS induces the
synthesis of the positive transcriptional regulator SpvR, which
controls spv plasmid virulence genes important for intracellular
survival and the development of systemic infection (95, 251). In
L. monocytogenes the situation appears to be the converse,
because activation of the central virulence regulator PrfA trig-
gers the downregulation of a general stress response effector.
As discussed above, these differences probably stem from the
differences in intracellular behavior of the two bacteria. Thus,
Salmonella organisms proliferate within a vacuole, presumably
a hostile environment in which stress proteins and virulence
factors involved in intraphagolysosomal survival would be si-
multaneously required. In contrast, Listeria cells rapidly escape
from the phagosome and actively multiply in the more permis-
sive environment of the host cell cytoplasm. The repression of
clpC by PrfA is entirely consistent with the observed activation
of the PrfA system when bacteria enter the cytoplasm (see
below) and with the nonrequirement for stress proteins for the
proliferation of L. monocytogenes in this cellular compartment
(see above). The coupling of PrfA activation with ClpC down-
regulation in L. monocytogenes is a good example of the clever
strategies that facultative intracellular pathogens have evolved
to coordinate gene expression and to ensure that genes encod-
ing factors superfluous at a given step of the infectious cycle
are appropriately turned off. It has been recently shown that
ClpC is required for adhesion and invasion of L. monocyto-
genes, possibly by modulating the expression of InlA, InlB, and
ActA (460a).
ClpE is, like ClpC, a member of the Clp family of HSP-100
stress proteins and is also required for prolonged survival at
42°C and involved in the virulence of L. monocytogenes (460).
A double clpC clpE mutant was found to be totally avirulent in
the mouse model and was readily eliminated from liver tissue.
clpE expression was found to be upregulated in a clpC mutant,
suggesting that ClpC and ClpE have redundant roles in stress
tolerance and that the absence of one is compensated for by
upregulation of the other (460).
ClpP is a 22-kDa protein belonging to a family of stress
proteases highly conserved in prokaryotes and eukaryotes
(198). Deletion of clpP showed that ClpP is required for
growth under stress conditions and for survival in macrophages
in vitro and in mouse tissues in vivo. In the clpP mutant, LLO
production was low under stress conditions, and virulence and
hemolytic activity were totally restored by complementation
with clpP. This suggests that the ClpP protease is important for
the observed stress-induced upregulation of Hly (see above).
ClpC, ClpE, and ClpP are regulated by CtsR, the first gene
of the operon including clpC (459). L. monocytogenes CtsR is a
homolog of the B. subtilis CtsR repressor of stress response
genes. A ctsR deletion mutant of L. monocytogenes displayed
enhanced survival under stress conditions and normal viru-
lence in mice, whereas a wild-type strain engineered to over-
express ctsR had significantly attenuated virulence, presumably
due to a restricted stress response (459). This is consistent with
CtsR being a negative regulator of Clp proteins. It would be
interesting to investigate whether repression of clpC is due to
PrfA-mediated activation of ctsR, resulting in silencing of the
CtsR-controlled stress response regulon.
Another locus that may be involved in stress tolerance and
virulence in L. monocytogenes has recently been identified.
This locus, lisRK, encodes a two-component system and was
identified in an acid-tolerant transposon-induced mutant of L.
monocytogenes. Deletion of the gene encoding the histidine
kinase component of this LisRK system, lisK, resulted in
greater resistance to acid and high ethanol concentrations in
the stationary phase and, apparently, also in lower virulence
(109). The mechanism underlying the phenotype of the mutant
is unclear.
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GENETIC ORGANIZATION AND EVOLUTION OF
VIRULENCE DETERMINANTS
Although plasmids have been reported in Listeria spp. (370,
504, 521), all the listerial virulence determinants identified to
date are chromosomally encoded. The virulence genes of Lis-
teria spp., as in other pathogenic bacteria, are mostly organized
into discrete genetic units known as pathogenicity islands
(PAIs). PAIs are presumably acquired by bacteria via horizon-
tal gene transfer, sometimes as part of mobile genetic ele-
ments, and consequently play a key role in the evolution of
bacterial virulence (49, 249, 259, 260).
Central Virulencee Gene Cluster
Six of the virulence factors responsible for key steps of L.
monocytogenes intracellular parasitism (prfA, plcA, hly, mpl,
actA, and plcB) are physically linked in a 9-kb chromosomal
island formerly known as the hly or PrfA-dependent virulence
gene cluster (88a, 350) and now referred to as LIPI-1 (for
Listeria pathogenicity island 1) (670a). Figure 8 shows the
physical and transcriptional organization of this “intracellular
life” gene cassette. The hly monocistron, encoding LLO, occu-
pies the central position in this locus. Downstream from hly
and transcribed in the same orientation is the lecithinase
operon, comprising the mpl, actA, and plcB genes (434, 672).
These genes are transcribed either as a single 5.7-kb mRNA
under control of the mpl promoter or as shorter transcripts,
one specific for mpl and the other starting at a promoter
immediately upstream from actA and covering the actA and
plcB genes and three additional small open reading frames
(ORFs). The plcA-prfA operon is located upstream from hly
and is transcribed in the opposite orientation, either as a bi-
cistronic mRNA of 2.1 kb or in monocistronic transcripts of 1.2
and 0.8 to 0.9 kb, respectively (187, 188, 433).
Phylogenetic analyses based on the sequence of the 16S and
23S rRNA have revealed that the genus Listeria comprises two
evolutionary branches, one relatively distant, corresponding to
L. grayi, and the other containing the remaining species. The
latter are in turn divided into two sublines of descent, one
comprising L. monocytogenes and the closely related nonpatho-
genic species L. innocua, and the other containing L. ivanovii
and the nonpathogenic species L. seeligeri and L. welshimeri
(98, 579) (Fig. 9). L. ivanovii, which has an intracellular life
cycle similar to that of L. monocytogenes (320), carries a copy
of LIPI-1 (232, 350, 670a) (Fig. 8). The genetic structures of
LIPI-1 from L. monocytogenes and L. ivanovii are identical, but
the corresponding DNA sequences exhibit only 73 to 78%
similarity (350, 670a), a degree of divergence compatible with
the genetic distance that separates the two species. One gene
of LIPI-1, actA, is specially dissimilar, reflecting a divergent
FIG. 8. Physical and transcriptional organization of the central virulence gene cluster (LIPI-1) of L. monocytogenes and structure of the locus
in other Listeria spp. Genes belonging to LIPI-1 are in grey, and the flanking loci are in black. Dotted lines above L. monocytogenes LIPI-1 genes
indicate known transcripts. LIPI-1 is inserted in a chromosomal region delimited by the prs and ldh genes, encoding the housekeeping enzymes
phosphoribosyl-pyrophosphate synthase and lactate dehydrogenase, respectively. In the plcB-ldh intergenic region, two ORFs, orfA and orfB, are
found in all Listeria spp., indicating that the insertion point of LIPI-1 is between the prs and orfB loci. In the plcB-orfB intergenic region of L.
monocytogenes, there are two small ORFs, orfX and orfZ (stippled), which delimit the putative excision point of LIPI-1 in L. innocua. In the
plcB-orfB intergenic region of L. ivanovii, two small ORFs, orfX (encoding a homolog of the orfX product from L. monocytogenes) and orfL
(stippled), are also present, which, like those in L. monocytogenes, delimit the deletion point of LIPI-1 in the nonpathogenic species L. welshimeri.
orfZ and orfL encode polypeptides with significant similarity to bacteriophage proteins (respectively Orf6 of the A511 Listeria phage and a
serine/threonine protein phosphatase from l [88a, 670a]), suggesting that LIPI-1 was originally acquired by phage transduction (see text for
details). The additional ORFs found in the L. seeligeri virulence gene cluster are hatched (the orfK product shows 39% similarity with the
phosphatidylinositol phospholipase PlcA and dplcB is a truncated duplicate of the plcB gene). The figure has been constructed using data from
references 88a, 232, 350, and 672 and unpublished results from J.K. (L. seeligeri) and B.G.-Z. and J.-A.V.-B. (L. ivanovii). (Adapted from reference
670a with permission of the publisher.)
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evolution in these two Listeria spp. This lack of similarity is also
reflected at the amino acid level (34% identity) even though
the corresponding ActA proteins have similar functions in ac-
tin-based motility (230, 348). LIPI-1 is absent from the ge-
nomes of the nonpathogenic Listeria spp. with one exception,
L. seeligeri (88a, 350, 670a). Although in this species LIPI-1
genes are present in a structurally intact form (232, 257), they
are not expressed correctly due to the insertion of a divergently
transcribed ORF (orfE) between plcA and prfA, disrupting the
positive autoregulatory loop crucial for adequate PrfA-depen-
dent virulence gene activation (321, 350) (Fig. 8) (see below).
The L. seeligeri LIPI-1 contains additional ORFs (orfCD) and
duplications of the plcA and plcB genes (350, 670a). In L.
monocytogenes, L. ivanovii, and L. seeligeri, LIPI-1 is stably
inserted at the same chromosomal position (Fig. 8), has a DNA
composition similar to that of the core genome, lacks any
obvious traces of mobility factors (integrases, transposases, or
insertion sequences [IS]), and its insertion point is devoid of
typical integration signals (direct repeats or tRNA genes) (88a,
350, 670a). These data are consistent with LIPI-1’s having been
acquired a long time ago by a common listerial ancestor (350,
670a).
It is clear that LIPI-1 provides the host bacterium with
access to a new niche, animal host tissues, which imposes
selection pressures totally different from those encountered in
the environment. The evolutionary history of the genus Listeria
can thus be interpreted such that the acquisition of LIPI-1 by
a clone of the primordial listerial ancestor was a crucial event
that led to separation of the genus into two different phyloge-
netic branches, one corresponding to bacteria that remained
saprophytic, resulting in the current species L. grayi, and the
other to bacteria which, by virtue of the intracellular life cas-
sette, became parasitic (350, 670a) (Fig. 9). It is reasonable to
assume that the outcome of LIPI-1 in each of the two lines of
descent of the parasitic branch also played a key role in the
further diversification of the genus, as follows: (i) stabilization,
in L. monocytogenes and L. ivanovii; (ii) early deletion (possibly
when LIPI-1 still had its original mobility functions), in L.
innocua and L. welshimeri; and (iii) functional inactivation, in
L. seeligeri (Fig. 9). The persistence of the LIPI-1 genes in
intact form in L. seeligeri is intriguing. Because these genes no
longer confer any virulence properties on the host bacterium,
one would expect them to be eliminated or corrupted during
evolution. One explanation for their conservation is that the
prfA-inactivating insertion was a relatively recent event in the
evolution of L. seeligeri, the additional ORFs present in LIPI-1
of this species representing subsequent gene insertions that
were tolerated by the afunctional PAI. Alternatively, the gene
cluster present in L. seeligeri may represent an ancestral form
of LIPI-1 which is still evolving and which, in its present form,
provides an advantage in a specific natural habitat other than
the mammalian host but which also requires phagosome es-
cape functions for survival (e.g., in protists that take up bac-
teria from soil) (350).
Two virulence determinants present in LIPI-1, hly and plcB,
have homologs which are exclusively present in low-G1C
gram-positive bacteria closely related to Listeria, such as Ba-
cillus and Clostridium. Homologs of two other LIPI-1 genes,
plcA and the thermolysin-related zinc-metalloprotease gene
mpl, are also common in this branch of gram-positive bacteria.
This clearly suggests that the source of LIPI-1 genes is within
the same phylogenetic division to which the genus Listeria
belongs. PrfA, a member of the Crp/Fnr superfamily of tran-
scription factors, is widespread in both gram-negative and
gram-positive bacteria (221). ActA is the only LIPI-1-encoded
protein for which no obvious structural homolog has been
identified yet in prokaryotes. ActA carries functional domains
present in eukaryotic proteins involved in the assembly of the
actin cytoskeleton, such as vinculin, zyxin, and the WASP fam-
ily of proteins (see above). It remains to be determined
whether this reflects convergent evolution or indicates horizontal
gene transfer between Listeria and eukaryotic cells. Whether
LIPI-1 was acquired in a single recombinational event or
whether it specifically evolved in the Listeria ancestor by a
stepwise assembly process also remains unclear. Recent se-
quence analyses of the prs-ldh intergenic region of L. innocua
and L. welshimeri have provided evidence that LIPI-1 was
indeed once present in the chromosome of these species and
that it became entirely excised, possibly in a single event, from
the chromosome of these bacteria. Consistent with this, two
small ORFs at the right end of LIPI-1 have been shown to
exhibit significant similarity to bacteriophage or viral proteins,
suggesting that the gene cluster (or at least part of it) was
originally mobilizable by phage transduction (88a, 670a) (Fig. 8).
Internalin Islands
Internalins belong to a multigene family exclusive to Listeria.
Except for the inlC and inlF genes of L. monocytogenes, the
members of this family are always found in clusters of two to
several genes, all oriented in the same direction (Fig. 10). The
largest of the known internalin islands is LIPI-2, a chromo-
somal locus specific to L. ivanovii which contains 10 inl genes
(see below). All inl genes have very similar sequences and
encode highly homologous proteins with variable numbers of
LRR repeats and, in the case of the large, surface-associated
internalins, B and Csa (or GW) repeats. These repetitive DNA
sequences are naturally prone to recombination, suggesting
FIG. 9. Evolution of the central virulence gene cluster (LIPI-1) in
the genus Listeria. The presence of LIPI-1 at the same chromosomal
position in various species belonging to distinct evolutionary branches
of the genus suggests that the virulence gene cluster was acquired
before speciation (see text for details). Thick lines indicate the evolu-
tionary pathway followed by LIPI-1; solid arrows indicate conservation
of a functional LIPI-1 (in L. monocytogenes and L. ivanovii), whereas
the dotted lines with an open arrowhead indicate functional corruption
of the virulence gene cluster (in L. seeligeri). L. innocua and L. welshi-
meri presumably arose by excision of LIPI-1 in the corresponding
evolutionary branches. The dendrogram is a schematic reconstruction
of the phylogeny of Listeria according to references 98 and 579.
(Adapted from reference 670 with permission of the publisher.)
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that the diversity of inl genes on the listerial chromosome is the
result of gene duplications and intra- and intergenic rearrange-
ments. There is evidence for such recombination events in inl
genes. Comparison of the same internalin locus in two different
L. monocytogenes strains revealed a different gene organiza-
tion. The two strains shared only two structurally identical inl
genes (inlG and E), and two internalin genes present in one
isolate (inlC2 and inlD) (150) presumably recombined to gen-
erate a new internalin gene in the other (inlH) (527) (Fig. 10).
In L. ivanovii, a tandem fusion of two small, secreted internalin
genes in LIPI-2 has led to the generation of a hybrid gene
encoding a larger, secreted internalin, i-inlG (Dominguez-Ber-
nal et al., unpublished). (Fig. 7).
The origin of the inl genes is intriguing. LRR domains are
widespread in eukaryotic proteins but rare in bacterial pro-
teins, suggesting that they are a relatively recent acquisition by
prokaryotes. inl genes are also found in the nonpathogenic
species L. innocua (193; European Listeria Genome Consor-
tium, unpublished). The presence of members of the internalin
multigene family in Listeria spp. representing distinct phyloge-
netic branches of the genus suggests that inl genes were already
present in the common listerial ancestor and, consequently,
that evolutionarily they are probably as old as LIPI-1. How-
ever, inl loci have a different distribution, gene organization,
and location in the different Listeria spp. The inlG(C2D/H)H
internalin islet of L. monocytogenes is present between two
housekeeping genes (ascB and dapE) that are contiguous in L.
ivanovii and other Listeria spp. (350). Also, inlC of L. mono-
cytogenes is inserted alone, whereas its counterpart in L. ivano-
vii, i-inlC, is adjacent to another inl gene (i-inlD), and both are
inserted at a different place of the chromosome (168). Another
example is the large internalin island LIPI-2 of L. ivanovii,
which is inserted between two housekeeping genes that are
otherwise contiguous in L. monocytogenes. The analysis of the
insertion points of i-inlCD and LIPI-2 revealed that these two
loci are associated with tRNA genes (168, 225). tRNA loci are
commonly used as a target for integration of lysogenic phages
and other mobile elements (539) and are frequently found at
the insertion sites of PAIs in gram-negative bacteria (259, 260).
Consequently, inl genes have probably been not only transmit-
ted vertically during evolution but also exchanged by horizon-
tal transfer within the genus Listeria, possibly carried by
phages, which in these bacteria are abundant, have interspecies
infectivity, and are capable of DNA transduction (287, 338).
The conservation of such a repertoire of inl homologs in the
genome of pathogenic Listeria spp. must necessarily reflect that
each of the individual internalins plays a role in the biology of
these bacteria. It has been suggested that variability in the
exposed face of internalin LRR motifs is important to create a
variety of specific protein-protein interactions (412b). Consis-
tent with this notion, a direct involvement in receptor-facili-
tated invasion of permissive host cells has been demonstrated
for the LRR domains of InlA and InlB (62, 373) and a role in
cell and host tropism has been demonstrated for these interna-
lins (149, 372) (see above). In L. monocytogenes, genes encod-
ing large, surface-anchored internalins are abundant (150, 193,
527), whereas there seem to be very few genes encoding small,
secreted internalins (only one, inlC, has been identified to
FIG. 10. Internalin islands and islets of L. monocytogenes and L. ivanovii. The scheme shows the different gene arrangements found for the same
internalin locus in two isolates of L. monocytogenes, possibly resulting from rearrangements between inl genes (inlH presumably arose by
recombination of the 59-terminal part of inlC2 and the 39-terminal part of inlD [350, 527]). See text for details.
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date) (167). In L. ivanovii, the reverse seems to be true, with
many genes encoding small, secreted internalins and no genes
encoding large, surface-associated internalins (168, 169, 226;
Dominguez-Bernal et al., unpublished). It is therefore possible
that the different gene complements in these two Listeria spp.
and the structural diversity of the internalins they encode fa-
cilitate the recognition of a variety of host receptors and are
thus at least partly responsible for their different pathogenic
characteristics.
In line with this assumption is the recent discovery in L.
ivanovii of LIPI-2, a large (22 kb) gene cluster composed of
many small, secreted internalin genes and the smcL gene,
encoding the L. ivanovii SMase (225). LIPI-2 is specifically
present in L. ivanovii within the genus Listeria and may play a
significant role in the pathogenic tropism of this species for
ruminants. At least for the smcL product, there are indications
for such a role in host tropism, as it selectively lyses sphingo-
myelin-rich membranes (e.g., those from sheep erythrocytes)
(226) and promotes intracellular proliferation in bovine
MDBK cells but not in canine MDCK cells (225). Most of the
LIPI-2 inl genes are PrfA dependent, whereas smcL is abso-
lutely independent of PrfA and is transcribed in the opposite
orientation (226). This suggests that LIPI-2 was formed by the
insertion of smcL into a preexisting core of inl genes. The
smcL-encoded enzyme is homologous to the S. aureus b-toxin
and the B. cereus SMase (226), suggesting that the gene was
acquired by L. ivanovii via horizontal transfer from either of
these two low-G1C gram-positive bacteria. LIPI-2 has a
DNA composition significantly different from that of the ge-
nome of L. ivanovii and is unstable, leading to a 17-kb deletion
that affects the right part of the PAI. These characteristics,
together with the expressional subordination of most of its
genes to the LIPI-1-encoded PrfA protein, indicate that LIPI-2
is a more recent development that LIPI-1 in the evolutionary
history of the genus Listeria. Spontaneous LIPI-2 deletion
mutants are significantly impaired in virulence for mice and
sheep and exhibit altered organ tropism in the latter animals
(Dominguez-Bernal et al., unpublished).
REGULATION OF VIRULENCE GENE EXPRESSION
Evidence for coordinate regulation of virulence genes in L.
monocytogenes was first provided by the analysis of spontane-
ous and transposon-induced mutants that were noninvasive
and had a combined deficiency in hemolysin (Hly) and lecithi-
nase (PlcB) production (325). Genetic analysis of these mu-
tants revealed that they were affected in the expression of the
prfA gene, located immediately downstream from plcA in
LIPI-1 (Fig. 8) (228, 379, 433). Trans-complementation exper-
iments in these mutants and in a heterologous host, B. subtilis,
confirmed that the prfA gene product, a 27-kDa protein called
PrfA (for positive regulatory factor A), was required for the
expression of hly and the other genes of LIPI-1 (89, 188, 380,
433). Accordingly, PrfA2 mutants had a markedly higher LD50
in mice (around 3 log units) and were unable to grow in host
tissues (89, 433, 613). Spontaneous prfA deletion mutants arise
frequently in L. monocytogenes strains kept in laboratory con-
ditions. Indeed, the current type strain of the species, SLCC
53T (also called CIP 82110T and ATCC 15313), one of the
original strains isolated by Murray et al. in 1926 (458) (see
Introduction), is one such mutant (324, 380, 433).
PrfA, Master Regulator of Virulence
PrfA is the only regulator identified to date in Listeria spp.
which is directly involved in the control of virulence gene
expression. This protein is the main switch of a regulon includ-
ing the majority of the known listerial virulence genes. Some of
the members of the regulon, including LIPI-1 genes (with prfA
itself; see below) and several genes of the subfamily of secreted
internalins (e.g., inlC of L. monocytogenes and i-inlE of L.
ivanovii), are tighly regulated by PrfA; others, such as the inlAB
operon, are only partially regulated by PrfA (148, 167, 350,
385, 433, 544). However, the expression of some listerial viru-
lence genes is totally independent of PrfA, as is the case for the
SMase gene of L. ivanovii, smcL (226), and the inlGHE in-
ternalin locus of L. monocytogenes (527). There is evidence
that PrfA also negatively regulates some L. monocytogenes
genes, such as the stress response mediator gene clpC (548)
and the motility-associated genes motA (439) and flaA (544).
This suggests that PrfA has a more global regulatory role in L.
monocytogenes.
The deduced amino acid sequence of the PrfA protein shows
similarities (20% overall identity) to that of the cyclic AMP
(cAMP) receptor protein of E. coli (Crp, also known as CAP),
on the basis of which the listerial regulator has been included
in the Crp/Fnr family of bacterial transcription factors (347,
364). Crp/Fnr-like proteins have a role in virulence gene reg-
ulation in other mammalian and plant pathogens (221, 347,
694). Although most members of the Crp family of transcrip-
tion factors are from gram-negative bacteria, Crp/Fnr-related
transcriptional regulators have been also described in gram-
positive bacteria (298). The PrfA homologs encoded by the
prfA genes of L. ivanovii and L. seeligeri have a primary struc-
ture 80% identical to that of the L. monocytogenes virulence
regulator protein. In L. ivanovii, PrfA also plays a central role
in the coordinate regulation of virulence gene expression. In L.
seeligeri, virulence genes are not expressed, but complementa-
tion with the plcA-prfA bicistron from L. monocytogenes acti-
vates transcription of the seeligerilysin O (slo) gene, leading to
bacterial escape from the phagosome and intracellular bacte-
rial multiplication (321). This suggests that the avirulence of
this Listeria species is at least partly due to the insertion of the
divergently transcribed orfE between the plcA and prfA genes
(Fig. 8), resulting in a PrfA2 phenotype even if prfA is intact
and the corresponding PrfA protein is potentially active (see
preceding section). Whether the complemented L. seeligeri
strain is virulent has not yet been tested.
Two structural features that are important for Crp function
are also present at the corresponding positions in PrfA (Fig.
11). One is a helix-turn-helix (HTH) motif in the C-terminal
region (amino acids 171 to 191) which, as in Crp, mediates the
interaction of the protein with specific DNA sequences in
target promoters (612). These target sequences, called PrfA-
boxes, are 14-bp palindromes centered on position 241.5 rel-
ative to the transcription start site in PrfA-dependent promot-
ers (187, 437, 672) (Fig. 11). DNA footprinting experiments
have shown that PrfA binds in vitro to the PrfA-box (136). The
second structural feature of Crp that is shared by PrfA is a
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series of short antiparallel b-strands delimited by Gly residues,
which form a b-roll structure involving most of the N-terminal
half of the protein (residues 19 to 99) (Fig. 11). In Crp, this
structure forms the binding site for the activating cofactor,
cAMP (344). However, cAMP is not detected and is not known
to function as an intracellular messenger in gram-positive bac-
teria (291). Accordingly, most of the Crp residues involved in
cAMP binding are not conserved in PrfA, and the addition of
exogenous cAMP to L. monocytogenes does not lead to PrfA-
mediated transcriptional activation (673). The role of this pu-
tative b-roll structure in PrfA is currently unknown. Two other
functionally important regions of Crp, the D a-helix (amino
acids 138 to 155), involved in transmission of the allosteric
effect from the cAMP-binding N-terminal domain to the DNA-
binding C-terminal domain, and activation region 1 (residues
156 to 164), involved in Crp-RNA polymerase interaction with
class II promoters, are also particularly well conserved in PrfA
(Fig. 11). PrfA does have some features that are unique among
the members of the Crp-related family of transcriptional reg-
ulators, an additional HTH motif in the N-terminal region of
unknown function, and a 25-amino-acid extension at its C
terminus, which may form a leucine zipper (Fig. 11). Mutant
forms of PrfA lacking this putative leucine zipper motif were
found to be inactive (221).
Environmental Control of Virulence Gene Expression
Virulence factors are primarily required to colonize animal
tissues and to overcome the host defense mechanisms brought
into play during infection. Therefore, their synthesis outside
the host may represent a burden compromising the ability of L.
monocytogenes to survive in the natural environment and lim-
iting its potential for transmission. Evidence is accumulating
that L. monocytogenes has evolved signal-sensing and signal-
transducing mechanisms to exploit the diverse physicochemical
environments it may encounter to adapt virulence gene expres-
sion to the particular needs of saprophytic versus parasitic
lifestyles. Temperature is one such environmental variables.
Thus, PrfA-dependent transcription is weak below 30°C (envi-
ronmental temperature) but becomes induced at 37°C (body
temperature of warm-blooded animals) (124, 378, 544). The
mechanism underlying this thermoregulation is unknown.
An increase in temperature is, however, not sufficient for
maximal levels of transcriptional activation of prfA and the
genes of the PrfA-dependent regulon to be reached in L.
monocytogenes. Wild-type strains express PrfA-regulated genes
very weakly in rich media (e.g., brain heart infusion [BHI]) at
37°C, but transcription of these genes is strongly activated if
the bacteria are cultured in BHI supplemented with activated
FIG. 11. Structure of PrfA (A) and its target DNA sequences in PrfA-regulated promoters (B). See text for details. In PrfA, amino acid
coordinates correspond to the peptide sequence deduced from the prfA gene (position 1 corresponds to the Met residue of the first triplet), whereas
in Crp they correspond to the actual amino acid position in the primary structure of the native protein, which lacks the residue encoded by the
first triplet. Therefore, the amino acid numbering of Crp is shifted one position with respect to that of PrfA, and hence, position 144 of Crp, where
the Crp* mutation Ala3Thr lies, aligns exactly with position 145 of PrfA, where the Gly3Ser substitution leading to the PrfA* mutant phenotype
is located. In Crp, A to F designate the a-helical stretches of the protein and AR1 is activating region 1 (two other activating regions [AR2 and
AR3] are embedded within the b-roll structure). In PrfA, structures specific for this protein are in light gray. (B) N indicates any nucleotide.
(Adapted from references 66 and 221.)
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charcoal (543–545, 548). The presence of this absorbent does
not affect bacterial growth, indicating that the effect on viru-
lence gene transcription involves a signal-sensing regulatory
mechanism rather than a nutritional stress response due to
sequestration of essential nutrients (545). One possible expla-
nation for the “charcoal effect” is that activated charcoal ab-
sorbs a substance that is present in BHI but not in infected
tissues and that allows L. monocytogenes to detect that it is
growing outside an adequate host compartment. One such
substance might be iron, because low free iron availability
defines the environment of host tissues (387) and there is
evidence that hly expression is activated in conditions of iron
limitation (101, 113, 207). The specific binding of PrfA to
target sequences in the hly and actA promoters is also strongly
inhibited under high-iron conditions (51). However, charcoal-
treated BHI does not retain its virulence-activating properties
after removal of the charcoal by filtration (Novella et al., un-
published data), suggesting that the mechanism responsible is
not related to the sequestration of a component of the culture
medium.
Although the mechanism of charcoal-mediated activation of
virulence genes remains unknown, the charcoal effect clearly
demonstrates that signals from the growth medium play a
critical role in regulating the expression of the PrfA regulon. It
also shows that L. monocytogenes needs to sense a suitable
combination of environmental signals of physical and, possibly,
chemical nature to upregulate the PrfA regulon. This may
represent a fail-safe mechanism by which Listeria bacteria pre-
vent the expression of virulence genes in situations in which
they are not required even if the temperature rises above the
critical activation threshold. An induction of prfA and PrfA-
dependent virulence genes similar to that observed with char-
coal takes place when L. monocytogenes bacteria growing in
BHI are transferred to minimal essential medium (MEM) (54,
635). MEM does not support normal growth of L. monocyto-
genes (635), so it is unclear whether the virulence gene-activat-
ing effect is due to a sensory mechanism involving chemical
signals, a stress response to starvation, or both.
L. monocytogenes has been shown to respond to various
stresses, such as exposure to high temperature (42°C) and
oxidants or entry into stationary phase, by increasing, via in-
duction of prfA, the expression of a set of genes including hly
(634, 635). The upstream mediator involved in the activation of
prfA under stress conditions is unknown. Detailed transcrip-
tional analysis of the genes of LIPI-1 at 42°C revealed selective
induction of hly and plcA, transcription of the genes of the
lecithinase operon (mpl, actA, and plcB) remaining at basal
levels (Ripio et al., unpublished). This expression pattern is
identical to that observed if bacteria are confined within a
phagocytic vacuole (75). It is therefore possible that a transient
stress response involving the transcriptional activation of some
genes of the PrfA regulon (those requiring lysis of the phago-
cytic vacuole) takes place when Listeria cells are still confined
within the acidified phagosome, during the early stages of cell
infection after invasion (see below). A simple decrease in pH
to between 5.0 and 6.0 (i.e., the pH of acidified phagosomes)
reduces hly expression in vitro (30, 124), indicating that other
growth-arresting stress conditions found within phagosomes
may be required for the induction of hly and the synergistic
phagosome-disrupting virulence determinant plcA. It is also
possible that de novo synthesis of hly plays a lesser role in
phagosome disruption than acid-induced release of preformed
intracellular stocks of the toxin, as postulated for PlcB (416).
Although wild-type L. monocytogenes cells produce low to
undetectable levels of virulence factors in BHI, they are as
virulent in mice as prfA* strains (545), which overexpress vir-
ulence genes constitutively in vitro (see below). As described
above, wild-type strains can strongly induce PrfA-dependent
virulence genes, up to expression levels similar to those in
constitutive prfA* mutants, if grown with charcoal or in MEM.
These observations led to the suggestion that the high levels of
virulence gene induction reached by wild-type strains in vitro
upon exposure to charcoal or MEM may correspond to the
levels of expression required in vivo by L. monocytogenes to
survive and proliferate in infected host tissues (545). A recent
study has provided support to this hypothesis by showing that,
despite their differences in spontaneous levels of expression in
vitro, there is no significant difference in intracellular virulence
gene activation between a wild-type strain and a prfA* mutant
(75). Indeed, several PrfA-dependent virulence genes, such as
plcA (336), actA (54, 137, 451), and inlC (167), and PrfA
synthesis itself (540), have been shown to be highly induced
intracellularly. Investigation of L. monocytogenes intracellular
gene expression using the green fluorescent protein as a re-
porter revealed that the actA promoter is activated within 30
min to 1 h of infection. This activation depended upon the
ability of L. monocytogenes to reach the host cytosol, as it was
not observed in a Dhly mutant unable to escape from the
phagocytic vacuole (185). All these findings indicate that the
expression of prfA and PrfA-dependent genes is upregulated if
L. monocytogenes senses activatory signals specific to the host
cytosolic compartment.
Carbon Source Regulation of Virulence Genes
Fermentable carbohydrates cause a strong repression of vir-
ulence genes in L. monocytogenes (30, 67, 124, 444, 543). This
downregulation occurs only if the carbohydrate is added in
amounts sufficient to promote bacterial growth, suggesting that
the underlying regulatory mechanism is related to catabolite
repression (CR) (444). However, an L. monocytogenes mutant
lacking CcpA, a central mediator of CR in gram-positive bac-
teria, did not show any alteration in carbon source regulation
of virulence genes (29). Sugar-mediated repression affects not
only the divergently transcribed virulence genes, plcA and hly,
which have overlapping promoters, but also plcB, belonging to
another transcriptional unit with no immediate physical link to
plcA and hly and the promoter of which (PactA) is strictly
dependent on PrfA (50, 67, 544) (Fig. 8). This suggests that
repression is mediated by a trans-acting pleiotropic factor and
somehow involves PrfA. Fermentable sugars such as cellobiose
(336, 444, 541) and glucose (unpublished data) reduce PrfA-
dependent virulence gene expression without affecting the lev-
els of PrfA protein, indicating that this regulation is mediated
by a repressor mechanism that either reduces the activity of the
PrfA protein or blocks the binding of PrfA to its target pro-
moters. The repressor mechanism appears to be situated hier-
archically over the positive control pathway that activates the
PrfA virulence regulon (see below), because fermentable car-
bohydrates annulate the induction of virulence genes by char-
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coal treatment (67, 543). Control of the synthesis of virulence-
associated products by carbon source has also been reported
for other pathogenic bacteria, such as E. coli (STb heat stable
enterotoxin) (80), Actinobacillus actinomycetemcomitans (leu-
kotoxin) (449), and Pseudomonas aeruginosa (PlcH hemolytic
phospholipase) (575). Such a CR-like regulatory mechanism
therefore seems to be widespread among pathogenic bacteria,
suggesting that it may be important for the coordinate control
of bacterial virulence. The actual relevance of this regulatory
mechanism to the modulation of virulence expression in vivo is
presently unknown.
An interesting observation is that in strain NCTC 7973 of L.
monocytogenes, virulence gene expression was downregulated
by the b-glucosides cellobiose and arbutin but not by common
sugars, such as glucose, mannose, or fructose (67, 500, 501).
Although the behavior of NCTC 7973 is anomalous and there
is evidence that this strain has accumulated several regulatory
mutations (30, 67, 543), it suggests that sugars may use two
independent mechanisms to bring about virulence gene repres-
sion in L. monocytogenes, one responding to any carbon source
and another specific for b-glucosides. This is also suggested by
the recent characterization of a mutant derived from the wild-
type strain EGD, in which a clear uncoupling between glucose-
and b-glucoside-induced PrfA-dependent virulence factor ex-
pression was observed (67). In addition, PlcB production is
inhibited in NCTC 7973 by cellobiose and arbutin, but not by
salicin (67), indicating that repression by b-glucosides is a
complex phenomenon in which various sugar-sensing mecha-
nisms, with different substrate specificities, may be involved.
Recently, a 4-kb operon specific to L. monocytogenes, bvrABC,
encoding a putative b-glucoside-specific phosphoenolpyruvate-
sugar phosphotransferase system similar to that of the bgl and
arb operons of E. coli and Erwinia chrysanthemi and the bgl
regulon of B. subtilis, has been reported to be involved in
virulence gene repression by cellobiose and salicin (67). Tran-
scription of the enzyme II permease gene, bvrB, was found to
be induced by cellobiose and salicin but not arbutin, and a
bvrAB knockout mutation abolished the repression exerted by
cellobiose and salicin. b-Glucosides are unique to the plant
kingdom and are presumably abundant in decaying vegetation.
Thus, Bvr-mediated sensing of b-glucosides may allow L.
monocytogenes to recognize its presence in a soil environment
and consequently switch off virulence genes. It is presently
unknown how the the bvr locus triggers repression of PrfA-
dependent genes. Another locus possibly involved in regula-
tion of hly expression by cellobiose has also recently been
identified by transposon mutagenesis (292).
In contrast to glucose and other common fermentable car-
bohydrates, glucose-1-phosphate (G1P) (in general, any hex-
ose phosphate) efficiently stimulates the growth of L. monocy-
togenes without causing virulence gene repression (543). Sugar
phosphate utilization is not constitutive in L. monocytogenes; it
is a strictly PrfA-dependent phenotype that is coexpressed with
other virulence factors (e.g., Hly, ActA, and PlcB), suggesting
a role in pathogenesis. Consistent with this, the capacity to
grow on hexose phosphate as a sole carbon source is also
present in the pathogenic species L. ivanovi (as a PrfA-depen-
dent phenotype as well) but absent from nonpathogenic Liste-
ria spp. As previously mentioned, PrfA-dependent genes be-
come selectively activated in the cytoplasm of the host cell. In
this compartment, the sugar phosphates G1P and glucose
6-phosphate are available as exogenous carbon sources for
bacterial growth as a result of glycogen mentabolism. A role of
hexose phosphate uptake in Listeria intracellular proliferation
has recently been confirmed with the identification and mu-
tagenesis of the PrfA-dependent gene hpt, encoding a sugar
phosphate transporter (Chico-Calero et al., submitted for pub-
lication). The lack of repression of virulence genes observed
with hexose phosphates indicates that uptake of these sugars
bypasses the regulatory circuit responsible for triggering the
CR response.
Regulatory Mechanism of PrfA
The clearest evidence that PrfA is a functional homolog of
Crp was provided by the characterization of prfA* mutants of
L. monocytogenes (544). These mutants were first identified by
Ripio et al. (545) when testing a panel of L. monocytogenes
strains for Hly and PlcB production as markers of PrfA-de-
pendent virulence gene expression. Three different phenotypes
were observed (Fig. 12). Phenotype 1 was exhibited by most of
the strains tested and was characterized by low to undetectable
levels of virulence factor production in BHI and the capacity to
substantially (by 10- to 25-fold) increase this production upon
culture medium supplementation with charcoal. Phenotype 2
was exhibited by only a few strains and was characterized by
spontaneously high levels of virulence factor production and by
unresponsiveness to charcoal, the levels of virulence factor
production already being maximal. The third phenotype was
exhibited by only one strain (LO28) and was characterized by
intermediate levels of spontaneous Hly and PlcB production
on BHI and responsiveness to charcoal. It was concluded that
phenotype 1 corresponded to the wild type of L. monocyto-
genes and that phenotypes 2 and 3 represented mutant or
variant phenotypes (545) (Fig. 12).
All phenotype 2 variants were strains that had been kept
under laboratory conditions for a long time. Some were well-
known collection strains widely used in research on listerial
virulence, such as NCTC 7973 (Fig. 12) and the EGD Macka-
ness strain used in the laboratory of one of us (P.B.), originally
obtained from R. J. North at the Trudeau Institute and there-
after renamed EGD-A to prevent confusion with the wild-type
EGD strain currently used as a reference strain by the Euro-
pean Listeria Genome Consortium (545). Phenotype 2 variants
were probably introduced inadvertently into research as model
strains because their conspicuous hyperhemolytic phenotype
facilitated the selection of Hly2 mutants during early studies
on the role of hemolysin in Listeria virulence. Phenotype 2
variants arise spontaneously at a very low frequency from wild-
type strains during subculture in the laboratory and may be
induced by chemical mutagenesis (171, 326, 545). The prfA
genes in all phenotype 2 strains tested to date have a point
mutation at codon 145, leading to an amino acid substitution
(Gly3Ser) in the PrfA protein. Complementation studies have
shown that this mutation is responsible for the constitutive
overexpression of virulence genes exhibited by phenotype 2
strains (544).
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A PrfA protein with the Gly145Ser substitution renders the
virulence regulon insensitive to a variety of environmental re-
pressor signals, such as growth in rich medium, low tempera-
ture, and the presence of readily fermentable carbon sources
(30, 543, 544). Gly-145 of PrfA aligns with Ala-144 of Crp (544,
673), a position at which any bulkier substitution (e.g.,
Ala144Thr) results in a mutant Crp* protein that no longer
requires the cofactor cAMP to become transcriptionally active
(344) (Fig. 11). Like Crp* mutant forms, the Gly145Ser PrfA
protein has greater binding affinity for the specific target DNA
sequence (673). The Gly145Ser mutation also increases the
capacity of the PrfA-RNA polymerase complex to initiate tran-
scription in vitro (Vega et al., unpublished data). From these
observations, it has been suggested that PrfA functions via a
cofactor-mediated allosteric transition mechanism similar to
that of Crp and that the Gly145Ser mutation represents a
cofactor-independent PrfA* form that is “frozen” in an active
conformation (544, 673).
The regulatory model currently proposed for PrfA is de-
picted in Fig. 13. This model is based on two premises. The first
is that PrfA has two functional states, inactive and active, and
shifts from one to the other upon binding of a low-molecular-
weight cofactor, not yet identified, that transduces the stimulatory
environmental signals to the PrfA transcriptional machinery
(544, 673). Evidence for the existence of this PrfA-activating
cofactor has been obtained by the fractionation of bacterial
extracts on sucrose gradients, in which a low-molecular-weight
component seems to stimulate PrfA-target DNA complex for-
mation (221). The second premise is that PrfA is always
present, at least in minimal amounts, in the bacterial cyto-
plasm, which is also the case. prfA is expressed in two ways: (i)
under the control of growth-regulated promoters in the plcA-
prfA intergenic region, generating a monocistronic transcript
from which PrfA is synthesized in low but detectable amounts
even if bacteria are exposed to PrfA regulon-nonactivating
conditions (186, 187, 433, 540, 541, 673); and (ii) under the
control of a PrfA-dependent promoter in front of the plcA
gene, which generates a plcA-prfA bicistronic transcript (83,
186, 187, 433) (Fig. 13; see also Fig. 8), creating an autoregu-
latory loop which is critical for the adequate activation of prfA
(378, 433, 541, 543, 544, 673). In the model proposed, the levels
of virulence gene expression depend primarily on the func-
tional status of the PrfA protein. This in turn controls the
levels of prfA expression via positive feedback, resulting in
strong PrfA-dependent transcriptional activation due to a
rapid increase in PrfA in the active conformation, provided
that the intracellular levels of the environmentally regulated
stimulatory cofactor remain high (see the legend to Fig. 13).
This positive-control model is highly versatile and makes pos-
sible a fine-tuned adaptive response to rapidly changing envi-
ronmental conditions, such as would be encountered by L.
monocytogenes during its transition from free to parasitic life
and during passage across the various physiological barriers,
tissues, and compartments of the infected host. The model
provides a coherent explanation of all the available experimen-
tal data on PrfA regulation and is also compatible with the
possible existence of additional regulatory elements modulat-
ing the activity of PrfA or its interaction with the target DNA.
These elements include the so-called PrfA-activating factor
(Paf), a proteinaceous substance that may be a fraction of the
RNA polymerase and that facilitates the formation of the
PrfA/RNA polymerase/target DNA complex (50, 51, 136, 221),
and the putative mediators of carbon source regulation of
virulence gene expression (see above).
Fine Regulation of Virulence Determinants
A second level of regulation is provided by the differential
response of PrfA-dependent promoters according to the struc-
ture of their PrfA-boxes (Fig. 11). Binding affinity to PrfA-
boxes is affected by the number of nucleotide mismatches they
carry, becoming weaker as the sequence diverges from the
FIG. 12. Hemolysin (Hly) and lecithinase (PlcB) phenotypes of L. monocytogenes. (A and B) Sheep blood agar; (C) egg yolk agar. (A) Original
plate from which prfA* mutants of L. monocytogenes were first isolated and identified; the culture shows a mixture of colonies of the wild-type
isolate P14 (weakly hemolytic) and its spontaneous prfA* derivative, P14-A (strongly hemolytic) (see text and references 544 and 545 for details).
(B and C) Hly and PlcB phenotypes of L. monocytogenes (streaks 1, 2, and 3) compared with those of L. ivanovii (streak 4). 1, weak to undetectable
hemolytic and lecithinase activities typical of the L. monocytogenes wild type (clinical strain P37); 2, strong hemolytic and lecithinase activities of
prfA* mutant (strains P14-A and NCTC 7973); 3, intermediate variant phenotype found in strain L028, of unknown molecular basis (L028 has a
wild-type prfA); 4, strong hemolytic and lecithinase activities by L. ivanovii (clinical isolate P26); all the strains of this species characteristically
overexpress PrfA-dependent virulence genes to levels similar to those of prfA* mutants of L. monocytogenes.
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perfect inverted repeat. Promoters with perfectly symmetrical
palindromes (e.g., Phly and PplcA) are more sensitive and
respond more efficiently to activation by PrfA than those with
nucleotide mismatches (e.g., Pmpl, PactA/plcB, and PinlA)
(Fig. 11), which require larger amounts of the regulatory pro-
tein for full activation (53, 72, 186, 187, 544, 613, 698). This
complementary cis-acting regulatory mechanism appears to be
critical for the temporal and spatial expression of virulence
genes and consequently for the correct development of the
intracellular infectious cycle of L. monocytogenes. Early work
by Freitag et al. (186, 187) and Camilli et al. (83) using differ-
ent combinations of mutants affected in the monocistronic or
bicistronic expression of prfA demonstrated that transcription
of prfA from its own promoters in the plcA-prfA intergenic
region was sufficient to mediate escape from the phagocytic
vacuole and subsequent intracellular proliferation, but not to
mediate cell-to-cell spread, which required a functional auto-
regulatory loop. These observations suggested that small
amounts of PrfA synthesized during the early stages of bacte-
rium-cell interaction are sufficient to activate rapidly and fully
the high-affinity promoters of the hly and plcA genes, the prod-
ucts of which are involved in phagosome disruption. In con-
trast, activation of the low-affinity actA promoter, which directs
the expression of the actA and plcB determinants involved in
cell-to-cell spread, requires higher levels of PrfA, as provided
by induction of the bicistronic transcript in the cytoplasm.
Consistent with this, a recent study comparing wild-type bac-
teria with hly and actA mutants (which are confined in the
phagosome and host cell cytoplasm, respectively) has shown
that the PrfA-dependent membrane-damaging determinants
hly and plcA are predominantly expressed in the phagosomal
compartment, whereas the actA and mpl genes are selectively
induced in the cytoplasm of the infected host cell (75).
As described above, experimental evidence has recently
been obtained that PrfA synthesis is indeed activated in the
host cell cytoplasm, correlating with higher activity of the PrfA-
dependent plcA promoter that directs the expression of the
plcA-prfA bicistron (540). However, prfA* mutants, in which
PrfA-dependent expression is constitutively activated, are
highly cytotoxic for the host cell (unpublished data). This may
result from excess, unrestricted production of toxic virulence
factors such as Hly and the phospholipases. In other words,
activation of the PrfA system in the cytoplasm may be delete-
rious and incompatible with intracellular parasitism unless
modulated by additional regulatory mechanisms (especially
when L. monocytogenes reaches high intracellular population
densities after multiplication). prfA transcript levels are sur-
prisingly low within host cells (75), suggesting that a high
turnover of prfA mRNA may be a mechanism that helps limit
PrfA synthesis within host cells. The reported short half-life of
Hly (127a, 311, 677) and PlcB (415) in the host cell cytoplasm
may also play an important role in posttranslationally regulat-
ing the intracellular levels of cytotoxic virulence factors. This is
clearly suggested by the observation that, whereas the levels of
actA transcription in the host cell cytoplasm are only three
times higher than those of hly, the amounts of the correspond-
ing proteins are very different, with 70 times more ActA than
Hly (451). Additional negative control mechanisms acting at
the transcriptional level may also contribute to modulate prfA
expression within the host cell. For example, uptake of glucose
from the host cell cytoplasm may counteract, by carbon source-
mediated repression (see above), the stimulatory effect of the
FIG. 13. Model for the mechanism of PrfA-mediated regulation. This model predicts that PrfA can undergo an allosteric transition between
inactive (light gray) and active (dark gray) forms upon interaction with a low-molecular-weight hypothetical cofactor (see text for details). (A)
Resting PrfA system. There is no cofactor, and the PrfA protein is synthesized at low, basal levels from the monocistronic transcripts generated
from growth phase-regulated promoters in front of the prfA gene (small light gray arrow). (B) Activated PrfA system. If L. monocytogenes senses
a suitable combination of environmental signals (i.e., 37°C and cytoplasmic environment), the intracellular concentration of the cofactor increases,
leading to activation of the PrfA protein (a), which binds with increased affinity to the PrfA-boxes (black squares) in PrfA-regulated promoters
(b); the transcriptionally active PrfA form causes the synthesis of more PrfA (in active conformation) via the positive autoregulatory loop generated
by the PrfA-dependent bicistronic plcA-prfA transcript (c), thereby inducing the transcription of all PrfA-dependent genes (d) (dark gray arrows
represent PrfA-dependent transcripts; the empty rectangle on the right represents any PrfA-dependent gene). The PrfA regulon remains switched
on as long as the cofactor is present in the bacterial cytoplasm, but is rapidly switched off if the activating environmental signals cease and the
concentration of the cofactor drops. (Reproduced from reference 673 with permission of the publisher.)
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intracellular environment on PrfA function. Freitag et al. (186,
187) reported that in the absence of PrfA, transcription from
the two promoters immediately upstream from prfA is in-
creased, and deletion of the 235 region of one of these two
promoters (P2) (see Fig. 11 and 13), with a structure reminis-
cent of a PrfA-box, leads to higher levels of prfA transcription.
This suggests that, by binding to the plcA-prfA intergenic re-
gion, PrfA may short-circuit the autoamplification loop,
thereby downregulating its own expression. One study did not
confirm the existence of such a PrfA-mediated negative auto-
regulatory mechanism (613), but a more recent study has
shown that the transcription of a reporter gene under the
control of the P2prfA promoter is significantly repressed by
PrfA (72).
Some L. monocytogenes virulence genes, although part of the
PrfA regulon, can also be expressed independently of PrfA.
This may provide additional expressional characteristics im-
portant for the specific role of individual virulence factors in
pathogenesis. A clear example is the internalin operon, inlAB,
which is expressed from three promoters, two of which are
PrfA independent. The third promoter is PrfA dependent, but
its PrfA-box has two substitutions, resulting in a low binding
affinity and inefficient induction by the listerial virulence reg-
ulator (53, 136, 148, 613). This promoter configuration is ob-
viously responsible for the peculiar expression characteristics
of the inlAB operon, which, in contrast to other PrfA-regulated
loci, is significantly expressed during extracellular growth in
broth medium at 37°C and positively regulated by elevated
iron concentrations (i.e., PrfA-downregulating conditions) but
poorly expressed within the cell cytoplasm or in MEM (i.e.,
PrfA-activating conditions) (53, 75, 101, 167). This is consistent
with the role of the products of this operon, the internalins
InlA and InlB, as invasins mediating internalization from the
extracellular space and with no known involvement in intra-
cellular proliferation.
The hly gene, which is primarily PrfA dependent, has an
alternative means of expression via a weak PrfA-independent
promoter (141). This explains why L. monocytogenes prfA de-
letion mutants have weak hemolytic activity (141, 544) and
low-level expression of hly is detectable in L. monocytogenes in
conditions of PrfA downregulation, such as extracellular
growth in broth culture. As discussed earlier (617, 619), low
concentrations of exogenous Hly released by extracellular
bacteria may contribute to pathogenesis by triggering cell re-
sponses, and the PrfA-independent promoter of the hly gene
may be important in this respect.
HOST CELL RESPONSES TO INFECTION
Signal Transduction Pathways Associated with
Epithelial Cell Invasion
Little is known about the signaling cascades triggered by
Listeria organisms during entry into cells that are normally
nonphagocytic. InlB has been shown to be an agonist of the
lipid kinase p85/p110 (PI 3-kinase [PI3K], and the InlB-medi-
ated uptake of L. monocytogenes by Vero cells has been shown
to be associated with activation of the PI3K (296, 297). In
addition to InlB, this activation also requires tyrosine phos-
phorylation in the host cell, because uptake is inhibited by
genistein treatment, which blocks tyrosine-specific protein ki-
nases. The mechanism by which the PI-3 kinase mediates
uptake is unknown. However, the products of the reaction
catalyzed by PI3K, phosphoinositide-3,4-bisphosphate and
phosphoinositide-3,4,5-triphosphate, may directly interfere
with the actin cytoskeleton by uncapping the barbed ends of
actin filaments, thereby affecting cytoskeleton dynamics. In
addition to phosphoinositide-phosphates, leukotrienes are
also thought to be involved in L. monocytogenes signaling
during the invasion of epithelial cells. Nordihydroguaretic
acid, an inhibitor of 5-lipooxygenase activity, which gener-
ates leukotrienes from arachidonic acid, also inhibits the
invasion by L. monocytogenes of Hep-2 cells (430). However,
it is not yet known at which step of the putative signaling
cascade leukotrienes are involved, or whether the leukotri-
ene signal is initiated by InlA- or InlB-receptor interactions.
The treatment of various types of cell with the protein kinase
C (PKC) inhibitor genistein (or staurosporine) inhibits inva-
sion by L. monocytogenes, suggesting that PKC activity is crit-
ical for regulating the cytoskeletal changes necessary for liste-
rial uptake (253, 353, 648, 675). It has recently been reported
(648) that the invasion of HeLa cells by L. monocytogenes
activates not only ERK-1 and ERK-2, but also two other MAP
kinases (p38 and JNK) and the MAP kinase kinase MEK-1.
ERK-2 is also phosphorylated upon invasion by LLO-negative
mutants and is a downstream target of MEK-1. These data
suggest that MEK-1/ERK-2 activation is one step in the sig-
naling cascade leading to L. monocytogenes uptake by host
epithelial cells. ERK-2 activation is not sensitive to wortman-
nin treatment, showing that it is not a downstream event of
PI3K activation. Obviously, the PI3K and MEK-1/ERK-2 path-
ways may form two components of converging or independent
signal transduction systems required for L. monocytogenes in-
vasion. Another protein tyrosine kinase, pp60c-src, is clearly
activated during the entry of L. monocytogenes into epithelial
cells because specific inhibition of pp60c-src by herbimycin
blocks inlAB-dependent entry (664). Treatment of host cells
with TcdB toxins led to a dramatic breakdown of the normal
actin cytoskeleton but did not abrogate L. monocytogenes in-
vasion (or actin-based motility), indicating that the small GTP-
binding proteins of the Rho and Ras subfamilies are not in-
volved in the entry process (162).
The L. monocytogenes invasion process has been found to be
sensitive to treatment with cytochalasin D for all cell types
tested, demonstrating the importance of microfilaments for
internalization (194, 359). Several recent reports have demon-
strated that microtubules also play some role in invasion. The
uptake of L. monocytogenes by mouse dendritic cells, mouse
bone marrow-derived macrophages, and human brain endo-
thelial cells is sensitive to nocodazole treatment, which disrupts
microtubules (246, 253, 352).
Activation of NF-kB and Modulation of Host Gene
Expression in Macrophages
Differential gene expression in eukaryotic cells depends
largely on modification of the transactivating activity of induc-
ible transcription factors. NF-kB, which is involved in regula-
tion of the expression of many immunologically important
genes (622), is the prototype of a family of transcription fac-
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tors. NF-kB DNA-binding activity in response to L. monocy-
togenes infection has been studied in the macrophage-like cell
line P388D1 (272, 273), endothelial cells (330, 600), and epi-
thelial cells (271). A rapid invasion-independent increase of
the NF-kB RelA/p50 DNA-binding activity is observed in mac-
rophages within 10 to 20 min of addition of the bacteria.
Studies with in-frame deletion mutants have shown that NF-kB
is induced with biphasic kinetics upon L. monocytogenes infec-
tion. The first transient induction of NF-kB requires only the
adhesion of L. monocytogenes to the P388D1 cells. This induc-
tion also occurs upon infection with mutants of L. monocyto-
genes that have lost one or more of the known virulence genes
and involves lipoteichoic acid, a cell surface component of L.
monocytogenes. A second, permanent induction of NF-kB is
detectable after release of the Listeria bacteria into the cyto-
plasm of the host cell. This occurs exclusively with virulent L.
monocytogenes strains and requires the synthesis of the bacte-
rial phospholipases PlcA and PlcB in the infected host cell. It
has been speculated that DAG and CER, likely products of the
two enzymes (see above), act as second messengers in the
induction of persistent NF-kB activation.
The expression of cytokines upon treatment of mammalian
cells with L. monocytogenes or L. monocytogenes-derived prod-
ucts has been analyzed in many different cell systems. Infec-
tions were performed with defined cell populations, such as
mouse bone marrow-derived macrophages (BMM), macro-
phage-like cell lines, and complex mixtures of cells, like spleen
cell preparations (356, 357). We will briefly review some of the
studies and focus on those in which defined cell types were
used as hosts for L. monocytogenes.
Early studies by E. A. Havell (274–276) showed that murine
fibroblasts infected with L. monocytogenes produce significant
amounts of alpha/beta interferon (IFN-a/b) and IL-6 and that
mouse alveolar macrophages respond to L. monocytogenes in-
fection by producing IL-6 and TNF-a. Differences in the in-
duction of cytokine expression were assessed for macrophages
infected with live and killed L. monocytogenes-infected macro-
phages. Live and killed bacteria differ in IL-1, IL-6, and TNF-a
production (447, 709), whereas IL-12 is induced in vitro by live
and killed Listeria cells (94).
Using various well-defined mutants of L. monocytogenes, it
has been shown that viable bacteria rapidly induce IL-1a, IL-
1b, IL-6, and TNF-a mRNAs in the mouse macrophage-like
cell line P388D1, whereas killed bacteria induce only IL-1b
mRNA (355). Hly2 mutants are unable to induce IL-1a, IL-6,
and TNF-a but do induce IL-1b mRNA. The infection of
BMM with L. monocytogenes also induces the proinflammatory
cytokines (132). However, an Hly2 L. monocytogenes mutant
was found to induce the same types and amount of cytokines as
the wild-type strain, indicating that intracellular growth is not
necessary for the transcriptional induction of these cytokines in
BMM.
Not all the bacterial products mediating the induction of
cytokines upon L. monocytogenes infection have been identi-
fied. The bacterial cell wall polymer lipoteichoic acid has been
shown to induce the expression of the proinflammatory cyto-
kines IL-1a/b, IL-6, and TNF-a in BMM (353) and in human
monocytes (40). Nishibori et al. (474) analyzed cytokine gene
expression upon treatment of spleen cells with purified LLO.
Total spleen cell preparations containing macrophages and NK
cells responded rapidly with increases in the synthesis of IL-1a,
IL-6, IL-10, IL-12, TNF-a, and IFN-g mRNAs. By depleting
the cell preparations of either NK cells or macrophages, the
contribution and interaction of the two cell types to cytokine
production were assessed. It was found that IL-1a, IL-12, and
TNF-a were produced mainly by macrophages, whereas IFN-g
was clearly produced by NK cells stimulated by macrophages,
probably via TNF-a and IL-12.
The synthesis of cytokine receptor mRNAs in BMM infected
with L. monocytogenes seems to be regulated inversely to the
corresponding cytokines (132). TNF receptor type I and IFN-g
receptor are transcriptionally downregulated following the in-
fection of BMM with L. monocytogenes, whereas IL-1 receptor
type II mRNA is unaffected. In contrast, TNF receptor type II
expression is upregulated. The bacterial requirements for this
downregulation of cytokine receptor expression are unknown,
but the downregulation is specific for infection with L. mono-
cytogenes and was not found upon infection with nonpatho-
genic L. innocua strains.
Phagocytosis of L. monocytogenes is required for transcrip-
tional induction of the heat shock protein 70 (hsp70) gene in
macrophages. The synthesis of LLO seems to accentuate the
hsp70 response (598). In contrast, expression of the gene en-
coding MHC class II antigen I-Ab is downregulated upon
phagocytosis, at a time when the bacteria are still located
mainly in the phagosomal compartment (595). Again, LLO
seems to be important for this host response. Another impor-
tant host cell gene that is downregulated on infection of mac-
rophages by L. monocytogenes encodes antigen H-2K, a major
component of the class I MHC molecule. Unlike downregula-
tion of the gene encoding antigen I-Ab from the class II MHC,
this event requires not only LLO, but also the expression of
one or more genes of the listerial lecithinase operon (595).
Host Responses during Infection of Endothelial Cells
Host cell responses elicited in endothelial cells during infec-
tion or by treatment with listerial exotoxins include lipid sec-
ond-messenger generation (617, 618), NF-kB activation (330,
600), stimulation of cytokines and chemokines, and induction
of cell adhesion molecule expression (152, 153, 247, 330, 351,
699). HUVECs were shown to respond to L. monocytogenes
infection or treatment with purified LLO by increasing phos-
phoinositide metabolism and inducing the production of the
vasoactive inflammatory mediators platelet-activating factor
and prostaglandin I2. This LLO-triggered second-messenger
induction is further stimulated by the phospholipase PlcA,
which acts in synergy with LLO (see above). It has been spec-
ulated that the pore-forming activity of LLO might facilitate
the uptake of PlcB by the HUVECs, resulting in DAG and
inositol phosphate generation (617). Listerial phospholipase-
mediated increased levels of CER were also found in
HUVECs during L. monocytogenes infection. This increase is
followed by an elevation in the activity of the transcription
factor NF-kB (152, 600). The cell adhesion molecules for
which expression was analyzed in L. monocytogenes-infected
HUVECs and BMECs include E-selectin, P-selectin, VCAM-1,
and ICAM-1 (152, 153, 351, 699). P-selectin expression peaked
30 to 60 min after infection, whereas the induction of E-
selectin, ICAM-1, and VCAM-1 started 4 to 8 h postinfection.
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Cell adhesion molecule expression is partly dependent on
LLO expression (351). E-selectin expression and the concom-
itant induced adhesion of polymorphonuclear leukocytes to
HUVECs is particularly dependent on PlcA and PlcB synthesis
by L. monocytogenes. These data show that the phospholipases
are important virulence factors in the L. monocytogenes-endo-
thelial cell interaction, interfering with signal transduction
pathways mediated by lipid second messengers and causing
changes in gene expression (600). The expression of IL-6 and
IL-8 is also induced during the infection of HUVECs, but no
data are available concerning the bacterial requirements for
the induction of cytokine and chemokine expression upon in-
fection (247).
Apoptosis
L. monocytogenes has recently been shown to induce apo-
ptosis in hepatocytes (560), Caco-2 epithelial cells (662), and
dendritic cells, in which it was also demonstrated that LLO is
the bacterial component triggering this event (252). L. mono-
cytogenes-infected hepatocytes undergo apoptosis in vitro and
in the infected mouse. It has been suggested that hepatocyte
apoptosis, which is linked to neutrophil recruitment, eliminates
infected cells rapidly from the tissue. Thus, apoptosis would
inhibit the spread of L. monocytogenes to the neighboring cells
and simultaneously would make the intracellular Listeria cells
accessible to effector cells. In dendritic cells, which are impor-
tant antigen-presenting cells, LLO-induced apoptosis should
result in lower levels of antigen presentation to immune cells,
thereby downregulating the immune response.
Figure 14 summarizes the information available on the sig-
naling cascades involved in the host cell response to Listeria
infection.
CONCLUDING REMARKS AND FUTURE
PERSPECTIVES
In the last 15 years, listeriosis has undergone a transforma-
tion from an infectious disease of limited importance to one of
the most topical food-borne infections and a source of major
concern for health authorities and the food industry alike. In
the same period of time, the work of various groups in Europe
and the United States has made the causal agent of this dis-
ease, L. monocytogenes, one of the best-characterized intracel-
lular parasites at both the molecular and cellular levels. One
particular aspect of the interaction between L. monocytogenes
and the eukaryotic host cell, the actin-based motility mediated
by the surface protein ActA, is today a true paradigm of cell
biology. Despite the major progress made towards understand-
ing the mechanisms of virulence of Listeria spp., our current
insight into the process of pathogenesis is still very partial and
fragmentary. We have unraveled fundamental details of the
FIG. 14. Summary of modulated signal transduction pathways and host cell responses identified during L. monocytogenes infection of murine
bone marrow-derived macrophages, murine P388D1 and J774 cell line macrophages, human Caco-2 and HeLa epithelial cells, mouse dendritic
cells, and human umbilical vein endothelial cells. Abbreviations: aSMase, acidic sphingomyelinase; gC1q-R, complement C1q receptor; Hsp70,
heat shock protein 70; Hsp90, heat shock protein 90; HSPG-R, HSPG receptor; ICAM-1, intercellular adhesion molecule 1; IFN-gR, IFN-g
receptor; IPx, inositolphosphates; LTA, lipoteichoic acid; MEK-1, mitogen-activated protein kinase kinase 1; Met, receptor tyrosine kinase for
HGF; MKP-1, mitogen-activated protein kinase phosphatase 1; PAF, platelet-activating factor; PGI2, prostaglandin I2; PIP2, phosphatidylinositol-
(3,4)-bisphosphate; PIP3, phosphatidylinositol-(3,4,5)-trisphosphate; PI-PLC, phosphatidylinositol-specific phospholipase C; SR, scavenger recep-
tor; TNF-RI, TNF receptor type 1; VCAM-1, vascular cell adhesion molecule-1. Reproduced with modifications from reference 357 with
permission of Elsevier Science.
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intracellular parasitism practiced by these bacteria and the
molecular determinants responsible for key stages in their life
cycle within the cells of the host. However, we know very little
about the mechanisms used by pathogenic Listeria spp. to pen-
etrate the organism, to cross the host’s physiological barriers,
and to interact with the target cells in which they proliferate,
causing disease. The same holds true for the strategies used by
Listeria spp. to resist and counteract the defense mechanisms of
the host for long enough after intestinal translocation to produce
invasive disease in the target organs. Only about 15 listerial ge-
netic determinants have been found to date to be associated with
pathogenesis, including true virulence genes and housekeeping
genes required for survival in the host. This number is very small
compared with the nearly 3,000 genes predicted for the 2.9-Mbp
genome of L. monocytogenes (438, 679; European Listeria Ge-
nome Consortium, unpublished). It is therefore clear that there
must be other, as yet unknown loci in the Listeria chromosome
that are required for the development of infection.
To date, studies of the molecular determinants of Listeria
virulence were mainly based on the analysis of mutants affected
in conspicuous phenotypes displayed under in vitro conditions.
The clearest illustration of this is the central virulence gene
cluster, which was discovered by genetic analysis of transposon
mutants affected in hemolytic and lecithinase activities, two
phenotypes easily detectable on agar plates. With hindsight, it
was a clear stroke of luck that the mutated hly and plcB genes
were located in the same chromosomal locus together with
other essential virulence genes such as prfA and actA. In other
cases, the in vitro phenotype used to identify potential virulence
genes during mutagenesis was a priori more directly related to
functions relevant to Listeria pathogenesis, such as loss of inva-
siveness in eukaryotic cells. The extensively studied inlAB operon
was identified in this way. However, although the inlAB products
have been clearly shown to have an invasin function in cell mono-
layers in vitro, no clear role for this locus in pathogenesis has been
demonstrated yet in infection models in vivo. This illustrates the
limitations inherent to the approaches used to date in the molec-
ular analysis of Listeria virulence, particularly when combined
with in vitro models of infection that do not necessarily reproduce
reliably the natural conditions encountered by L. monocytogenes
in the tissues of the host.
This scenario is likely to change radically in the immediate
future with the availability of the complete sequence of the
genome of L. monocytogenes. This will make it possible to shift
from an investigation largely based on reductionist analysis of
the role in virulence of individual microbial products in an
isolated form, to a holistic approach to Listeria pathogenesis.
In conjunction with appropriate in vivo expression technolo-
gies, which are beginning to be applied to Listeria spp. with
promising results (158, 192), the genomic approach will make
it possible to identify systematically the entire set of genes
required by L. monocytogenes for its survival and proliferation
in the various tissues and compartments of the host. The com-
parative genomic investigation of pathogenic versus nonpatho-
genic Listeria species, and of environmental versus epidemic
strains of L. monocytogenes, will lead to the discovery of new
pathogenicity determinants, providing us at the same time with
insight into the evolution of virulence in this bacterial genus.
Progress in human genomics will also make it possible to de-
fine the host components and processes engaged during Liste-
ria infection, as shown by a recent study in which cellular
responses to L. monocytogenes were monitored using oligonu-
cleotide microarrays (97a). Characterization of the expression
profiles of both the host cell and the pathogen at various stages
of the infection process will undoubtedly represent a quantum
leap in our understanding of host-microparasite interaction.
The shift towards genomic technology as the primary ap-
proach for analyzing the molecular determinants of Listeria
pathogenesis will not make reductionist strategies of investiga-
tion less important. Indeed, functional analysis of the genome
of L. monocytogenes will bring to light a growing number of
potential virulence factors, and the intimate mechanisms of
interaction of these factors with the molecules of the host will
still require investigation by the classical techniques of molec-
ular and cell biology. The importance of this reductionist ap-
proach is illustrated by the recent study by Lecuit et al. (372),
suggesting that the host tropism of L. monocytogenes may de-
pend on a single residue of E-cadherin, the cell receptor for
InlA. It has required the continuous efforts of various research
groups over several years to make the first steps towards elu-
cidating the molecular mechanisms of actin-based motility,
which involves only one Listeria protein. This indicates the
enormity of the task ahead of us if we are to understand in
precise molecular terms the way in which Listeria interacts with
its various vertebrate hosts to produce infection.
Fundamental research on Listeria molecular biology and
pathogenesis can be exploited in the rational design of novel
biotechnological tools to fight disase. The characterization of
the listerial intracellular life cycle and of the role that hemo-
lysin plays in it, together with the knowledge accumulated
concerning the immunobiology of experimental listeriosis in
the mouse, has made L. monocytogenes a most promising can-
didate as antigen delivery system for the development of novel
recombinant oral live vaccines (254). By its phagosome-dis-
rupting activity, Hly permits the antigens secreted by the pro-
ducer bacteria to be released into the cytoplasm and thus to be
presented by MHC class I molecules, inducing a cytotoxic
response useful for combating intracellular parasite infections
or tumoral disease (327). Indeed, successful vaccination of
mice using L. monocytogenes-based recombinant live vaccines
has been reported for several viral and tumor model systems
(183, 227, 293, 307, 418, 492, 496, 497, 614, 688). Recently, a
plasmid containing model antigen genes under the control of a
eukaryotic promoter and an endolysin gene from a Listeria
phage under the control of the strictly PrfA-dependent pro-
moter of the actA gene (which is selectively activated in the
host cell cytoplasm) were introduced into an L. monocytogenes
strain attenuated by a deletion in the lecithinase operon. Bac-
teria lysed upon entry into the cytosol and generated an MHC
class I-restricted immune response against the model antigens
expressed from the plasmid (137). These and similar experi-
ments (104) show that L. monocytogenes is also a good poten-
tial candidate for a vector to transfer DNA into eukaryotic
cells, of potential value for DNA vaccines or for gene therapy
(637). Increasing our knowledge of the molecular and cellular
mechanisms of listerial pathogenesis by genomic research will
make it possible to improve these Listeria-based biotechnolog-
ical tools by endowing them with optimal biosafety and target
cell specificity characteristics. Progress in Listeria genomics
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and comprehensive understanding of the complete physiolog-
ical pathways of L. monocytogenes may also enable us to iden-
tify targets for the development of novel antimicrobial agents
to treat listeriosis and other bacterial infections, or of inhibi-
tory substances for selectively controlling the survival and
growth of L. monocytogenes in foods.
We are still very far from completely understanding at the
molecular level how pathogenic Listeria spp. interact with the
host to cause infection. Many questions remain unanswered.
For example, what is the true role of the large internalin
multigene family in Listeria biology and pathogenesis? Why
does L. monocytogenes preferentially infect the CNS and the
placenta? Why is it that only certain serovars of L. mono-
cytogenes are associated with listeriosis and certain clones of
serovar 4b are associated with epidemic episodes of invasive
disease? Why do pregnant women develop neither meningo-
encephalitis nor septicemic disease while suffering miscarriage
due to Listeria infection? What mechanisms are involved in the
direct invasion of neighboring cells during cell-to-cell spread?
What pathways are involved in transduction of the signals
involved in the induction of phagocytosis during cell invasion?
In the coming years of the new era of postgenomic Listeria
research, we will certainly witness spectacular progress in un-
derstanding of the complex molecular mechanisms used by
these versatile bacteria to survive as parasites in the tissues and
cells of the vertebrate host, and we will no doubt find answers
to these and many other questions.
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